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ABSTRACT 
  Ranaviruses have been proposed as a major threat to amphibian biodiversity, 
however the impact of these pathogens on reptiles is less well understood. In this 
dissertation, a quantitative PCR was developed that was 100% efficient in detecting the 
54 bp segment of the major capsid protein of frog virus 3 (FV3) (Genus: Ranavirus; 
Family: Iridoviridae). This assay was used to estimate the prevalence of ranavirus 
infections in 606 eastern box turtles (Terrapene carolina carolina) from several different 
states. The overall prevalence of ranaviruses in this study population was 1.5% (95% 
confidence interval: 0.8 – 2.9%), with a non-significantly higher prevalence in juveniles 
(3.5%; 95% CI: 0.9 – 11.9%) than adults (0.5%; 95% CI: 0.1 – 1.8%). The low 
prevalence found in this population supports the theory that this virus is associated with 
acute disease and death. Clinical signs recorded in box turtles that were significantly 
associated with ranavirus infection were fractures and diarrhea.  In challenge studies at 
two separate environmental temperatures, red-eared sliders (Trachemys scripta elegans) 
inoculated through intramuscular injection with a FV3-like virus had higher mortality 
rates when maintained at 22
o
C than at 28
o
C, supporting the theory that this virus is less 
virulent at higher temperatures. FV3-like DNA was detected in whole blood, oral swabs, 
and cloacal swabs.  The sensitivity and specificity of detection in whole blood samples 
when compared to necropsy were 100%, while sensitivity and specificity in oral and 
cloacal swabs were found to be 83% and 100%, respectively. Skeletal muscle from 
injection site and kidney had the highest viral copy number post-mortem, while tongue 
had the lowest. Significant histopathological changes included fibrinoid vasculitis in all 
tissues. Clinical signs observed in experimentally inoculated red-eared sliders included 
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lethargy, conjunctivitis, oral plaques, oral ulcers, and injection site swelling. Hematologic 
changes were evaluated in both free-ranging box turtles and experimentally inoculated 
red-eared sliders. Red-eared sliders showed only one significant change, a reduction in 
total solids over time. Box turtles were non-significantly lymphopenic. Intracytoplasmic 
inclusions were identified in two infected red-eared sliders and one infected box turtle, 
but they were not consistently associated with ranavirus-status. Treatment of ranavirus 
with anti-viral therapy has been reported to have variably poor success, but was based on 
anecdotal dosing recommendations. Pharmacokinetic analysis of a single oral dose of 
valcyclovir demonstrated measureable levels, and may prove useful against this virus. 
The work presented in this dissertation provides new insight into the epidemiology of 
ranavirus in chelonians. 
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CHAPTER 1 
INTRODUCTION 
 
Wildlife are subject to an array of diseases that threaten their long-term sustainability. 
There are a number of factors that can influence the impact of these diseases on wildlife. 
Alterations in the environment, including habitat degradation, fragmentation, and contamination, 
can have a major impact on the epidemiology of wildlife diseases, especially at the human-
wildlife interface (Daszak et al., 1999; Fox, 2001; Holladay et al, 2001; Bhatia et al., 2005; 
Howsam et al. 2004).  Furthermore, ectothermic animals, such as reptiles, are dependent on 
environmental temperature for many physiologic and immunologic functions (Brown and 
Sleeman, 2002), making them more sensitive to environmental factors than birds or mammals 
(Donaldson, 2005; Ultsch, 2006). Because these different factors can influence the course of a 
disease, it is important to evaluate them when characterizing the epidemiology of a disease in a 
particular species of animal.   
Several terrestrial and aquatic turtles and tortoises (chelonians) are experiencing 
population declines across the world.  The International Union for Conservation of Nature 
(IUCN) redlist listed 32 chelonians as critically endangered, 44 as endangered, and 58 as 
vulnerable in 2011. It listed an additional species as conservation dependent and 36 as near 
threatened (van Dijk, 2011).
 
In 2011, 15 chelonians changed their redlist status, two were 
downgraded to critically endangered, four were newly listed as endangered, and four were newly 
listed as vulnerable; only 3 were upgraded to least concern (van Dijk, 2011).  Therefore, of the 
328 total species of chelonians in the world, 178 (53%) are listed with population stability as 
near-threatened or worse, including 8 species that are already extinct (Rhodin et al., 2010). 
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One species, the North American box turtle (Terrapene carolina carolina), has 
experienced significant population declines in numerous areas throughout its range, leading to its 
population status being downgraded in 2011 from near threatened to vulnerable (IUCN, 2011). 
Historically, North American box turtles have been used as sentinels of environmental health due 
to their wide distribution, small home range, and longevity (Sleeman, 2008, Donaldson and 
Echternact, 2005; Ultsch, 2006). A product of these investigations are reports of free-ranging box 
turtles being afflicted with different diseases, both infectious and non-infections in nature, that 
are affecting their population stability (Sleeman, 2008, Donaldson and Echternact, 2005; Ultsch, 
2006).    
Specific causes for the peril of box turtles have been attributed to human-induced factors 
including: road and mowing mortality, collection for the pet trade, nest depredation, prescribed 
burning, disturbance of nest sites by off-road vehicles, and habitat loss (Green et al., 2007; Lee, 
2007; Tarasan and Delis, 2007; Nazdrowicz et al., 2008).  Habitat encroachment and climate 
change can affect resource availability, which has been shown to delay sexual maturity and alter 
life cycle characteristics (Ernst et al., 1994).  These types of negative impacts are especially 
detrimental to long-lived, low fecund animals and could prevent population recovery from 
catastrophic disturbances, such as disease outbreaks (Budischak et al., 2006; Dodd and Dreslik, 
2008).  Therefore, the impacts of anthropogenic changes, such as global climate changes, 
suburbanization, and habitat fragmentation, may be considerable for box turtle populations and 
are worth further investigation.   
While a combination of factors is likely playing a role in the population declines of the 
box turtle, disease has been emerging across the eastern USA in chelonians.  There have been 
several investigations into the health of box turtles, including recent retrospective studies in 
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Virginia and Tennessee (Brown and Sleeman, 2002; Schrader et al., 2010). These and other 
investigations have identified trauma, aural abscessation, organochlorine exposure, 
mycoplasmosis, and Ranavirus infection as historic and current threats to box turtles (Brown and 
Sleeman, 2002; Schrader et al., 2010; Allender et al., 2006, 2011; Feldman et al.; Holladay et al., 
2011). Ranavirus has been emerging in several chelonian species across the United States 
(Allender, 2011 JMIH abstract). It is imperative to further evaluate morbidity and mortality 
events in box turtles to determine the cause and prevalence of this and other diseases and their 
potential role(s) in population declines. 
Several species of ranaviruses have been isolated during disease outbreaks.  Since 1991, 
over 70 epizootics involving ranaviruses in reptiles and amphibians have been reported in the 
literature (as summarized in this dissertation). These outbreaks have occurred throughout the 
world including North America (New Hampshire, Colorado, North Dakota, Minnesota, Utah, 
Maine, Idaho, Tennessee, Massachusetts, Wyoming, North Carolina, Arizona, Georgia, Florida, 
Pennsylvania, New York, Texas, Kentucky, Saskatchewan, Ontario), South America (Brazil, 
Venezuela, Uruguay), Europe (Croatia, United Kingdom, Spain, Portugal, Denmark, Germany), 
Asia (China, Japan), and Australia. The type species of the genus is frog virus 3 (Granoff, 1966); 
it is the only ranavirus shown to infect chelonians.  
 This dissertation aims to address key gaps in the epidemiology of ranaviral disease in 
chelonians.  The following objectives will be presented: 
1. Develop a quantitative (real-time) polymerase chain reaction (PCR) assay for detection of 
frog virus 3-like DNA in chelonians. 
2. Determine prevalence of frog virus 3-like virus in free-ranging eastern box turtles 
presented to rehabilitation and non-rehabilitation centers in the southeastern US. 
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3. Determine the clinical pathologic response to experimental frog virus 3-like infection in a 
red-eared slider (Trachemys scripta) model. 
4. Determine the survival rate and pathologic response to experimental frog virus 3-like 
infection in a red-eared slider (Trachemys scripta) model. 
5. Determine the earliest time of detection and progression of viral load of frog virus 3-like 
virus in whole blood, oral swabs, and cloacal swabs using the qPCR in a red-eared slider 
(Trachemys scripta) model. 
6. Establish the pharmacokinetic profile of a single dose of oral valcyclovir in healthy box 
turtles. 
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CHAPTER 2 
LITERATURE REVIEW 
 
Background 
 Wildlife diseases have been on the rise across the world (Daszak et al., 1999).  While 
some of these diseases receive a great deal of attention, such as of chytridiomycosis in 
worldwide amphibian declines, white-nose syndrome in North American bats, West Nile virus in 
birds, and Chronic Wasting Disease in cervids (Daszak et al., 1999; Conner et al., 2008; Lorch et 
al., 2011), others are poorly understood and require further study.  Disease events can have a 
dramatic impact on local populations, increasing as population size decreases (Daszak, 1999).  
Alarmingly, these disease events are likely underreported (Daszak, 1999) due to a lack of 
awareness, few long-term research studies, and a lack of disease monitoring in biological studies.  
Reptiles are not exempt from these factors, and often times there are fewer disease reports in 
these species than mammals or birds.  To fully appreciate the role of disease on wild reptile 
populations it is important to characterize the epidemiology of those diseases we do recognize. A 
disease that has been reported in numerous reptile species that possibly leads to population 
declines in herptiles and warrants further study are from the family Iridoviridae. 
  The family Iridoviridae consists of five genera and several unclassified species (ICTV, 
2011).  Chloriridovirus and Iridovirus are known to infect invertebrates, while Lymphocystivirus, 
Megalocytivirus, and Ranavirus affect ectothermic vertebrates including fish, amphibians, and 
reptiles (ICTV, 2011). They are large, icosohedral, DNA viruses that can be found in an 
enveloped or non-enveloped form. Diseases caused by viruses in the genera Ranavirus are a 
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growing concern in aquaculture, as well as free-ranging amphibian and reptile populations 
(Chinchar, 2002).  There are six recognized species in the genus Ranavirus including frog virus 3 
(FV3), Ambystoma tigrinum virus (ATV), Bohle iridovirus (BIV), Epizootic hematopoietic 
necrosis virus (EHNV), European catfish virus (ECV), and Santee-Cooper ranavirus (ICTV, 
2011). These viruses are found worldwide and cause significant morbidity and mortality in 
affected species (Williams et al., 2005). Recently, ranaviral disease was placed on the World 
Organization for Animal Health list of reportable diseases for amphibians (OIE, 2012).   
 There have been several reviews of iridoviruses, as well as reviews of amphibian and 
reptile diseases (Williams et al., 2005; Densmore and Green, 2007; Chinchar, 2009; Gray et al., 
2009; Duffus et al., 2010; Robert, 2010); however, there is a paucity of information on reptile 
iridoviruses. Because of these limitations, we must rely on knowledge of this virus in fish and 
amphibians to elucidate general virus ecology to help frame current and future research in 
reptiles. 
 
Epidemiology 
The discovery of FV3 was first reported in leopard frogs being studied for Lucke’s renal 
adenocarcinoma in the 1960’s (Granoff, 1966).  Since that time numerous outbreaks have 
occurred in both free-ranging and captive herpetofauna across the world (Table 2.1). Today, 
active monitoring of both free-ranging and captive animals is occurring on nearly every 
continent.   
Since 1991, over 80 epizootics involving ranaviruses in reptiles and amphibians have 
been reported in the literature (Table 2.1).  These outbreaks have occurred throughout the world, 
including North America (New Hampshire, Colorado, North Dakota, Minnesota, Utah, Maine, 
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Idaho, Tennessee, Massachusetts, Wyoming, North Carolina, Arizona, Georgia, Florida, 
Pennsylvania, New York, Texas, Kentucky, Saskatchewan, Ontario), South America (Brazil, 
Venezuela, Uruguay), Europe (Croatia, United Kingdom, Spain, Denmark, Germany, 
Netherlands), Asia (China, Japan), and Australia.  
 Various ranaviruses accounted for the epizootics, including FV3, ATV, soft-shelled turtle 
virus (STIV), BIV, and as of yet unclassified iridoviruses. FV3-like virus is the only virus 
identified in turtles in North America, and is also the most commonly reported iridovirus for 
anurans. ATV mainly affects salamanders in the western US, while BIV is the main ranavirus 
identified in Australia (Greer et al., 2009; Ariel, 1997). Outbreaks in amphibians have accounted 
for anywhere between 1 and 600 deaths during each outbreak, accounting for up to 90% 
mortality of a single population (Miller et al., 2011).  
A majority of the reported epizootics have involved amphibians, which include 70 
species from the following fourteen families: Ranidae, Bufonidae, Hylidae, Dendrobatidae, 
Plethodontidae, Cryptobranchidae, Hynobiidae, Myobatrachidae, Salamandridae, Alytidae, 
Ambystomatidae, Rhacophoridae, Scaphiopodidae, Leptodactylidae as summarized in Miller et 
al., (2011). High mortality is reported for most species during these outbreak investigations. 
Roughly 60% of the outbreaks involved larval amphibians, 30% involved adults, and 10% 
involved recent metamorphs (Green et al., 2002; Gray et al., 2009; Miller et al., 2011).   
Unfortunately, there has been a rise in the number of reports and cases in chelonians, and 
specifically box turtles (Terrapene sp.), in the US (Johnson et al., 2008; Allender et al., 2006, 
DeVoe et al., 2004). The cause of these increases is unknown, but may be due to an increased 
incidence or awareness, or improved testing methods and increased surveillance. Reptile species 
involved in these outbreaks include eastern box turtles (Terrapene carolina carolina), gopher 
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tortoises (Gopherus polyphemus), soft-shelled turtles (Trionyx sinensis), Burmese star tortoises 
(Geochelone platynota), green tree pythons (Morelia viridis), and leaf-tailed geckos (Uroplatus 
fimbriatus). Reptile outbreaks have mainly involved adult animals (Johnson, 2006).  Box turtles 
have been implicated in ten of the outbreaks, all occurring within North America (Allender et al., 
2011b; DeVoe et al., 2004; Allender et al., 2011a; Johnson et al., 2008; Ruder et al., 2008; 
Johnson et al., 2010).  Eastern box turtles have been observed frequently associated with 
ranavirus outbreaks and should be investigated. While eastern box turtles are primarily 
terrestrial, they have been shown to spend a considerable amount of time in temporary ponds 
(Donaldson and Echternacht, 2005), which may expose them to ranavirus through water. 
Additionally, juvenile turtles may be at higher risk based on other transmission studies and 
warrant further investigation. 
Ranaviruses have a wide species distribution, with significant differences in species 
susceptibility even within the same isolate (Schock et al., 2008; Hoverman et al., 2010). There 
are several species that appear uniquely sensitive to these viruses, including tiger salamanders to 
ATV (Greer et al., 2009), wood frogs to FV3 (Greer et al., 2005; Harp and Petranka, 2006; 
Schock et al., 2008), and eastern box turtles to FV3 (Allender et al., 2006; Johnson et al., 2006; 
Ruder et al., 2010).  
 Many reports indicate that larval amphibians in North America are more susceptible to 
mortality than adults, whereas adults are more commonly reported in European amphibians 
(Hoverman et al., 2010; Miller et al., 2011; Duffus et al., 2010; Robert, 2010).  In Dybowski’s 
frogs, both adults and tadpoles demonstrated mortality, although mortality in tadpoles (42.5%) 
was higher than adults (5.7%).  The mechanisms for the difference in mortality based on age/ life 
stage is unknown, but may be associated with undeveloped immune responses, entirely aquatic 
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lifestyles, feeding habits, or behaviors that result in density-dependent transmission (Robert, 
2010).  
Adult chelonians have been more commonly reported to develop FV3-like infections than 
juveniles (Johnson, 2006).  However, there are fewer overall reports in reptiles with FV3-like 
than amphibians, leading to the likelihood that adult reptiles are more likely sampled and 
diagnosed than juveniles. A current survey in eastern box turtles demonstrated a significant 
association between FV3-like positive animals and age (juveniles) (Allender et al., 2012a). In 
Australia, juveniles of two species of tortoise (Emydura krefftii and Elseya latisternum) were 
susceptible to BIV, while adult tortoises, juvenile crocodiles, and three species of snakes were 
not affected after experimental transmission (Ariel, 1997). Despite the lack of clinical signs, 
isolation of BIV was successful in an adult brown tree snake and indicates a permissible 
reservoir host (Ariel, 1997). Therefore, it is likely to consider that other ranaviruses, including 
FV3, may display the same juvenile predilection (e.g. high juvenile mortality and possible adult 
carriers) in reptiles that is observed in amphibians.  
Disease events in amphibians are often clustered into local epizootics, with significant 
impact on local populations (Miller et al., 2011). These epizootics have been scattered across 
numerous habitats and landscapes in the USA, and in some cases have occurred on an annual 
basis (Fox et al., 2006; Carey et al., 2009; Greer et al., 2009). In a multi-year survey of ponds 
that experience recurrent ATV outbreaks in tiger salamanders, prevalence ranged from 0% in one 
year to 57% in other years (Greer et al., 2009). Unfortunately, disease predictability outside these 
annual occurrences has not been successful. The effect of population stability in the face of 
ranavirus outbreaks has been debated. Several reports have concluded that ranaviruses are a 
threat to biodiversity within an ecosystem (Pearman et al., 2005; Gray et al., 2009; Teacher et al., 
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2010; Miller et al., 2011), while others suggest it can have a local population impact but does not 
lead to extirpation (Greer et al., 2008). In a retrospective analysis of population stability and 
ranavirus outbreaks in the UK, the authors observed an 81% decline in the number of adult frogs 
in infected ponds from 1996 to 2008, while comparative uninfected ponds showed no change 
(Teacher et al., 2010). Utilizing these same populations, the authors found that ranavirus 
infection could affect mate selection behavior, resulting in decreased relatedness and elevated 
homozygote excess, and concluded that this could serve as a detrimental, non-lethal impact of 
ranavirus infection on these amphibian populations (Teacher et al., 2009). During a transmission 
study of ATV in tiger salamanders, a species that has experienced significant mass mortality 
events in the western USA, it was observed that population density was a significant predictor of 
mortality (Greer et al., 2008). Animals in higher density populations had higher mortality rates 
and died more quickly, however, it was also observed that extinction events were unlikely 
because as mortality reduced density below a critical threshold remaining animals were able to 
recover (Greer et al., 2008).  This has been supported by field studies in Arizona (USA) that 
demonstrate a high number of salamander deaths, but not local extinction (Greer et al., 2009). In 
addition to lethal effects on amphibians, developmental instability (a measure of stress and 
overall quality of organisms) is more frequently observed in adult frogs, indicating possible non-
lethal effects on population stability (St-Amour et al., 2010). These examples suggest that the 
impact of the disease may be local or regional, and that it is a complex, multifactorial system that 
determines outcome. More research is needed to further elucidate the impact and role of this 
virus on amphibians. Investigations of landscape factors that increase ranavirus pathogen 
prevalence indicate that within-pond stressors are more important than vector movement (Gahl et 
al., 2008). Furthermore, high catchment (drainage basin) and headwater wetlands such as vernal 
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ponds were significantly associated with ranavirus larval mortality events (Gahl et al., 2008). 
Water conditions, including aluminum concentrations, temperature, and conductivity, have also 
been found to be associated with ranavirus outbreaks, but it was unclear if they increased the 
mortality events or were just associated with an outbreak (Gahl et al., 2010). The authors of that 
study concluded that each wetland will have a unique set of biological, chemical, and physical 
stressors that lead to mortality events (Gahl et al., 2010). Other authors have also found that 
environmental factors can have an impact on the epidemiology of ranavirus in amphibians.  
Greer and Collins (2008) found that ponds with less vegetation had higher prevalence rates; this 
was attributed to higher densities of larval amphibians at the edge of ponds seeking shelter and 
thereby increasing density-dependent transmission of the virus.  While that study was done under 
natural conditions, experimental transmission of the virus did not find similar results regarding 
animal density. Harp and Petranka (2006) found that mortality was > 98% in wood frogs infected 
with ranavirus under both laboratory and field mesocosm settings regardless of animal density. 
Virulence of the virus likely plays an important role regarding the epidemiology of the virus and 
was not evaluated in these two studies. Wetland restoration is a common technique to mitigate 
the effects environmental degradation, but long-term monitoring of these wetlands is lacking for 
most sites beyond 3 to 5 years (Petranka et al., 2006). During an eight-year study comparing 
reconstructed and natural ponds, ranavirus was significantly associated with increased juvenile 
survival that threatened long-term sustainability (Petranka et al., 2006). As more is learned about 
the epidemiology of this virus and long-term studies are performed on different cohorts, it will be 
possible to further decipher the role of landscape factors on the pathogenicity of this virus in 
amphibians. 
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 Most ranavirus surveillance programs utilize pathogen-based (PCR, virus solation) assays 
to confirm the presence or absence of the organism in an animal or its environment (Gray et al., 
2009); however, certain studies have utilized serologic (e.g., enzyme-linked immunosorbent 
assays [ELISA]) assays to determine exposure (and recovery) from ranaviruses in some animals 
(Johnson et al., 2010). Serologic surveys of ranaviruses in reptiles have been performed in only 
two studies (Ariel, 1997; Johnson et al., 2010). Both of these reports utilized ELISA to determine 
exposure in juvenile and adult animals. In a serologic survey of 1000 gopher tortoises in the 
southeast USA, the seroprevalence of FV3-like virus was 1.5% (95% confidence intervals [CI]: 
0.5-2.2) (Johnson et al., 2010).  In that same study, the prevalence of FV3-like virus in 55 box 
turtles was 1.8% (95% CI: 0.7-2.9) (Johnson et al., 2010). The authors suggested that antibody 
response against FV3 is low in North American turtles because the course of disease is short and 
the animals die before developing an effective and measureable antibody response. However, 
several species of adult reptiles tested in Australia demonstrated high levels of exposure, 
including tortoises (Ariel, 1997). The assay used in the Australian study identified exposure as 
reactivity to BIV-like proteins in the ELISA and not fully definitive for antibody presence (Ariel, 
1997). The low seroprevalence noted in the gopher tortoises and box turtles may have also been 
associated with the misidentification of the animals. The sensitivity and specificity of these 
assays was not described, but if the specificity of the assay was <96%, it is possible that the 
animals characterized as positives could have been false positives. This is important to consider 
because the theory that the seroprevalence was low because of the acute nature of the disease is 
based on these results, when in fact this may not be true if the animals were misclassified. 
Additional work is required to further determine the value of these assays in characterizing the 
status of exposed/infected reptiles.  
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Serologic surveys in amphibians are less common, but have demonstrated antibodies in 
the giant toad (Bufo marinus) on two continents (Zupanovic et al. 1998b). However, the 
significance of the findings is unknown in light of the fact that antibodies are not routinely 
produced early in infections and likely do not reflect the true prevalence.  
 Several of the reports of FV3-like infections in reptiles have been in captive animals 
(Marschang et al., 1999; DeVoe et al., 2004; Benetka et al., 2007; Johnson et al., 2008) (Table 
2.2). FV3-like infections were described in two juvenile diseased Hermann’s tortoises (Testudo 
hermanni) in Germany using PCR in which all seven animals in the group died with similar signs 
(Marschang et al., 1999). These tortoises were described with systemic disease that was 
characterized as hyperemia and ulcerations of the oral cavity of undetermined duration 
(Marschang et al., 1999). A leopard tortoise (Geochelone pardalis pardalis) with nasal 
discharge, stomatitis, and lethargy had a concurrent ranavirus and herpesvirus infection 
confirmed by PCR (Benetka et al., 2007). The animal received supportive care and recovered 
after four months (Benetka et al., 2007). A group of ten juvenile green tree pythons with chronic 
ulceration of the nasal mucosa, pharyngeal edema, and necrosis of the liver had a ranavirus 
isolated from pooled necropsy tissues that was 97% homologous to FV3 (Hyatt et al., 2002). A 
leaf-tailed gecko with granulomatous glossitis and hepatitis died unexpectedly and was 
diagnosed with a ranavirus (related to FV3) infection based on EM, restriction endonuclease 
assay, and sequencing (Marschang et al., 2005). Captive farmed reptiles are increasing in 
popularity in China, especially as a food source, and reports of ranavirus infections in soft-
shelled turtles are on the rise (Chen et al., 1999). 
Farmed amphibians are common in many countries, and recent outbreaks of ranaviruses 
have occurred in leopard frogs (Rana pipiens) in Brazil and Uruguay and Chinese giant 
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salamanders (Andrias davidianus) and pig frogs (Rana grylio) in China (Zhang et al., 2001; Galli 
et al., 2006; Mazzoni et al., 2009; Geng et al., 2011). Additionally, American bullfrogs 
(Lithobates catesbeianus) have suffered high mortality rates from ranavirus infections in a 
ranaculture facility in the US (Miller et al., 2007) and in Japan (Une et al., 2009). Larval or 
recently metamorphosed frogs were affected in both outbreaks (Miller et al., 2007; Une et al., 
2009). In Japan, the outbreak occurred over 45 days and included several thousand animals (Une 
et al., 2009). These patterns of age structure and short disease duration with high mortality are 
consistent with free-ranging amphibian outbreaks. 
 Reptiles have also been infrequently observed with unclassified or other genera of 
iridoviruses. These include a captive collection of moribund chameleons (Chamaeleo 
quadricornis and Chamaeleo hoehnelli) with an iridovirus that was characterized using electron 
microscopy (Drury et al., 2002). A case series involving two bearded dragons (Pogona vitticeps) 
and a chameleon (Chamaeleo quadricornis) identified an iridovirus with 97% homology to Chilo 
iridescent virus (genera Iridovirus) (Just et al., 2001). While these iridoviruses have not been 
associated with free-ranging reptile diseases, similar pathogenesis or immune response to these 
viruses may help to characterize the epidemiology of other iridoviruses, including ranaviruses, in 
reptiles. 
Additionally, there are several iridoviruses that have been observed within erythrocytes 
of reptiles; however, the clinical and epidemiological importance of these findings is unknown. 
A single fer de lance (Bothrops asper) with renal carcinoma had intraerythrocytic inclusions in 
conjunction with a regenerative anemia (Johnsrude et al., 1997). Acidophillic inclusions within 
erythrocytes were observed in nine flap-necked chameleons (Chamaeleo dilepsis) and a single 
Fischer’s chameleon (Bradypodion fischeri) in Tanzania (Telford and Jacobson, 1993). And 
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recently, a wild peninsula ribbon snake (Thamnophis sauritus sackenii) was observed with two 
types of erythrocytic inclusions that were identified as a distinct member of the Iridoviridae 
family based on PCR of the DNA polymerase gene segment that was amplified (Wellehan et al., 
2008). Further research is needed to determine the role of erythrocytic iridoviruses in 
epidemiology in captive and free-ranging reptiles. 
 Several reports exist in which surveillance of reptile and amphibian populations failed to 
demonstrate molecular evidence or exposure to ranavirus and are summarized below. Several 
species of frogs were negative for ranavirus exposure using ELISA on Dominica and Montserrat 
(Garcia et al., 2007). Additionally, non-clinical painted turtles (Chrysemys picta) and Blanding’s 
turtles (Emydoidea blandingii) did not show any PCR evidence of FV3-like virus (Allender et 
al., 2009.  A survey in Colorado that detected a high prevalence of chytridiomycosis in several 
hundred amphibians, failed to identify a single ranavirus positive case using culture or 
histopathology (Green and Muths, 2005). A survey of 111 amphibians from four different 
species collected in Pennsylvania found only a single positive case using virus isolation and PCR 
(Glenney et al., 2010). A survey of 300 anurans from Jersey Island, UK was done in an attempt 
to characterize ongoing declines of amphibian populations, and while ranaviruses were tested 
using PCR as part of the protocol, none were found (Loras et al., 2011). Studies in tropical areas 
have occurred with less frequency, but a study in Costa Rican amphibians failed to detect 
ranavirus in any sample (Picco et al., 2007). More cases of negative ranavirus results likely exist, 
but are not reported. These reports can be used to demonstrate that while ranavirus infections 
have been reported globally, there remain populations that are unaffected. The testing strategies 
used in these studies were based on confirming the presence of the pathogen (e.g., culture or 
PCR), and we would expect negative status in non-clinical animals. One exception is the study in 
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Jersey Island, UK where population declines were noted. The results from that study should 
affirm that amphibian declines can be associated with a number of different pathogens and/or 
environmental issues. These results also further support that affected free-ranging animals are 
likely lost to the disease before being detected, reinforcing that this virus is associated with an 
acute disease process.  Even in cases where captive animals are affected, clinical course of 
disease may be short with minimal signs, therefore it is even more critical that rapid diagnostic 
strategies are utilized in widespread assessments of vulnerable amphibian and reptile 
populations. 
  
Clinical signs and Pathology 
Amphibians, fish, and reptiles infected with ranaviruses share several common clinical 
and pathologic characteristics, including systemic disease with epithelial necrosis. While many 
reported infections lead to death prior to any premonitory signs (Gray et al., 2009; Miller et al., 
2011), there are examples of antemortem clinical signs described in all of the lower vertebrates. 
Fish with largemouth bass virus (LMBV) infections typically develop ulcerations of the skin and 
muscle (Deng et al., 2011). Skin ulcerations are also commonly seen in amphibians (Miller et al., 
2011; Cunningham et al., 2007b), although amphibians may also demonstrate systemic 
hemorrhages in the absence of skin lesions (Cunningham et al., 1996). Adult salamanders can 
develop abnormal swimming patterns and subcutaneous edema, while loss of pigmentation, 
lordosis, epithelial sloughing, and petechiation are reported in frogs (Tweedell and Granoff, 
1968; Docherty et al., 2003; Miller et al., 2011).  
In larval amphibians, erythema at the base of the tail, ventrum, and legs, as well as 
swelling of multiple areas of the body have been observed (Gray et al., 2009a).  Ecchymosis and 
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petechiation of the skin are common (Miller et al., 2011). The gall bladder may also be enlarged, 
but this is attributed to anorexia (Miller et al., 2011).   
Chelonians commonly develop nasal, ocular, and oral discharge, in addition to oral 
plaques (Allender et al., 2006; Ruder et al., 2010). Epithelial lesions are also observed in reptiles, 
but with less consistency (DeVoe et al., 2004). Poxvirus-like lesions have been described in 
bearded dragons and chameleons (Just et al., 2001). While a wide variety of clinical signs have 
been observed in reptiles, no study has investigated possible associations between clinical signs 
and infection. 
Pathologic findings in susceptible individuals are similar between adults and juveniles of 
both amphibians and reptiles (Miller et al., 2011; Johnson et al., 2007). Infections lead to 
systemic organ failure due to necrosis of epithelial cells of the spleen, liver, kidney, and 
intestines (Miller et al., 2009; Miller et al., 2011; Johnson et al., 2007). Hemorrhagic syndromes 
are common in anurans in the UK (Cunningham et al., 2007a) and in salamanders in western 
North America (Bollinger et al., 1999). Tiger salamanders (Ambystoma tigrinum) have been 
observed with polypoid lesions early in the course of the disease that progress to cover most of 
the body (Jancovich et al., 1997). There are also non-specific changes noted with ranavirus 
infections, such as lymphocytosis, lymphoid depletion, and vacuolation of hepatocytes and renal 
tubular cells, that may be confused with other diseases (Gray et al. 2007; Miller et al., 2009). 
Basophilic viral inclusions have been inconsistently observed in affected tissues (Johnson et al., 
2007; Gray et al., 2009a). When present, inclusions have been identified in erythrocytes, 
leukocytes, epithelial cells, meninges, gills, neuroepithelium, nasal tissues, adipose, trachea, 
muscle, and osteoclasts (Allender et al., 2006; Miller et al., 2011, Gray et al., 2009a; Docherty et 
al., 2003; Jancovich et al., 1997).  
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Genetic variation 
 Ranaviruses infect fish, amphibians, and reptiles across the world.  The relationship 
between different ranaviruses is still poorly known, but has recently been elucidated in 
amphibians (Jancovich et al., 2009).  Ranaviruses are large double stranded DNA viruses (105 
kbp) that encode 98 open-reading frames with a GC content of 55% (He et al., 2002; Tan et al., 
2004). Phylogenetic analysis has mainly concentrated on evaluation of major capsid protein 
(MCP) sequences (Mao et al., 1997; Jancovich et al., 2005), although most analyses have 
demonstrated very little genetic divergence based on the MCP (Jancovich et al., 2003; Jancovich 
et al., 2005). However, when other techniques such as RFLP and cell culture growth 
characteristics are used, differences are revealed in some cases that highlight that MCP alone is 
insufficient to characterize virus isolates (Majji et al., 2006). Studies using multiple gene 
segments and dotplot analysis have suggested that fish to salamander isolates are more closely 
related than salamander to frog isolates (Jancovich et al., 2009).  
 Recently, whole genome alignments were performed using six ranavirus (ATV, EHNV, 
FV3, TFV, SGIV, and GIV) isolated from fish, amphibians, and reptiles (Jancovich et al., 2009).  
Based on this analysis, two subspecies of ranaviruses were proposed: Grouper Iridovirus (GIV)-
like viruses and amphibian-like ranaviruses that include FV3 and ATV (Jancovich et al., 2009).  
Branch lengths within the amphibian ranaviruses are relatively short, indicating recent speciation 
(Jancovich et al., 2009). Using dotplot analysis, it was demonstrated that EHNV was colinear 
with ATV, but not with FV3 or TFV (Tiger Frog virus) (Jancovich et al., 2009).   
 Because ranaviruses within the amphibian-like ranavirus subspecies includes a fish 
species (ENHV), and that distantly related iridoviruses infect fish, it is likely that the common 
ancestor was a fish virus (Jancovich et al., 2009).  There are two theories on how host shifts have 
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led to a jump from fish to amphibians (Jancovich et al., 2009).  One theory suggests that there 
were two separate host shifts, one from fish to salamanders and another from fish to frogs 
(Jancovich et al., 2009). The other theory argues that the host shift to salamanders occurred in 
the common ancestral virus (Jancovich et al., 2009). Based on this theory, the host shift from 
amphibians would require a host shift back to fish (EHNV) and frogs (FV3-like) using the  
current taxonomy (Jancovich et al., 2009). All scenarios also demonstrate a host shift from frogs 
to turtles, as isolates from frogs are colinear with turtle isolates (Jancovich et al., 2009). 
Sequence analysis of soft-shelled turtle iridovirus (STIV, a ranavirus) demonstrated that it was 
identical to FV3, indicating a co-evolution (Huang et al., 2009). 
 It is speculated that these host jumps have occurred within the last 40,000 years due to an 
increase in human harvesting of aquatic organisms (Jancovich et al., 2009). Analysis of 
intraspecific phylogeny further revealed that human introduction of viruses is a possible 
mechanism for disease emergence (Storfer et al., 2007). Whole genome analysis has 
demonstrated numerous host shifts: fish to salamander, fish to frogs, and frogs to turtles 
(Jancovich et al., 2009).  This reinforces the occurrence of ranaviruses in several species of 
ectothermic vertebrates and increases the likelihood that more host shifts will occur (Jancovich et 
al., 2009). Understanding the phylogeny of these viruses is crucial to management of this group 
of viruses, as its host range is larger than any other group of viruses (Jancovich et al., 2009).  
 Other conserved gene segments have been less frequently used to establish phylogeny. 
One of those gene segments, thymidine kinase (TK), is a component of several large DNA 
viruses, including herpesviruses, poxviruses, and iridoviruses (Coupar et al., 2005). Sequences of 
TK genes were compared among several ranaviruses and showed similar homology (Coupar et 
al., 2005). 
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Molecular Characteristics 
The 105 kbp FV3 genome encodes 98 non-overlapping open reading frames (ORF). 
These ORF lead to the appearance of immediate early (IE), delayed early (DE), and late (L) viral 
transcripts (Majji et al., 2009).  IE and DE genes are responsible for nucleic acid metabolism and 
immune evasion, while L genes have been responsible for DNA packaging and virion assembly 
(Chinchar et al., 2009; Majji et al., 2009). 
 The cellular receptor (specific receptor not yet identified) for entry of FV3 is highly 
conserved among many vertebrate cell lines, including those derived from mammals, birds, 
herptiles, and fish (Chinchar et al., 2009).  However, in vivo hosts are restricted to ectotherms, in 
part because temperatures above 32°C do not allow viral replication, and/or these receptors are 
not widely represented in endothermic vertebrate hosts (Chinchar et al., 2009). 
 Ranaviruses have both enveloped and non-enveloped virions that are produced during 
infections, and both are infective.  Non-enveloped virions enter the cell by binding to plasma 
membrane and injecting viral particles into the cytoplasm, whereas enveloped virions enter the 
cell via receptor-mediated endocytosis. Enveloped virions are more infective, which may be due 
to at least two different host receptor proteins (Williams et al., 2005).  
 Viral DNA (enveloped virions) is translocated from the cytoplasm to the nucleus, where 
IE viral RNA synthesis begins using host RNA polymerases (Chinchar et al., 2009).  As IE 
proteins produce transcription transactivators, they set the stage for transcription of DE genes 
(Chinchar et al., 2009). Subsequently, the viral material in the nucleus begins first stage DNA 
synthesis of genome-sized molecules using viral DNA polymerase (Chinchar et al., 2009).  This 
viral DNA is then transported to the cytoplasm where concatameric  (multiple repeats) structures 
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are produced and methylated by a virus-encoded cytosine DNA methyltransferase (Chinchar et 
al., 2009).  This DNA methylation is critical to viral proliferation by preventing degradation due 
to host mechanisms (Chinchar et al., 2009). While the exact mechanism for this is unclear, some 
work suggests that methylation blocks toll-like receptor 9 (TLR) (Chinchar et al., 2009).  This is 
crucial as unmethylated DNA will bind to TLR-9 and may induce inflammatory responses 
(similar to herpes) that inhibit viral spread (Chinchar et al., 2009).  Furthermore, treatment with 
an inhibitor of DNA methylation (5-azacytidine) reduces virus production 100 fold (Chinchar et 
al., 2009). 
 Virions are assembled within the cytoplasm of the infected cell following late viral RNA 
and protein synthesis (Chinchar et al., 2009).  Late viral proteins are thought to encode structural 
elements, including the major capsid protein (a major gene segment used in PCR identification 
of FV3) (Zhao et al., 2007; Chinchar et al., 2009). Inhibition of MCP protein transcription 
corresponds to a reduction in viral titers (Sample et al., 2006). Mechanisms of virion assembly 
are poorly known, but packaging of the viral DNA results in a terminally redundant and 
circularly permuted virion (Goohra and Mutri, 1982; Chinchar et al., 2009).  This leads to a 
nonenveloped product that can be seen with electron microscopy in crystalline arrays (Chinchar 
et al., 2009).  Some virions become enveloped as they bud from the plasma membrane; however, 
the majority of virions are released upon lysis of the infected cell (Chinchar et al., 2009). 
 There is a marked reduction in host DNA, RNA, and protein synthesis during FV3 
infection (Chinchar et al., 2009).  Proposed mechanisms that lead to cell death have included 
both necrosis and apoptosis, although recent evidence suggests that apoptosis is the predominant 
mechanism (Chinchar et al., 2003; Chinchar et al., 2009).  This mechanism occurs in a host cell 
within 6-9 hours post-infection, as seen by DNA fragmentation, chromatin condensation, and 
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membrane reversal (Chinchar et al., 2009). With this virus, apoptosis can be triggered by a live 
virion or a heat and UV inactivated virus, which suggests viral protein is part of the driving 
mechanism (Chinchar et al., 2009). In soft-shelled turtle iridovirus (a ranavirus), it was observed 
that a mitochondria-mediated pathway was likely involved in the apoptotic pathway through 
caspase-3 activity (Huang et al., 2011). 
 
Diagnosis 
 Several methods have been proposed for the diagnosis of ranaviruses, including 
histopathology, PCR, virus isolation, ELISA, electron microscopy, restriction fragment length 
polymorphism (RFLP), and cytology (Hyatt et al., 2000; Gray et al., 2009a; Miller et al., 2011).  
 Conventional PCR against the MCP is commonly used to identify infections, but is 
limited by the fact that it only allows detection and doesn’t confirm active infection. Diagnosis is 
most successful on fresh or frozen tissues, but a method for successful recovery from formalin 
fixed tissues exists (Kattenbelt et al., 2000). Evaluation of ante-mortem (toe clip) vs. post-
mortem (liver) samples in anurans was evaluated for detection of FV3 (St-Amour and 
Lesbarreres, 2007). The study found that 88% of samples that were positive in liver samples 
were also positive in toe clips, leading the authors to conclude that both methods are effective for 
detection (St-Amour and Lesbarreres, 2007). The specificity and sensitivity of PCR was also 
evaluated comparing post-mortem (necropsy) and ante-mortem (tail clips) in salamanders (Greer 
and Collins, 2007). The study demonstrated that tail clips underestimate prevalence, although its 
agreement increases as time after exposure increases (Greer and Collins, 2007). In reptiles, 
necropsy tissues are most commonly tested, while antemortem sampling has not been evaluated. 
Studies have reported the use whole blood and oral or cloacal swabs in red-eared slider turtles 
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and box turtles, but those results have not been validated against necropsy samples (Johnson et 
al., 2008; Allender et al., 2011). Future studies should evaluate the specificity and sensitivity of 
antemortem diagnostic sampling techniques. 
Quantitative PCR (qPCR) has been developed to detect lower amounts of genetic 
material than conventional PCR, including several ranaviruses. A qPCR assay was developed for 
a 62-bp segment of the major capsid protein (MCP) of LBMV in largemouth bass during an 
experimental transmission (Getchell et al., 2007). LBMV persists in fish populations, and this 
assay was useful for detecting the subclinical state (Getchell et al., 2007). In a qPCR study for 
white sturgeon iridovirus, sensitivity was compared to histopathology (Kwak et al., 2006). The 
study found that the sensitivity of the qPCR assay was 98%, while histopathology was 64%, 
confirming that qPCR is a highly sensitive assay (Kwak et al., 2006). Quantitative PCR has been  
developed with primers targeting a segment of the ranavirus DNA polymerase gene (Holopainen 
et al., 2011). This assay was validated in cell culture for several ranaviruses and was found to be 
effective in detecting virus in fish tissues experimentally infected with EHNV (Holopainen et al., 
2011). A similar diagnostic assay for reptiles is lacking. 
A loop-mediated isothermal PCR assay (LAMP) was developed for detection of a 
segment of the TK gene in STIV (Liu et al., 2011). LAMP has the advantages of requiring 
simple equipment and having a rapid turnaround for results (Liu et al., 2011). When compared to 
qPCR in the same study, LAMP was shown to be 100 times more sensitive and the detection 
limit was 20 copies/µl (Liu et al. 2011). This has not been used in North American species, 
including reptiles, but may necessitate further investigation. 
Several molecular methods have been designed to differentiate viral isolates. A 
conventional PCR was developed to differentiate EHNV and BIV with primers targeting an open 
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reading frame (Gould et al., 1995), and later combined with restriction endonuclease patterns to 
differentiate EHNV, BIV, Warmena virus, and FV3 (Marsh et al., 2002). To differentiate 
between closely related ranaviruses, three qPCR assays directed against the MCP, DNA 
polymerase, and neurofilament H1-like protein gene were developed (Holopainen et al., 2009). 
These assays were able to distinguish between closely related phylogeny of 11 isolates, including 
FV3, EHNV, and BIV, among others (Holopainen et al., 2009). Another qPCR assay was 
developed with the aim of differentiating EHNV, BIV, European sheatfish virus, and European 
catfish virus (Pallister et al., 2007), and while the assay was found to be sensitive for the 
detection of ranaviruses, it needs further development to be able to differentiate these viruses 
(Pallister et al., 2007).  
Immunohistochemistry is useful in quickly confirming the presence of a pathogen in 
formalin fixed tissue. An immunohistochemical (IHC) method has been developed using rabbit 
antiserum against purified virus to definitively demonstrate systemic ranavirus infection in 
several tissues from fish, amphibians, and reptiles (Balseiro et al., 2009; Cinkova et al., 2010). 
Immunohistochemistry also has been developed in the UK that is capable of detecting ranavirus 
in lymphocytes, fibrocytes, and melanomacrophages, among other tissues from amphibians 
(Cunningham et al., 2008). IHC can be an invaluable diagnostic tool when working on an 
outbreak, and has been used in Australia for this purpose (Hyatt et al., 2002).  However, IHC can 
only be applied to biopsy or necropsy tissues, which are an invasive method that is not a 
preferred method for antemortem diagnosis. 
 Serologic assays have been developed to detect antibodies against iridoviruses in fish, 
amphibians, and reptiles (Kim et al., 2007; Johnson et al., 2010; Zhang et al. 2010). Antibodies 
in cane toads (Bufo marinus) were detected using a newly-developed ELISA against purified 
 25 
BIV and EHNV (Whittington and Speare, 1996; Whittington et al., 1997). The assay 
demonstrated stronger reactivity with BIV than EHNV in the cane toads, which was not 
surprising because BIV is an amphibian pathogen and EHNV is a piscine pathogen (Whittington 
et al., 1997). In a separate study, the additional step of pre-absorption of the toad sera with a 
monoclonal antibody against an EHNV protein improved the specificity of the ELISA, which the 
authors concluded made the assay a useful screening tool for toads (Zupanovic et al., 1998a). In 
chelonians, FV3 antigen and an anti-desert tortoise IgY were used in a secondary ELISA 
(Johnson et al., 2010). This assay demonstrated a high coefficient of variation (>15% in some 
replicates) but was used for evaluation of gopher tortoises and box turtles with low prevalence 
(Johnson et al., 2010), however the high coefficient of variation may have led to false positives.  
While the previous diagnostic tests are specific to characterizing ranaviruses, additional 
diagnostic methods that are less specific should also be considered when attempting to determine 
the presence or absence of these viruses. Clinical pathology is commonly used in clinical and 
fieldwork to characterize the health status of an animal. While not specific, it can be used with 
other diagnostic methods in a parallel testing method to increase the sensitivities of the assays. 
Flow cytometry has been developed using bromodeoxyuridine to assess lymphocyte proliferation 
response (Morales et al., 2007), which may be helpful when evaluating a host response to a viral 
infection. Viruses can induce lymphopenia or lymphocytosis, depending on the virus; this has 
not been characterized with amphibians or reptiles and ranaviruses.  Complete blood counts 
(CBC) may also prove valuable by providing insight into whether this group of viruses can 
induce inflammatory responses or leukopenias in these animals. A great benefit of these types of 
diagnostic methods compared to the others is that the samples can be screened quickly. 
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Pathogenesis 
Many different factors have been shown to affect the pathogenesis of ranaviruses in fish, 
amphibians, and reptiles, including species susceptibility, environmental factors, and host 
immune response (Hoverman et al., 2010). However, there remains much we don’t know about 
the pathogenesis of this group of viruses in these animals, especially reptiles. The following is a 
review of what has been done. Several ranavirus transmission studies have been performed in 
urodelans. Koch’s postulates were originally satisfied for ATV in tiger salamanders using an 
isolate that was responsible for an epizootic in 1995 (Jancovich et al., 1997). Intracoelomic 
inoculation of ATV in salamanders led to mortality within 13 days (Bollinger et al., 1999). 
Lesions in affected salamanders included necrosis of several tissues, including: liver, spleen, 
skin, kidney, and hematopoietic tissues (Bollinger et al., 1999). ATV also has been shown to be 
transmissible by direct interactions (bumping, biting, cannibalism, necrophagy) and indirectly 
via water and fomites (Brunner et al., 2007; Gray et al., 2009; Hoverman et al., 2010). 
Specifically, larval amphibians are infective soon after exposure and transmission increases with 
time (Brunner et al., 2007).  
Ranavirus transmission studies have also been done with anurans. A ranavirus isolated 
from an outbreak in free-ranging frogs from the UK induced death following systemic 
hemorrhages in inoculated frogs within 6 to 8 days post-infection (Cunningham et al., 2007a). 
Furthermore, a hemorrhagic syndrome seen in the UK frogs was shown to be more likely to 
result in disease compared with those animals demonstrating ulcerative signs alone (Cunningham 
et al., 2007b). These findings suggest that there might be tissue tropism for some viral strains 
that lead to differences in disease development (Cunningham et al., 2007b). 
 27 
Transmission studies in reptiles, and more specifically turtles, are limited.  Attempts to 
infect adult red-eared slider turtles using an oral inoculum of FV3 was unsuccessful; however, 
direct intramuscular injection of the virus was found to be effective at generating an infection 
model in this species  (Johnson et al., 2007). To date, no attempts to infect turtles using water-
borne or fomite based methods have been published, and while these techniques have been 
shown to be successful in infecting amphibians, there are clear anatomic and physiologic 
differences between these groups related to their integuments and how they absorb materials 
from the environment.  
The effects of inoculum dose and host factors have been investigated for ATV in 
salamanders (Brunner et al., 2005).  The study demonstrated that the time to the onset of clinical 
signs was correlated with inoculum dose, life history stage (juvenile), and genetic background 
(Brunner et al., 2005). In a follow-up study using a factorial design, ATV was experimentally 
transmitted to several familial lines of tiger salamanders) (Brunner et al., 2009). Virulence was 
highly correlated with viral strain and not amphibian lineage (Brunner et al., 2009).  Similarly, a 
North American FV3 isolate was inoculated in Italian agile frogs (Rana latastei) and 
demonstrated a dose dependent survival and that cannibalism increased mortality rates (Pearman 
et al., 2004). 
 In Canada, FV3-like isolates from salamanders were used to experimentally infect wood 
frogs (Rana sylvatica); infection was found to be dose dependent (Duffus et al., 2008). The study 
went on to hypothesize that horizontal transmission through infected water was the most likely 
route of transmission for amphibians (Duffus et al., 2008). However, another transmission study 
in wood frogs demonstrated that scavenging on infected tadpoles was highly lethal (Harp and 
Petranka, 2008). Another experiment in the same species did not demonstrate increased mortality 
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(compared to controls) from infected water and sediment, but PCR was positive in those pools 
indicating possible sublethal infections (Harp and Petranka, 2008). The mixed results 
encountered in these studies should serve to reinforce the complexity of the epidemiology of 
ranaviruses in amphibians. 
 Attempts to definitely identify the vertebrate and invertebrate reservoir hosts for FV3 
have been lacking. Much of this is because there have been limited field studies attempting to 
define the potential range of hosts. Attempts to evaluate different vertebrates using experimental 
models have been attempted with mixed results.  Experimental FV3-like infections in black 
bullhead catfish (Ameiurus melas) failed to induce disease, but the virus could be re-isolated 
from euthanized fish at the conclusion of the study (Gobbo et al., 2010). However, the same 
experiment failed to re-isolate FV3-like DNA from surviving fish, suggesting this species is not 
likely to serve as a reservoir species (Gobbo et al, 2010). Experimental transmission in pike 
(Esox lucius) with FV3-like infections failed to cause significant mortality, but the virus was 
successfully re-isolated after infection; this case suggests that this species may serve as a 
subclinical carrier (Bang Jensen et al., 2009). In amphibian populations, proposed reservoir 
species include those that develop over one year (American bullfrog), have neotenic 
development (tiger salamanders), or have aquatic adult life stages (red-spotted newt, 
Notophthalmus viridescens; black-bellied salamander, Desmognathus quadramaculatus) (Gray et 
al., 2009). A PCR survey in Ontario, Canada, of both frogs and salamanders detected FV3-like 
virus in several species of both Orders (Duffus et al., 2008). They demonstrated that caudate 
salamanders are likely both the reservoir and the hosts of FV3 infections based on prevalence 
and viral load (Duffus et al., 2009). While in Brazil, South America, bullfrogs have been 
suggested as a reservoir species following an outbreak at an amphibian farm (Mazzoni et al., 
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2009). In adult Xenopus laevis, persistence of viral DNA was detected in the kidneys, which 
could be activated when animals are immunosuppressed (Robert et al., 2007).  Furthermore, 
peritoneal macrophages were also identified as a site of viral persistence and further support the 
likelihood that this species can serve as a viral reservoir (Robert et al., 2007). Because 
amphibians undergo a metamorphosis, it is possible that juveniles infected during their larval 
development could serve as potential reservoirs if they survive into their later adult life stage 
(Brunner et al., 2004). 
 The effect of ranavirus on life history traits such as survival, growth rates, and 
developmental stage was evaluated in the Northern leopard frogs (Echaubard et al., 2010). 
Experimental inoculation showed that increased animal density lead to a higher mortality rate, 
shorter time to death, longer developmental period, and lower growth rates (Echaubard et al., 
2010). The authors speculated that individuals divert energetic resources away from the immune 
response to cope with increased environmental stress associated with high densities (Echaubard 
et al., 2010). Based on this theory, the emergence of ranavirus into naïve populations suffering 
from climate change, human encroachment, and other outside pressures could prove catastrophic. 
The effect of temperature on the pathogenesis of iridoviruses has been shown to be 
important. In the rock bream fish (Oplegnathus fasciatus), red sea bream iridovirus induced high 
mortality at 18°, 21°, and 25°C, but not at 13°C (Jun et al., 2009), although after the 13°C 
temperature group was exposed to 25°C mortality reached 100% (Jun et al., 2009). In perch 
(Perca fluviatilis) and trout (Oncorhynchus mykiss) exposed to EHNV, mortality was greatest at 
higher temperatures (19°- 21°C), and was lowest or delayed at low temperatures (Whittington 
and Reddacliff, 1995). In the study, trout failed to develop clinical signs, but it was still possible 
to isolate the virus from the fish. The authors concluded that environmental persistence might 
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have played a role in the findings (Whittington and Reddacliff, 1995). In tiger salamanders 
experimentally inoculated with ATV, animals showed high mortality at 10°C and 18°C, while 
lower mortalities were noted at 26°C (Rojas et al., 2005). Furthermore, viral loads were highest 
in the animals kept at 10°C and lowest in the animals kept at 26°C (Rojas et al., 2005). While 
FV3 growth is inhibited at temperatures above 32°C, the effects of other ranaviruses in other 
species clearly indicate either virus or species-specific differences in pathogenesis, and further 
studies are needed in several species to better characterize the role of temperature in 
development of disease. 
 Disease susceptibility in amphibians, including to ranaviruses, has been linked to 
environmental contamination (Forson et al., 2006; Gray et al., 2007; Greer and Collins, 2008; 
Hayes et al., 2010). Atrazine exposure has been found to reduce peripheral leukocyte response in 
amphibians, and not surprisingly increase the susceptibility of larvae to ATV infection (Forson et 
al., 2006; Kerby et al., 2009). Chlorpyrifos (an organophosphate insecticide) has also been found 
to increase tiger salamander susceptibility to ATV  (Kerby et al., 2009). While in some cases the 
source or type of contaminant is known, in others it is not. In these cases the contamination is 
insidious and often tied to some behavior. For example, amphibians with access to cattle farms  
(and likely environmental contamination) were three times more likely to be FV3 positive than 
controls (Gray et al., 2007). Tiger salamanders in Arizona were also more likely to be infected 
with ATV in ponds that had cattle access (Greer and Collins, 2008). Conversely, deltamethrin (a 
pyrethroid ester insecticide) was found to have very little immunosuppressive effect at 
environmentally relevant concentrations and not likely to lead to increased iridovirus infections 
(Froese et al., 2009). To date, the role of organic and inorganic contaminants on the 
susceptibility of reptiles to ranaviruses has not been evaluated, but merits investigation. 
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 Besides toxicants in the environment, other anthropogenic factors have been shown to 
play a role in disease transmission in amphibians. The global trade in amphibians is a significant 
factor in disease epidemiology and threatens conservation; the concern for this has grown so 
large that it has received listing status by the Office International des Epizooties (OIE) to ensure 
the safety of international trade (Schloegel et al., 2009; Schloegel et al., 2010). It was suggested 
that human transport of bait salamanders from the Midwest USA to Arizona and Colorado was 
responsible for the introduction of ATV to these otherwise naïve environments (Jancovich et al., 
2004; Jancovich et al., 2005; Picco and Collins, 2008). The authors concluded that because of the 
limited genetic variation seen in ranaviruses in North American salamanders, human movement 
is a plausible mechanism for its spread (Jancovich et al., 2005; Picco and Collins, 2008). 
Furthermore, in a survey of fisherman in the western USA, bait salamanders were commonly 
released into local waters, which the authors concluded could serve as a significant threat to 
releasing ranavirus into native populations (Picco and Collins, 2008).  More importantly, these 
salamander isolates are able to infect but not kill fish in the environment, potentially leading to 
viral persistence and the spread of infections in the face of amphibian outbreaks (Picco et al., 
2010). In a cross-sectional study evaluating Rana clamitans, the prevalence of ranavirus was 
influenced by industrial activity, degree of human influence, and distance to human habitation 
(St-Amour et al., 2008). It is clear from these studies that humans have both directly and 
indirectly increased ranaviral disease in amphibians, and therefore, it is reasonable to consider 
that these or other anthropogenic factors will occur in reptiles. 
 Innate or natural immunity of amphibians may play an important role in protecting 
susceptible species. Anti-microbial peptides (AMP), which are normal components of the 
mucous layer on amphibian skin, have been shown to significantly reduce viral infectivity 
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through inactivation of the virus (Chinchar et al., 2001; Chinchar et al., 2004; Rollins-Smith, 
2009). However, when comparing channel catfish virus to FV3, FV3 were less sensitive to the 
effects of the anti-microbial peptides (Chinchar et al., 2004).  This was supported by the 
suggestion that cell culture isolates (which have no AMP) were more likely to induce disease 
than infected amphibian skin itself (which have AMP) (Cunningham et al., 2007b).  The role of 
peritoneal leukocytes has recently been evaluated as a critical innate defense mechanism in X. 
laevis (Morales et al., 2010). An increase in peritoneal leukocytes (1 day), natural killer cells (3 
day), and T-cell response (6 day) are observed after infection (Morales et al., 2010). In addition, 
proinflammatory cytokine genes including interleukin-1β, tumor necrosis factor, and arginase 1 
are upregulated in response to FV3 infection  (Morales et al., 2010). When evaluating the role of 
these leukocytes, it was found that peritoneal leukocyte response was weaker than the response 
in the kidney, which the authors concluded was the main site of infection (Morales et al., 2010). 
This may be helpful in identifying sites of viral persistence in subclinical or reservoir hosts. 
Similar immune responses have not been discovered in reptiles 
Adaptive immune responses have been shown to induce a CD8 T-cell response and IgY 
production in adult X. laevis, which shows protection upon re-infection with FV3 (Gantress et 
al., 2003; Robert, 2010). Anti-FV3 antibodies in adult frogs are not detected using ELISA after a 
primary infection, but are robust within 10 days to 8 weeks after secondary infection (Maniero et 
al., 2006; Robert, 2010). However, mRNA is active in B-cells during the primary infection, 
indicating that despite there not being detectable IgY, the antibody response is active (Robert, 
2010). In an experimental ranavirus transmission study using red-eared slider turtles, ELISA 
positive results were not consistently observed within 30 days, nor were they observed reliably in 
Australian reptiles after experimental exposure (Johnson et al., 2007; Ariel, 1997). It is possible 
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that a similar mechanism in reptiles exists compared to amphibians, in which antibody 
development is robust only after a secondary infection. It was demonstrated in X. laevis that CD8 
T-cells were upregulated within 6 days post-infection after primary infection and sooner after 
secondary infection (Morales et al., 2007). The authors concluded that CD8 T-cells provided in 
vivo protection against ranavirus in X. laevis  (Morales et al., 2007). Larval amphibians infected 
with ranavirus have been found to experience greater mortalities than adults; these animals were 
also found to be deficient in the expression of MHC class I (Gantress et al., 2003; Robert, 2010). 
However, the authors caution that the lack of MHC class I molecules is not the only mechanism 
involved in disease development in larvae, as IgY conversion is not efficient in larval 
amphibians either and may play a role as well (Gantress et al., 2003). The adaptive immune 
response in reptiles is temperature dependent and future studies should evaluate the response to 
FV3 under various environmental conditions. 
Physiologic responses of the hypothalamus-pituitary-interrenal axis (HPI) to infection 
have been evaluated in wood frogs and can influence pathogenesis (Warne et al., 2011). The 
authors determined that FV3-infected tadpoles had significantly higher corticosterone, rapid 
developmental changes, and a decrease in weight compared to controls (Warne et al., 2011). The 
authors concluded that while corticosterone usually enhances immunity, it accelerates 
metamorphosis that may be maladaptive in juveniles (Warne et al., 2011). Therefore, the 
epidemiology of FV3 infections in larval amphibians may be due to the energetic trade-offs 
between metamorphosis and response to infection and might favor those individuals that are in 
better body condition (Warne et al., 2011).  
In conclusion, many factors affect the immune response and pathogenesis that still need 
to be elucidated in amphibians and reptiles. However, it is apparent that environmental 
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temperature plays a role in the development of disease either through virus-specific factors (e.g. 
growth not supported above 32°C, possible tissue specificity) or host factors (e.g. immune 
response is more robust at higher temperatures in reptiles, habitat preference [aquatic or 
terrestrial], age [juveniles have less developed immune system to fight infections than adults]).  
Furthermore, the presence of FV3 in reservoir species or other factors (pond substrate) need to be 
determined for reptiles.  
 
Treatment 
Therapeutic interventions in free-ranging settings are often impractical for combatting 
disease outbreaks. However, in captive animals or in those situations where an endangered group 
of free-ranging animals are brought into captivity, an appropriate treatment protocol needs to be 
established. Therapeutic protocols to many viral diseases in reptiles have not been established. 
However, several texts have recommended the use of anti-viral medicine (acyclovir) in treatment 
of herpesvirus infections in tortoises. 
Acyclovir is a guanine analogue antiviral drug (Elion, 1993).  It is active against 
herpesviruses due to the presence of the thymidine kinase (TK) enzyme, which rapidly activates 
acyclovir to the monophosphate form (Beutner, 1995). Once phosphorylated three times, the 
antiviral competes with deoxyguanosine triphosphate (dGTP) for the viral DNA polymerase. 
Acyclovir uptake has been shown to be enhanced in herpesvirus-infected cells, with a 10- to 30- 
fold greater affinity in infected cells than uninfected cells (Beutner, 1995).  Once incorporated 
into the viral genome, relatively low levels of the drug are needed to achieve viral inhibition and 
adequate intracellular concentrations can be maintained for several hours (Beutner, 1995). 
Valcyclovir, an esterified version of acyclovir, is rapidly converted to acyclovir after absorption 
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and has greater oral bioavailability than acyclovir (Garre et al., 2008).  In humans, the oral 
bioavailability of valcyclovir is 3-5 times greater than acyclovir, while in horses and cats it is 8 
times and 2-3 times more bioavailable than oral acyclovir itself, respectively (Garre et al., 2007; 
Nasisse et al., 1997). 
Several isolates of iridoviruses have been shown to have thymidine kinase genes or 
functional TK enzymes (Coupar et al., 2005; Jakob et al., 2001; Scholz et al., 1988; Tsai et al., 
2005). Inhibition of this gene has been shown to slow viral replication (Coupar et al., 2005). 
When genetically compared, iridoviruses and herpesviruses appeared to have more closely 
related mitochondrial TKs (Coupar et al., 2005). This suggests that if iridovirus TK genes are 
similar to herpesvirus TK genes, it is plausible that they too could phosphorylate and activate 
acyclovir. The activity of valcyclovir has been shown to be entirely due to the conversion to 
acyclovir, but with higher bioavailability (Beutner, 1995). 
The half-life of acyclovir after a single oral dose varies in humans (3.1 h), cats (3.1 h), 
and horses (5.05 h) given oral valcyclovir and marginated tortoises (Testudo marginata) (8.8 h) 
given oral acyclovir (Gaio et al., 2007; Owens et al., 1996; Garre et al., 2007; Beutner, 1995).  
The results demonstrate a slower elimination in turtles, which could reduce dosing intervals.   
The bioavailability of acyclovir in humans, horses and cats is 20%, 3-8%, and 15-21%, 
respectively, and it decreases with increasing doses (Beutner, 1995; Wilkins et al., 2005; Owens 
et al., 1996; Nasisse et al., 1997).  
Acyclovir has been proposed for treatment of herpesvirus in several species, and for 
iridovirus in chelonians (Beutner, 1995; Gaio et al., 2007 DeVoe et al., 2004; Funk and 
Diethelm, 2006; Marschang et al., 1997). For herpesvirus in humans and horses, inhibitory 
concentrations need to be maintained above 0.45 μg/ml and 3 μg/ml, respectively (Gaio et al., 
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2007).  However, in vitro concentrations that completely inhibit tortoise herpesvirus were above 
50 μg/ml (Marschang et al., 1997).  Additionally, in vitro studies against an iridovirus using 
acyclovir indicated only a dose-dependent partial inhibition at 25 μg/ml  (Johnson, 2006). There 
have been no in vivo studies evaluating efficacy or inhibitory concentrations in chelonians 
against either virus. Future studies should evaluate in vivo efficacy against iridoviruses to 
determine if higher concentrations of drug are reached in infected cells, as has been 
demonstrated with herpesviruses in other species. 
Toxicity of therapeutic use using these anti-virals is unknown in turtles. In cats, 
nephrotoxicity and bone marrow suppression were seen with repeated dosing of acyclovir and 
valacyclovir (Owens et al., 1996).  If studies evaluating these drugs are pursued in reptiles, 
animals should be monitored closely for these potential side effects. 
Besides pharmacologic treatment, other mechanisms to control FV3 include disinfection. 
One study investigated the effects of chlorhexidine, sodium hypochlorite, potassium 
peroxymonosulfate, and potassium permanganate on ranavirus (Bryan et al., 2009).  
Chlorhexidine at 0.75%, sodium hypochlorite at 3%, and potassium peroxymonosulfate at 1% 
were all effective at inactivating ranavirus after a 1 minute exposure (Bryan et al., 2009), while, 
potassium permanganate (100% concentration) after a 60 minute exposure, chlorhexidine at 
0.25% and sodium hypochlorite <3% were found to be ineffective (Bryan et al., 2009).  
Field studies in areas where infectious diseases are present risk human spread of 
ranaviruses between field sites. Hygiene methods have been established for amphibians to reduce 
this potential risk: 1) low stringency – clean and dry equipment and clothing; 2) moderate 
stringency – disinfect equipment and vehicle; and 3) high stringency – site-dedicated or 
disposable equipment or thorough cleaning and vehicle is washed and disinfected (Phillott et al., 
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2010).  Furthermore, the authors have established a set of easy to use criteria to determine the 
risk based on prior activity, proposed activity, remoteness of site, presence of pathogen at site, 
and population status of all species at site (Phillott et al., 2010). 
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Table 2.1. Species and locations ranaviruses have been isolated from free-ranging amphibians and reptiles. 
 
  
Class Continent Country State/Province Family Virus References 
Amphibia 
North 
America 
USA 
New Hampshire Ranidae Unclassified iridovirus Jancovich et al., 1997 
Colorado Ambystomatidae FV3 Green, 2002 
North Dakota Hylidae ATV Docherty et al., 2003 
Minnesota Bufonidae   Converse and Green, 2005 
Maine Plethodontidae   Gray et al., 2007 
Utah Cryptobranchidae   Gray et al., 2009a 
Idaho Scaphiopodidae   Glenney et al., 2010 
Tennessee     Torrence et al., 2010 
Massachusetts     Davidson and Chambers, 2011 
Wyoming     Miller et al., 2011 
North Carolina       
Arizona       
Texas       
Virginia       
        
        
Canada 
Saskatchewan Ambystomatidae ATV Bollinger et al., 1999 
Ontario Ranidae   Greer et al., 2005 
Quebec Hylidae   Duffus et al., 2008 
  Salamandridae   St-Amour et al., 2008 
      Schock et al., 2010a 
      Echaubard et al., 2010 
      Schock et al., 2010b 
      Paetow et al., 2011 
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Table 2.1, continued. 
 
  Continent Country State/Province Family Virus References 
Amphibia, 
cont. 
South 
America 
Venezuela   Bufonidae Unclassified iridovirus Zupanovic et al., 1998c 
Brazil   Ranidae FV3 Galli et al., 2006 
Uruguay   Leptodactylidae   Fox et al., 2006 
Argentina         
Europe 
United 
Kingdom   Ranidae Unclassified ranavirus Fijan et al., 1991 
Croatia   Discoglossidae FV3 Drury et al., 1993 
Spain   Salamandridae   Cunningham et al., 1996 
Belgium   Bufonidae   Hyatt et al., 2000 
Netherlands   Alytidae   Pasmans et al., 2008 
Israel       Alves de Matos et al., 2008 
Portugal       Balseiro et al., 2009 
        Ariel et al., 2009 
        Duffus et al., 2010 
        Balseiro et al., 2010 
        Hyatt et al., 2010 
Australia Australia   Myobatrachidae Unclassified ranavirus Speare and Smith, 1992 
Asia 
China   Ranidae FV3 Xu et al., 2010 
Japan       Une et al., 2009 
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Table 2.1, continued. 
 
  Continent Country State/Province Family Virus References 
Reptilia 
North 
America 
US 
Florida Testudinidae 
FV3 or  
FV3-like 
Westhouse et al., 1996 
Georgia Emydidae Johnson et al., 2006 
Florida   Ruder et al., 2010 
Pennsylvania   Allender et al., 2011 
New York     
Texas     
Tennessee     
North Carolina     
Kentucky     
Asia China   Trionychidae STIV Chen et al., 1999 
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Table 2.2. Reports of non-erythrocytic iridoviruses in captive reptiles.  
 
 
Continent Country Family Virus Reference 
North America USA Testudinidae FV3 Johnson et al., 2006 
  Emydidae FV3-like DeVoe et al., 2004 
Europe  Agamidae Chilo-iridescent 
virus 
Just et al., 2001 
 Chameleonidae Chilo-iridescent 
virus 
Just et al., 2001 
Germany Gekkonidae FV3 Marschang et al., 
2005 
Switzerland Testudinidae Unclassified 
ranavirus 
Benetka et al., 2007 
 Germany Testudinidae FV3-like Marschang et al., 
1999 
 UK Chameleonidae Unclassified 
iridovirus 
Drury et al., 2002 
Australia  Boidae BIV Hyatt et al., 2002 
Asia China Trionychidae STIV Chen et al., 1999 
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CHAPTER 3 
 
DEVELOPMENT AND VALIDATION OF TAQMAN QUANTITATIVE PCR FOR 
DETECTION OF FROG VIRUS 3-LIKE VIRUS IN EASTERN BOX TURTLES 
(TERRAPENE CAROLINA CAROLINA)
1
 
 
Objective: Develop a quantitative real-time PCR (qPCR) assay using a TaqMan probe-based 
assay derived from a highly conserved region of the major capsid protein of frog virus 3 (Family 
Iridoviridae, genera Ranavirus) and use the qPCR to identify FV3 or FV3-like infections in a 
collection of 31 eastern box turtle samples.   
Design: Assay development for cross-sectional study 
Animals: Thirty-one eastern box turtles (Terrapene carolina carolina) 
Procedures: Standard curves were generated from a viral DNA segment cloned within a plasmid. 
Blood and oral swab samples from free-ranging box turtles were evaluated.  
Results: The TaqMan assay detected viral DNA copies 1000 times lower than conventional PCR. 
The linear range for TaqMan was between 5.3 x 10
9
 to 5.29 x 10
4
 with an R
2
 of 0.999 (slope = -
3.3; 100% efficiency). The prevalence of ranavirus in blood was 3% (95% CI:0-9) and was 6% 
(95% CI: 0-14) in oral swab samples. 
Conclusions and Clinical Relevance: Viral isolation and conventional PCR are the most common 
methods for diagnosis. In this study, a qPCR was developed that allows for a superior, rapid, 
sensitive, and quantitative method for detecting Ranavirus in box turtles.  Thirty-one clinical 
                                                        
1 Content of this chapter has been partially or fully submitted for publication as cited in 
bibliography as Allender et al., 2012a. 
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samples (whole blood and oral swabs) from box turtles were tested using this assay and the 
prevalence of the virus determined.  This assay will be useful for early detection and disease 
monitoring.  . 
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Introduction 
Ranavirus is one of five genera from the family Iridoviridae and one of three genera 
reported to infect reptiles. They are large, icosohedral, DNA viruses that have emerged as a 
significant cause of mortality events in free-ranging herpetofauna throughout the world (Green et 
al., 2002; Johnson et al., 2008; Miller et al., 2011).  Ranavirus has specifically been linked with 
numerous outbreaks occurring in the US (Green et al., 2002; Jancovich et al., 2003). Recently, 
ranaviral disease in amphibians was placed on the World Organization for Animal Health list of 
reportable diseases. Disease events in amphibians are often clustered into local epizootics, with 
significant impact on the local population.
5
 These epizootics have been scattered across 
numerous habitats and landscapes in the US; however, disease predictability has not been 
successful. Furthermore, there have been increasingly more reports and cases in chelonians, and 
specifically box turtles, in the US (Allender et al., 2006; DeVoe et al., 2004; Johnson et al., 
2008). 
Diagnostic assays that are validated and optimized to detect the presence of pathogens in 
certain species are key to characterizing the disease and understanding disease ecology. 
Quantitative PCR (qPCR) has not been previously developed for detection of ranavirus in turtles. 
Its use would likely provide much greater sensitivity in detection of ranavirus as compared with 
conventional PCR, and additionally would allow the quantitation of virus levels within specific 
tissues. Identifying clinical samples with the highest viral load will allow for more efficient 
sampling methods that target those tissues and potentially direct therapy toward those sites. 
Additionally, the greater sensitivity of qPCR will allow for the detection of ranavirus in animals 
with lower titers of virus, as might be seen in early or subclinical infections. In studies 
investigating iridoviruses in fish, TaqMan real-time PCR was shown to be 100 times more 
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sensitive than conventional PCR, and crucial for the identification of subclinical disease states 
(Getchell et al., 2007; Pallister et al., 2007). Animals with subclinical infections may serve as 
important carriers or reservoirs for infectious disease; therefore, it is critical to develop assays 
capable of detecting the pathogen in these animals. To date, no such assay has been reported for 
ranavirus quantification in free-ranging or captive chelonians.   
 The purpose of this study was to develop and evaluate different diagnostic methods for 
characterizing an emerging pathogen, frog virus 3-like virus (FV3; genera Ranavirus, Family 
Iridoviridae) in box turtles. The hypotheses tested in this study were that a qPCR TaqMan based 
assay would be both sensitive and specific for characterizing FV3-like disease in box turtles. 
This is essential when considering the application of these assays to free-ranging populations 
and/or experimental models. Furthermore, it allows for evaluating potential climatic and 
environmental impacts on the disease, as well as treatment, and management options.   
 
Materials and Methods 
DNA extraction 
 Whole blood and an oral swab were collected from a positive eastern box turtle that 
presented to the University of Tennessee (Knoxville, Tennessee, USA) wildlife clinic in 2007. 
DNA was extracted following manufacturers instructions (QIAamp DNA blood mini kit, Qiagen, 
Valencia, CA). Concentrations and purity of DNA were determined using a spectrophotometer 
(Nanodrop spectrophotometer, Thermo Scientific, Wilmington, DE).  
Conventional PCR, Sequencing, and Cloning 
 Conventional PCR was performed using primers targeting a portion of the major capsid 
protein (MCP) (Mao et al., 1997)  Products were sequenced in both directions using the 
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University of Illinois Core DNA Sequencing Facility (Urbana, Illinois, USA) and compared to 
known sequences in GenBank using TBLASTX.  For cloning, the PCR product (531 bp) from 
the MCP 4 primers (Mao et al., 1997) was then cloned in E. coli (TOPO TA Cloning
®
 kit, 
Invitrogen, Carlsbad, CA). The cloning product was verified through sequencing in both 
directions.  Plasmids were linearized with EcoR1, purified (QIAfilter plasmid Maxi kit, Qiagen, 
Valencia, CA), and quantified using spectrophotometry. Ten-fold serial dilutions of linearized 
plasmids were made from 10.0 x 10
2
 ng/µl to 10 x 10
-8
 ng/µl. Viral genome (DNA) copy number 
was calculated using the following formula: 
 # copies/µL =  (ng DNA of plasmid + clone/ µL) (6.022 x 10
23
 copies/mol)     
   (bp length)(1x 10
9 
ng/g) (650 g/mol of bp) 
The final copy number for ten-fold serial dilutions ranged from 5.29x10
9
 to 5.29x10
1
 viral copies 
per reaction. 
Real time qPCR Assay 
 A primer/probe assay for a TaqMan-MGB (TaqMan® primers, Applied Biosystems, 
Carslbad, CA) based qPCR assay were designed using a commercial software program (Primer 
Express
®
, Applied Biosystems, Carlsbad, CA) based on published sequences of the major capsid 
protein of FV3 (Mao et al., 1997).  TaqMan assay was performed using forward 
(AACGCCGACCGAAAACTG), reverse (GCTGCCAAGATGTCGGGTAA), and probe 
(CCGGCTTTCGGGC) targeting a 54 bp segment of the major capsid protein (MCP) of frog 
virus 3. Real-time qPCR assays were performed using a real-time PCR thermocycler (7500 ABI 
real-time PCR System, Applied Biosystems, Carlsbad, CA) and data was analyzed using 
associated software (Sequence Detection Software v2.05, Applied Biosystems, Carlsbad, CA).
.
 
Each reaction contained 12.5 μl of 2x TaqMan Platinum PCR Supermix-UDG with ROX 
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(TaqMan Platinum PCR Supermix-UDG with ROX, Invitrogen, Carlsbad, CA), 1.25 μl TaqMan 
primer-probe, 2.5 μl turtle-derived FV3 dilution, and water to a final concentration of 25 μl. 
Cycling parameters were as follows: 1 cycle at 50°C for 2 minutes followed by 95°C for 10 
minutes, then 40 cycles at 95°C for 15 seconds and 60°C for 60 seconds, and a final cycle of 
72°C for 10 minutes. 
Standard curve, Specificity, and Sensitivity 
 To determine the sensitivity, assays were performed in three technical repeats on 
dilutions of turtle-derived positive control plasmid of FV3 MCP DNA (5.29x10
9
 - 5.29x10
1
 
copies/rxn) within a single run. Standard curves were generated using the cycle threshold (Ct) 
values of the positive control plasmid dilutions. Intra-assay variation was determined for both 
assays by calculating the mean Ct values, standard deviations (SD), and coefficient of variations 
(CV) separately for each control plasmid DNA dilution.  Efficiency curves of the dilutions were 
performed in uninfected cell culture lysates (spiked with plasmid dilutions), infected cell lysates, 
and turtle whole blood extracts from a positive sample. 
Box turtle samples 
 Thirty-one eastern box turtles that were presented to the University of Tennessee College 
of Veterinary Medicine Wildlife clinic for treatment of either traumatic or infectious disease 
identified by Good Samaritans were sampled during March through October 2007. Whole blood 
and swabs of the oral cavity were collected as previously described (Allender et al., 2011). The 
University of Tennessee Institutional Animal Use and Care Committee approved all animal use 
(protocol 1864). Results for detection were compared to published conventional PCR results for 
the same samples (Allender et al., 2011).  
Statistical Analysis 
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 The quantity of ranavirus target DNA in infected whole blood and oral swabs was 
determined using a standard curve method. The copy number of the target DNA was determined 
from the standard curve generated with ten-fold dilutions of the positive control plasmid that 
contained the target sequence of the respective qPCR assay. 
 Copy numbers were tabulated and evaluated for normality using the Shapiro-Wilk test.  
Mean, median, standard deviation, 95% confidence interval, and 10-90% percentiles were 
determined for positive cases (copy number) for each assay. The Mann-Whitney U test was used 
to evaluate between assay differences. The prevalence of ranavirus was determined for each 
assay (categorical variable assigned; 1=positive, 0=negative). Exact 95% binomial confidence 
intervals were determined for all proportions. Level of agreement (kappa) was determined 
between both the real-time PCR assays and the conventional PCR previously reported based on 
prevalence. All statistical analysis was performed using statistical software (IBM SPSS Statistics 
20, Chicago, IL). 
 
Results 
Conventional PCR was performed to evaluate the level of detection of turtle-derived 
FV3-like dilutions (Figure 3) (Mao et al., 1997) The TaqMan primer set was designed to detect a 
54 bp length gene segments of a conserved portion of the MCP gene of FV3. 
 Serial ten-fold dilutions of positive control plasmids were assayed with our TaqMan 
assay and standard curves were generated based on Ct values (Figure 1). The linear range for 
TaqMan was between 5.29 x 10
9
 to 5.29 x 10
4
 with an R
2
 of 0.999 (slope = -3.277) (Figure 1). 
Efficiency curves carried out on spiked-uninfected cell lysates (controlled for total DNA per 
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rxn), infected cell lysates, and turtle whole blood extracts performed equally well (data not 
shown). The amplification plots of TaqMan qPCR are presented in figure 2.  
 The intra- and inter-assay reproducibility was evaluated for the serial dilutions of the 
control plasmids (Table 2). The intra-assay CVs for TaqMan were between 0.04 – 0.24%. The 
inter-assay CVs were 0.14 – 0.3%, respectively. These results indicate high reproducibility 
between assays at all dilutions. The dynamic range for qPCR assays at which point the Ct value 
of the triplicates was from 5.29 x 10
9
 to 5.29 x 10
1
.   
Box turtle samples 
 Twenty-nine blood samples and thirty oral swabs were collected routinely from turtles 
presented to the University of Tennessee from March through October 2007.  Mean quantity of 
DNA recovered from blood samples measured through spectrophotometry was 726 ng/ul (95% 
CI: 550.38 – 902.05) and mean purity A260/280 was 1.85 (95%CI: 1.82 – 1.88). Median 
quantity of DNA recovered from swabs was 19.42 ng/μl (10-90%: 3.22 – 57.06) and A260/280 
was 1.81 (10-90%: 1.20 – 2.05).  Conventional PCR assays previously reported a 3% (n=1; 95% 
CI:0-9) prevalence rate for these samples (Allender et al., 2011). Quantitative PCR determined 
the presence of ranavirus in blood of the same individuals (prevalence = 3%; n=1; 95% CI:0-9). 
However, prevalence of ranavirus in the oral swab samples using qPCR identified the same 
individuals as conventional and an additional positive animal (prevalence = 6%; n=2; 95% CI: 0-
14).  Mean viral quantity in blood for the single animal that was positive using TaqMan was 1.72 
x 10
8
. The mean viral copy number in the swab sample from the same individual was 6.48 x 10
8
. 
The number of viral copies in the other swab sample that was positive (no corresponding positive 
blood sample) was 4785. Level of agreement between was substantial between conventional 
PCR and TaqMan qPCR (kappa=0.651). 
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Discussion 
 Ranaviral disease is one of only two amphibian diseases listed as reportable to the World 
Organization for Animal Health. This is in part due to the mass mortality events that have 
affected amphibian populations worldwide (Miller et al., 2011). Despite its listing and severity of 
disease outbreaks, the epidemiology of this virus in amphibians, and hence reptiles, is not 
completely understood.  Future and current epidemiologic surveys that determine the extent of 
disease and species range depend on diagnostic assays.  The current study developed a 
quantitative PCR assay that allows detection of ranavirus in levels up to 1000 viral copies below 
conventional PCR based on dynamic range and levels of detection. The greater sensitivity 
provides the opportunity to potentially detect early, subclinical, or reservoir states of the disease, 
which are crucial factors, that are currently unknown, but needed to characterize the 
epidemiology of ranavirus. 
The level of detection included a lower viral copy than the linear range for the assay.  The 
linear range was more reliable for quantification of higher viral copies than lower viral copies. It 
is likely that primer concentrations need to be optimized for low viral copy numbers, resulting in 
a separate protocol based on viral copy.  Future studies should lower primer concentrations in 
assays of with less than 5.29 x 10
4
 viral copies to establish a linear range that is more reliable for 
detection and quantification of low viral copy numbers. In the absence of that optimization, the 
developed assay is reliable for absolute quantitation of ranaviral DNA, with greater than 5.29 x 
10
4
 viral copies and relative quantitation for the entire dynamic range.  This might not 
biologically significant for this disease in this species, as viral quantity in infected animals is 
frequently above 5.29 x 10
4
 viral copies (Allender, unpub. data). 
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TaqMan assays utilize a third selection step (probe), which provides for greater 
specificity not seen with other qPCR assays. The TaqMan assay is more stringent in requiring the 
hybridization of a probe to target sequence between the PCR primers. Its degradation during 
PCR amplification is responsible for emitting a fluorescent signal. This additional step provides 
for a higher specificity when testing clinical samples. The assay had highly reproducible results 
with intra- and inter-assay variability coefficient of variation of less than 5%.  The primers were 
designed to be specific for a segment of the major capsid protein gene that previous studies have 
targeted with conventional PCR (Mao et al., 1997). It is highly conserved among various 
ranaviruses (Jancovich et al., 2010; Jancovich et al., 2005; Jancovich et al., 2003; Liu et al., 
2007; Marsh et al., 2002).  
DNA from twenty-nine blood samples and thirty oral swabs were screened for ranavirus.  
These samples were selected because they had previously been screened using conventional PCR 
(Allender et al., 2011). The results indicate that the TaqMan qPCR assay developed in this study 
was able to only identify a single additional positive oral swab sample, which was not identified 
using conventional PCR (Allender et al., 2011). This may signify that this population of turtles 
indeed had a low prevalence of FV3-like DNA (not infected), were not shedding ranavirus in the 
sample, or did not have enough viral copies to return a positive result. The parallel testing 
strategy used evaluating the two assays suggests that indeed the prevalence of infection was low 
in this population of box turtles. The pathogenesis of ranavirus in turtles is not known, and 
therefore it is possible that when a susceptible individual is exposed to the virus, it replicates 
quickly to a level above 529,000 viral copies (conventional PCR level of detection) or does not 
replicate well.  This would explain the results of conventional PCR and qPCR being similar.  
Regardless of the viral copies present in a clinical animal (as represented by these samples), early 
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and subclinical detection that might detect the intermediate viral stage between exposure and 
high viral copy will provide a valuable tool for control, monitoring, and management of this 
disease. However, specific transmission studies are needed to determine whether a subclinical or 
carrier state even exists in chelonians.  To further elucidate the sensitivity of this assay compared 
with conventional PCR, it will be important to apply it to a set of experimental samples where 
the prevalence of disease is high. As such, the quantitative assays reported here may be more 
useful in detecting and tracking the persistence and development of disease as once the animals 
present clinically they are likely overwhelmed with similar viral loads. 
Concentrations of DNA, measured by spectrophotometry, were greater from extracted 
whole blood samples than oral swab samples. This is not surprising, as whole blood of reptiles 
contains nucleated red blood cells, which leads to significantly more DNA. Swab samples mostly 
contain epithelial cells in fewer numbers and therefore less DNA. This difference may not be 
diagnostically significant as viral DNA concentrations are not necessarily increased in whole 
blood samples, and furthermore the increase in host DNA may lead to reduced efficiency during 
PCR assays. Additionally, the assays are not based on a uniform amount of isolated material, 
therefore, blood should be normalized based on milliliter of blood. There were too few positive 
turtle samples to evaluate if higher DNA concentrations correlated with higher viral load, but 
future studies should investigate this correlation. Purity of DNA, determined by A260/A280 
ratio, was within the ideal range (1.7 – 1.9) based on extraction guidelines for both whole blood 
and swab samples. However, the ratio was non-normally distributed for swab samples and the 
range was greater than whole blood samples. When the purity of the sample is outside the ideal 
range, it can lead to a decrease in assay efficiency or an increase in non-specific parameters and 
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inaccurate results. Therefore, purity should be evaluated prior to qPCR assay for all swab 
samples and samples outside the ideal range should be further purified before assaying. 
 The current study demonstrated that a TaqMan assay is reliable, specific, and sensitive 
for the detection of a gene segment of the MCP of frog virus 3. The TaqMan assay has low 
variability and was not likely to produce a non-specific product because of the additional probe 
step and therefore is the recommended assay for turtle ranavirus surveys.  This assay can be used 
as a tool in the conservation of turtles by identifying emerging and ongoing outbreaks. This assay 
is more sensitive in detecting fewer viral copies than conventional PCR, thereby allowing for 
early, subclinical, or reservoir status detection if those states exist in turtles.  As ranavirus 
continues to emerge as a major threat to reptiles and amphibians, it is critical that early and 
accurate identification of epidemics occur. 
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Table 3.1.  Intra- and inter-assay variability of two SYBR green and one TaqMan qPCR assays detecting frog virus 3 major capsid 
protein. 
                    Intra-assay                    Inter-assay 
Viral Copy CT mean CT SD CV CT mean CT SD CV 
 
TaqMan 
       
5290000000 13.14 0.02 0.14% 13.14 0.03 0.19% 
529000000 16.45 0.04 0.20% 16.45 0.04 0.23% 
52900000 19.93 0.03 0.14% 19.94 0.03 0.14% 
5290000 23.31 0.04 0.14% 23.30 0.04 0.16% 
529000 26.34 0.07 0.23% 26.30 0.09 0.30% 
52900 29.36 0.08 0.24% 29.33 0.07 0.22% 
5290 30.16 0.02 0.04% 30.14 0.05 0.15% 
529 31.24 0.05 0.14% 31.17 0.09 0.26% 
52 31.80 0.01 0.03% 31.85 0.07 0.19% 
NTC 37.94 1.05 2.26% 37.94 1.05 2.26% 
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Figure 3.1. Standard curve for a TaqMan probe-based primers obtained with tenfold serial 
dilutions from 5.29x10
9
 to 5.29x10
4
 FV3-like viral copies per reaction.  The graph is plotted 
against a logarithmic concentration of the serial dilutions. 
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Figure 3.2.  Amplification plots for the standard curve for TaqMan probe-based primers obtained 
with tenfold serial dilutions from 5.29x10
9
 to 5.29x10
4
 FV3-like viral copies per reaction plotted 
as the change in signal generated by each PCR amplicon (ΔRn) during each cycle. 
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Figure 3.3.  Gel electrophoresis of conventional PCR products using the MCP 4 primer targeting 
the major capsid protein of frog virus 3. Lane 1: 100 bp marker; Lane 2-11: Tenfold serial 
dilutions from 5.29x10
8
 to 5.29x10
1
 viral copies per reaction; Lane 12: 100 bp marker. 
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CHAPTER 4 
 
PREVALENCE, CLINICAL SIGNS, AND NATURAL HISTORY CHARACTERISTICS IN 
EASTERN BOX TURTLES (TERRAPENE CAROLINA CAROLINA) WITH FROG VIRUS 3-
LIKE VIRUS
 2
 
 
Abstract: Ranaviruses, specifically frog virus 3-like virus (FV3-like), have been associated with 
chelonian mortality events and may threaten biodiversity.  To help characterize the disease 
ecology of FV3-like in chelonians, 606 free-ranging eastern box turtles (Terrapene carolina 
carolina) from either a free-living setting or those presented to rehabilitation centers in 
Tennessee, Virginia, North Carolina, Alabama, and Georgia were sampled from 2007 through 
2011.  Whole blood and swabs of the oral mucosa were collected from 458 adults (248 female, 
199 male, 1 unknown sex) and 61 juveniles.  Sex and age were unknown in 87 individuals. The 
prevalence of infection using quantitative PCR was 1.5% (n = 8; 95% CI: 0.8 – 2.9%). The 
prevalence in turtles presented to rehabilitation centers (n=7, 3.13%; 95% CI: 1.5 – 6.3%) than 
free-living turtles (n=1, 0.3 %; 95% CI: 0 – 1.8%). Four of the individuals were positive in whole 
blood samples and four individuals where positive in oral swab samples. Three of the eight 
infected were females while the other five individuals had unknown sex. Two of the eight were 
adults, two were juveniles and the remaining four animals had unknown age. DNA concentration 
was significantly higher in extracts of blood samples than swab samples, except for FV3-like 
positive animals in which oral swab extracts (41.3 μg/ml; 95% CI: 11.0 – 56.8) had higher 
                                                        
2 Content of this chapter has been partially or fully submitted for publication as cited in 
bibliography as Allender et al., 2012b. 
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concentration than whole blood extracts (22.5 μg/ml; 95% CI: 14.2 – 100).  DNA purity 
(A260/A280 ratio) was non-significantly more variable for extracts of swab samples than blood 
samples. Clinical signs significantly associated with infection were diarrhea and bone fractures.  
Results of this study indicate a low prevalence of disease in box turtles that is characteristic of an 
acute disease process.  Based on this study and other published reports, eastern box turtles are 
sensitive to frog virus 3 infection, and this virus represents a potential threat. 
 
 
Key Words: Ranavirus, Terrapene carolina, qPCR, chelonian, infectious disease 
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Introduction 
 Ranaviral disease has been linked to several mortality events in amphibians and reptiles 
(Green, 2002; Johnson et al., 2008). These outbreaks have been variable across the landscape, 
often leading to significant mortalities that may threaten biodiversity (Grey et al., 2011). Reports 
in chelonians have been fewer than amphibians, but it is unclear whether this is a natural bias or 
under reporting.  When reported, several species of chelonians, notably the eastern box turtle 
(Terrapene carolina carolina), have had severe disease of short duration (Allender et al., 2011). 
 The eastern box turtle has been downgraded to vulnerable status by the International 
Union on the Conservation of Nature and Natural Resources (IUCN) (van Dijk, 2011). 
Significant declines have been observed in numerous areas throughout its range, with an 
estimated 30% decline over the previous three generations (Swarth and Hagood, 2006; van Dijk, 
2011). Specific causes for the decline are not entirely known, but are attributed to human-
induced factors including: road and mowing mortality, collection, nest depredation, prescribed 
burning, disturbance of nest sites by off-road vehicles, and habitat loss (Swarth and Hagood, 
2006; Nazdrowicz et al., 2008; Currylow et al., 2011; van Dijk, 2011).
  
While a combination of 
factors is likely playing a role in the population declines of the box turtle, disease outbreaks due 
to Ranavirus have been emerging across the eastern United States (US) in chelonians and are 
also listed as a suspected cause of decline by the IUCN (Allender et al., 2011; Johnson et al., 
2008; van Dijk, 2011). 
 Ranavirus is one of five genera from the family Iridoviridae and one of two genera from 
the family reported to infect reptiles. They are large, icosohedral, DNA viruses, and viruses from 
this genus have emerged as a significant cause of mortality events in free-ranging herpetofauna 
throughout the world (Green et al., 2002; Johnson et al., 2008; Mao et al., 1997). Ranaviral 
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infection was placed on the World Organization for Animal Health list of reportable diseases for 
amphibians in 2010.  Most disease events in chelonians have been associated with FV3-like virus 
(Allender et al., 2011; Johnson et al, 2008). Epizootics of frog virus 3 have been scattered across 
several habitats and landscapes in the US; however, disease predictability has not been 
successful (Allender et al., 2011). To date in the US, ranaviral disease has been diagnosed in 
seven species of chelonians; this includes ten outbreaks in eastern box turtles across ten different 
states (Allender et al., 2011b). 
The present study estimated the prevalence of frog virus 3 from different populations of 
eastern box turtles in the US.  Our hypotheses were that: 1) Frog virus 3-like disease is 
associated with an acute mortality events in box turtles; 2) The prevalence of frog virus 3-like 
DNA in ante-mortem samples collected from box turtles in the US will be low (<5%); 3) Clinical 
signs of conjunctivitis, ocular discharge, oral plaques, and respiratory distress will be associated 
with ranaviral infection in box turtles; 4) The prevalence of ranaviral disease will not be 
associated with age, sex, or weight characteristics; 5) The prevalence in wild animals presented 
to rehabilitation facilities would be higher than that found in wild caught animals.  
 
 
Materials and Methods 
Sample populations.  Turtles sampled for this study were derived from two populations: wild 
caught, free-ranging turtles and wild turtles presented to rehabilitation facilities. The wild caught, 
free-ranging turtles were actively sought in their natural habitat, while the turtles presented to 
rehabilitation facilities represented animals found in an unnatural place, or that were injured or 
diseased. The wild caught turtles were sampled from 2008 through 2011 from a population near 
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Oak Ridge, TN, USA (OR). These turtles were actively searched through human visual 
encounters or canine search (Figure 4.4). Wild turtles presented to rehabilitation facilities were 
sampled prospectively in 2007, 2010, and 2011 and opportunistically in 2008 and 2009; five 
different wildlife rehabilitation centers participated: University of Tennessee (UT)(Knoxville, 
TN, USA), Wildlife Center of Virginia (WCV)(Waynesboro, VA, USA), North Carolina State 
University (NCSU)(Raleigh, NC, USA), Alabama Wildlife Center (AWC)(Pelham, AL, USA), 
and the University of Georgia (UGA) (Athens, GA, USA). All procedures were approved by the 
Institutional Animal Care and Use Committee approval through the University of Tennessee and 
University of Illinois (UT: 1630-0507, UI: 10057). The sample size used for this study was based 
on the following assumptions: an FV3 prevalence of 10% in rehabilitation population and 1% in 
free-ranging population with an alpha of 0.05 and power of 0.8. 
Field Methods. Mass of free-living turtles was measured to the nearest gram.  Turtles from the 
rehabilitation facilities were weighed with a variety of devices, and to at least the nearest 1 g.  
Blood samples (less than 0.8% body weight) were collected from the subcarapacial sinus using a 
22 gauge needle and 3 ml syringe (Figure 3). The samples were immediately placed in a lithium 
heparin coated microtainer (Becton Dickinson, Franklin Lakes, NJ, USA) and mixed by gentle 
rocking. Oral epithelium and mucus was collected from within the oral cavity using cotton-
tipped plastic handled applicators (Fisher Scientific). The swab tips were placed in a 1.7 mL 
polypropylene microcentrifuge tube (Costar, Corning Inc., Corning, NY, USA) for storage.  The 
blood and swabs were labeled with a unique identification number and remained on-site at -20ºC, 
batch shipped on ice, and stored at -20ºC until analysis. 
Polymerase Chain Reaction.  Quantitative PCR was performed as previously described (Allender 
et al., 2012a).  Briefly, DNA was extracted from whole blood and oral swabs using 
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manufacturer’s instructions (QIAmp Blood Mini Kit, Qiagen, Valencia, CA, USA).  TaqMan 
assay was performed using forward (AACGCCGACCGAAAACTG), reverse 
(GCTGCCAAGATGTCGGGTAA), and probe (CCGGCTTTCGGGC) targeting a 54 bp 
segment of the major capsid protein (MCP) of frog virus 3. All samples were assayed in three 
technical repeats using a real-time PCR thermocycler (7500 ABI real-time PCR System, Applied 
Biosystems, Carlsbad, CA, USA), analyzed using commercial software (Sequence Detection 
Software v2.05, Applied Biosystems), and results averaged. 
Clinical Survey. Clinical signs were evaluated by the admitting clinician at each institution and 
recorded on a standard data sheet provided (Figure 4). The presence or absence of clinical signs 
compatible with those previously described for Ranavirus infection or other non-specific 
systemic disease were documented. Specific clinical signs included aural abscess, cellulitis, 
conjunctivitis, cutaneous abscessation, nasal discharge/rhinitis, ocular discharge, oral 
abscessation, oral discharge/stomatitis, oral plaque, oral ulceration, and respiratory distress. Each 
sign was scored as absent (0) or present (1). Clinical signs for systemic disease not specifically 
reported in upper respiratory tract (URT) infections (at present) include fracture of appendage(s) 
or shell and diarrhea.   These signs were also scored as present (1) or absent (0).  Most turtles 
(328) at OR had engaged their plastron hinge, making it impossible to perform a complete 
physical examination. Furthermore, 63 rehabilitation turtles had no clinical sign recorded. 
Statistical Analyses. Descriptive statistics were tabulated for all continuous variables (weight, 
viral copy number, DNA concentration, DNA purity).  Normality was assessed using the 
Shapiro-Wilk test. Comparisons were made using ANOVA/Kruskal-Wallis and t-test/Mann-
Whitney U for within and between group differences for normally distributed and non-normally 
distributed data, respectively. Overall prevalence proportions (based on qPCR) and their 95% 
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confidence intervals were computed. In cases where the prevalence estimate was 0, the 95% 
confidence intervals were calculated with the technique described by Van Belle and Millard 
(1998). Prevalence proportions were evaluated for equal probabilities using a One-sample Chi-
square test. PCR results, natural history characteristics, and clinical signs were performed using 
McNemar’s Chi-square and Fisher’s exact. Chi-square or Fisher exact tests were used to evaluate 
the presence or absence of natural history characteristics or clinical signs by PCR test results.  
Odds ratios were calculated for each clinical sign based on frog virus 3-like status. Logistic 
regression models were created for any of the above variables that had a p value <0.1. Hosmer-
Lemeshow goodness-of-fit test was used to evaluate model fit. A stepwise approach was used to 
build the model. Despite multiple comparisons of clinical signs with prevalence, no p value 
correction was made due to small sample size and risk for Type I error as previously described 
(McDonald, 2009). Statistical significance was considered when p<0.05.  All analysis was 
performed using statistical software (SPSS 20, IBM statistics, Chicago, IL). 
 
Results 
There were 606 (wild turtles: 367, 61.1%; rehabilitation turtles: 231, 38.9 %) turtles 
sampled from 2007 through 2011, with 109 (18.5%) turtles sampled in 2007, 87 (14.6%) in 
2008, 7 (1.2%) in 2009, 261 (41.6%) in 2010, and 142 (24.1%) in 2011.  There were 38 (6.3%) 
individuals sampled from UT, 370 (61.1%) from OR, 125 (20.6%) from WCV, 47 (7.8%)from 
NCSU, 17 (2.8%) from AWC, and 9 (1.5%) from UGA.  Five hundred and twenty-five turtles 
had sampling months recorded; 7 (1.3%) from April, 75 (14.3%) from May, 208 (39.6%) from 
June, 142 (27%) from July, 24 (4.6%) in August, 46 (8.8%) in September, 20 (3.8%)in October, 
2 (0.4%) in November, and 1(0.2%) in December.  Of the 522 animals with age and sex 
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recorded, 199 (38.1%) were male, 248 (47.5%) were female, and 75 (14.4%) were of unknown 
sex, 458 (87.7%) were adult, 61 (11.7%) were juvenile, and 3 (0.6%) had unknown age recorded. 
Institutions, year, sex, and age classes were not sampled with equal probabilities 
(p<0.0001).  There was no difference in the age of turtles sampled by institution (p=0.698), year 
(p=0.460), or month (p=0.968).  Juvenile turtles were significantly associated with unknown sex 
(p<0.0001). There was no difference in the sex of turtles sampled by institution (p=0.093) or 
month (p=0.635). There were significant differences in the sex of turtles when evaluating year 
(Figure 4.1) (p=0.007). There was a significant difference in the month turtles presented by year 
(Figure 4.2) (p<0.0001) and institution (Figure 4.3) (p<0.0001). There were no significant 
difference in the month turtles presented based on age (p=0.968) or sex (p=0.635). 
Mean weight for females (350 g, 95% CI: 338 – 362) and males (345 g, 95% CI: 335 – 
354) was significantly (p<0.0001) higher than that of unknown sex turtles (202 g, 95% CI: 174 – 
231); there was no significant difference between females and males (p=0.77).  Adult turtles 
weighed 353 g (95% CI: 347 – 360), juveniles weighed 131 g (95% CI: 115 – 147), and 
unknown aged turtles weighed 203 g (Min/Max: 95 – 265).  Adults were significantly heavier 
than juveniles (p<0.0001) and unknown age turtles (p=0.001).  Turtle weight was not 
significantly different by institution (p=0.717). 
 There were 444 blood samples collected and 434 oral swab samples collected, for a total 
of 540 turtles with either a blood sample or oral swab or both (400) collected. Mean DNA 
concentration in blood samples was 161.9 µg/ml (95% CI: 142 – 180) and swab samples 20.7 
µg/ml (95% CI: 19 – 22). DNA concentration of blood sample extracts was significantly higher 
than swab samples (p<0.0001), but there was no difference in purity between blood and swab 
samples (p=0.195). Purity of DNA (A260/A280) in blood samples was 1.81 (95% CI: 1.79 – 
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1.82) and swab samples was 1.91 (95% CI: 1.75 – 2.06). Purity of DNA from swab samples was 
not significantly (p=0.262) different by institution.  However, significant differences were seen 
with DNA concentration of blood samples (p<0.0001), DNA concentration of swab samples 
(p<0.0001), and purity of DNA from blood samples.  There was a significant difference in DNA 
concentration of blood samples between NCSU (325 µg/ml) and UT (152 µg/ml) (p=0.003), OR 
(171 µg/ml) (p<0.0001), WCV (101 µg/ml) (p<0.0001), and AWC (25 µg/ml) (p<0.0001). There 
were significant difference in the DNA concentration from swab samples between OR (26.9 
µg.ml) and WCV (15 µg/ml) (p<0.0001), OR and NCSU (7 µg/ml) (p<0.0001), UT (21 µg/ml) 
and NCSU (p=0.003). There were significant differences in the purity of DNA from blood 
samples between UT (1.89) and OR (1.81) (p=0.009), UT and WCV (1.81)(p=0.014), UT and 
NCSU (1.77) (p<0.0001), and UT and AWC (1.74) (p=0.005). 
 There were significant differences in DNA concentration from blood samples (p<0.0001) 
and swab samples (p<0.0001) by year. DNA concentration in blood samples was higher in 2007 
than 2008 (p<0.001), 2010 (p<0.001), and 2011 (p<0.001). DNA concentration in swabs samples 
was lower in 2007 compared to 2008 (p=0.014), 2010 (p=0.001), and 2011 (p<0.001); as well as 
2008 compared to 2011 (p=0.03). There no differences in weight (p=0.188), DNA purity from 
blood samples (p=0.328), or DNA purity from swab samples (p=0.579) by year (Table 4). There 
were significant differences in weight (p<0.0001) and DNA concentration from blood between 
sexes (female: 171.5 µg/ml; male: 152.6 µg/ml; unknown: 234.14 µg/ml). There were no 
differences between sexes for DNA concentration from swab samples (p=0.352), DNA purity 
from either blood (p=0.090) or swabs (p=0.853).   
 Turtles presented to rehabilitation centers had a higher prevalence of FV3-like infections 
than free-living box turtles (p=0.01). There were four positive swab samples and four positive 
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blood samples, no turtle was positive on both sample types despite both sample types being 
tested in each animal. There were no significant differences in FV3-like status by year (p=0.493; 
observed power ranged 0.02 through 0.42), sex (p=0.156; observed power ranged from 0.05 
through 0.76), or age (p=0.073; observed power = 0.9). UT, WCV, NCSU, and AWC had higher 
prevalence than UGA or OR (p<0.0001). When month was recorded, FV3-like prevalence was 
detected in April (n=1), June (n=2), and July (n=1) which were not significantly different.  
However, FV3-like prevalence was different between those months and the months that no FV3-
like was detected (p=0.04). There was no association of FV3-like status with year (p=0.515) 
(Table 2), age (p=0.081) (Table 3), or sex (p=0.157) (Table 3). Logistic regression modeling for 
overall FV3-like status that included independent variables of institution, month, and age was not 
significant (p=0.260). Logistic regression modeling for FV3-like prevalence in blood that 
included independent variables of year, month, and institution was not significant (p=0.338). 
Logistic regression modeling for FV3-like prevalence in swab that included independent 
variables of age, institution, and sex was not significant (p=0.796). Weight was significantly 
lower in ranavirus-positive animals (198g) than ranavirus-negative animals (325 g) (p=0.012). 
 Two hundred and eight animals had full physical examinations performed.  There were 
significant associations with FV3-like presence and fracture (n=3) (p=0.045) and diarrhea (n=1) 
(p=0.017) when no Bonferroni correction was made. However, neither clinical sign was 
significant when the correction was made. The other clinical signs that were evaluated were not 
found to be significantly associated with FV3 prevalence: aural abscess (p=0.895), cellulitis 
(p=0.967), conjunctivitis (p=0.934), cutaneous abscessation (p=0.983), lethargy (p=0.902), nasal 
discharge (p=0.910), ocular discharge (p=0.910), oral discharge (p=0.934), oral plaque 
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(p=0.967), or respiratory distress (p=0.910).  FV3-like positive turtles were 153 times more 
likely (95% CI: 4.7 – 4942) to have diarrhea than in FV3-like negative turtles. 
 There were no differences in weight (p=0.134), DNA blood concentration (p=0.243), or 
DNA purity in blood (p=0.242) based on FV3 prevalence in blood (Table 4).  There was a 
significant difference in weight (p=0.21) between ranavirus positive (positive: 325 g) and 
negative turtles (198 g).  There were no differences in DNA concentration in swabs (p=0.067) or 
DNA purity (p=0.928) based on FV3-like status (Table 4). 
 Median FV3-like virus copy number from blood samples in positive animals was 1927 
(Min/Max: 3854 – 28060) not significantly different from median FV3-like virus copy number 
from swab samples in positive animals was 2505 (Min/Max: 5011 – 29893) (Table 4).  
 There were 13 (6.3%; 95% CI: 3.7-10.4%) animals with an aural abscess, 4 (1.9%; 95% 
CI: 0.8-4.8%) with cellulitis, 8 (3.9%; 95% CI: 1.9-7.4%) with conjunctivitis, 115 (55.8%; 95% 
CI: 48.5-61.9%) with fracture, 11 (5.3%; 95% CI: 2.9-9.2%) with lethargy, 11 (5.3%; 95% CI: 
2.9-9.2%) with nasal discharge, 11 (5.3%; 95% CI: 2.9-9.2%) with ocular discharge, 8 (3.9%; 
95% CI: 1.9-7.4%) with oral discharge, 4 (1.9%; 95% CI: 1.9-7.4%) with oral plaques, and 11 
(5.3%; 95% CI: 2.9-9.2%) with respiratory distress.  Other clinical signs seen in single animals 
included tongue discoloration, rear limb ataxia, edema of the neck and forelimbs, and skin 
lacerations.  There were three animals that were positive for FV3-like DNA in blood that had 
clinical signs recorded.  None of these three positive turtles had aural abscess, cellulitis, 
conjunctivitis, lethargy, nasal discharge, ocular discharge, oral plaque, or respiratory distress.  
However, all three animals had a fracture and one of the animals had diarrhea.  None of turtles 
with FV3-like virus positive swab samples had clinical signs recorded. 
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Discussion 
 As populations of box turtles decline, the opportunity for disease-related events to lead to 
catastrophic events increase. A disease that has a short duration of effect with high mortality may 
lead to such a catastrophic event. Thus far, over 70 reports of Ranavirus infections in free-
ranging amphibians have indicated that mortality rates may be as high as 90% locally, with 
potential to cause local extirpations (Jancovich et al., 2003; Miller et al., 2011).  Large events 
such as these have not been documented in chelonians, and it is unknown whether they are 
occurring or going unnoticed.  However, there have been at least sixteen reports of ranaviral 
disease in chelonians, with 10 of them involving the eastern box turtle (Allender et al., 2011b; 
DeVoe et al., 2004; Allender et al., 2011a; Johnson et al., 2008; Ruder et al., 2008; Johnson et 
al., 2010). Most of these represent single case reports of less than ten individuals involved in an 
outbreak.  This is not surprising as the solitary behavior and habitat of the turtle may prohibit 
multiple animals from being detected.  This is in contrast to amphibians that breed in ephemeral 
ponds and are commonly seen in high densities.  It would be of great concern if the same level of 
mortality was occurring in box turtles, but was going unnoticed because of these natural history 
characteristics. The solitary behavior of turtles may prevent or slow the spread of disease if 
infrequent intra-species contact occurs, but high level of interactions may still occur during 
certain times of the year (e.g. mating). 
  The prevalence across several states was variable, but was confirmed in Alabama, 
Tennessee, and Virginia. The prevalence was highest in Alabama, which was significantly higher 
than all other institutions except UT, but is likely due to the small sample size tested from that 
state.  Frog virus 3-like infection in eastern box turtles have previously been seen in Tennessee 
and Virginia (Allender et al., 2011a), but this is the first report from Alabama. The low 
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prevalence in this study is similar to that reported for gopher tortoises and box turtles using an 
ELISA (Johnson et al., 2010). This low prevalence in combination with a high mortality reported 
in chelonians (Johnson et al., 2006; Allender et al., 2012c) reinforces that this is a disease with 
an acute duration and continued monitoring is needed to document range expansion of frog virus 
3 in eastern box turtles. 
 Larval and metamorphic amphibians of most species have higher documented mortality 
to FV3 than adult amphibians (Miller et al., 2011), but no such information is available for 
chelonians.  In this study, we found that juvenile turtles were more likely to be infected with frog 
virus 3 than adults. However, there were only 57 juveniles tested, while 400 adults were tested. 
Juvenile turtles are more difficult to find, and may represent a highly susceptible age class that 
should be monitored more closely. Juvenile box turtle survivorship is reported to be low (Dodd, 
2001), and threats that further reduce it may threaten long-term sustainability. 
 There was a statistically significant difference in prevalence of frog virus 3-like virus 
based on year, with 2008 higher than 2007, 2009, and 2011. However, this observation is not 
expected to represent a biologically significant finding, as the prevalence remained low in all 
years. The year with the lowest prevalence also had the lowest number of animals tested. And 
even though there are several amphibian populations that have endured annual outbreaks (Fox et 
al., 2006; Carey et al., 2009), this pattern has not been seen in chelonians. The absence in certain 
years likely represents sampling bias rather than the virus being absent from the environment. 
This study found two cases in June, and one each in April and July, and four cases with no 
month recorded. Differences in infectivity of ranaviruses due to temperature have been shown 
for amphibians (Rojas et al., 2005) and turtles (Allender et al., 2012c), which likely will lead to 
differences in detection based on season and environmental temperature. Future studies need to 
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identify the time of year and locations of known cases and begin ongoing surveillance of those 
locations to further characterize the epidemiology in relation to environmental temperature. The 
ability to target a season or temperature range that turtles are likely to be infected may aid in 
management efforts of threatened or endangered populations and increase the probability of 
finding infected turtles. 
 There were three females and no known males diagnosed with frog virus 3-like in the 
current study. Five positive animals had no sex recorded and were not included in the analysis of 
sex as a factor in FV3-like status.  There has been no sex predilection described in other reports 
on amphibians or reptiles and the results of this study are likely only a statistical anomaly.   
 This was the first study to utilize quantitative PCR to survey populations of chelonians.  
This method is considered more sensitive than conventional PCR, allowing for the detection of 
potential subclinical disease states.  However, there has been no evidence that box turtles exist in 
a subclinical state. The severity of disease and high mortality in this species indicates that if the 
animal is exposed, mortality occurs. The eight animals that tested positive in this study were lost 
to follow-up and confirmation that these animals died from ranavirus would need to be 
confirmed based on necropsy evaluation. Previous reports have demonstrated that the virus is 
detectable in many different tissues post-mortem (Johnson et al., 2007); however, clinical 
antemortem samples have typically involved whole blood or swabs of the oral mucosa.  This 
study utilized both blood and oral swabs and viral copy number was not significantly higher in 
blood than oral swabs. Previous studies have shown that samples that are positive in blood are 
also positive in swabs (Allender et al., 2011), but qPCR development in turtles indicated that 
detection in swabs may occur prior to blood (Allender et al., 2012).  In this study, there were 
eight positive animals detected with four positive in blood and four positive in oral swabs. There 
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are several factors that may have lead to one sample being positive and the other sample 
negative, such as inefficient DNA extraction, poor sample collection, inappropriate sample 
handling, or absence of viral shedding in the sample. In experimental transmission in turtles, 
infected animals demonstrate viremia from initial detection through death and therefore absence 
of shedding is not likely the cause of the negative status in blood samples. Additionally, the 
detection in swab samples only may represent the mode of transmission, which is unknown in 
chelonians. If transmission occurs through an oral route, then DNA might be detected in the oral 
swab sample prior to blood. Regardless, future investigations should continue to sample multiple 
tissue types to increase detection ability in a population. 
 One molecular factor that may lead to false negatives includes the DNA concentration 
and DNA purity. This study utilized a spectrophotometer that allowed for the quantification of 
DNA and assessment of its purity by using 1 µl of sample. This technology allows the user to 
assess whether the extraction was ideal for the developed PCR.  If not ideal, then purification of 
the extract can be performed.  However, it doesn’t allow differentiation of viral DNA or host 
DNA. There was no statistically significant difference in DNA quantity or purity between blood 
and swab samples that were positive for FV3 in the current study, however DNA concentration 
was higher in positive swabs rather than positive blood. Similarly, DNA concentration in 
positive blood was lower and concentration of positive swabs was higher than the negative 
samples.  Positive blood may have less DNA because of disease-related anemia or increased total 
solids in samples that dilute total DNA concentration. However, decreases in total solids have 
been seen with experimental transmission of FV3-like infection in red-eared sliders (Allender et 
al., 2012d).  Positive swab samples may have had more DNA because there was increased cell 
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sloughing that was disease-related or other pathogens such as bacteria, other viruses, and 
parasites. 
Manufacturer’s instructions indicate that the ideal range for DNA of A260/A280 is 1.7 to 
1.9, and that this represents a pure sample.  Swab extracts were much more variable than blood 
samples despite the fact that the median value was nearly the same as the median value of the 
blood extracts. This is likely due to less DNA in the sample or inhibitors in the cotton on the 
applicators.  Conversely, blood samples were more frequently purified because of impure 
original extraction.  This impurity is likely due to the overwhelming amount of host DNA and 
cell lysis that is required in samples with nucleated blood cells. All of these blood samples were 
isolated based on 200 μl of whole blood sample, however, recent manufacturer’s 
recommendations indicate that 10 μl of whole blood is the current volume that should be used for 
samples with nucleated red blood cells. This will undoubtedly decrease not only the potential 
host DNA that is available for extractions (as is anticipated by the manufacturer’s changes), but 
it will consequently decrease the potential viral DNA.  Alternatively, extractions can use higher 
volumes of blood, but require more reagents and time for extraction.  Future studies should 
determine if smaller sample volumes can be optimized that maximize detection of FV3. 
 Several clinical signs have been associated with FV30like infection in turtles, including 
ocular discharge, oral discharge, respiratory distress, and oral plaques (DeVoe et al., 2004; 
Johnson et al., 2006).  Unfortunately, none of those clinical signs were associated with positive 
status in this study. The absence of significant associations with clinical signs is likely due to the 
low prevalence of ranavirus and the relatively high number of clinical signs in non-infected 
animals. Despite this low prevalence, both fracture and diarrhea were significantly associated 
with FV3-like infection in this study.  This was a biased population in that several rehabilitation 
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clinics were included, but this allowed animals with fractures to be identified with FV3-like 
infection.  This is valuable to clinicians at these or other rehabilitation clinics to not overlook 
infectious diseases in the face of the fracture. Diarrhea has high odds of occurring with FV3-like 
infection. This likely represents a manifestation of systemic disease rather than a specific disease 
process. The failure of this study to identify other clinical signs indicates that other signs are 
non-specific and several other FV3-like negative turtles were exhibiting oral plaques, ocular 
discharge, and nasal discharge. All future studies should continue to record clinical signs, it may 
be possible to better determine associations with clinical signs in populations that have higher 
prevalence.  
In summary, this was the largest cross-sectional study to estimate the prevalence FV3-
like virus in wild and rehabilitating eastern box turtles. It demonstrated that the prevalence of 
FV3-like virus is low in both populations, and that temporal and geographical influences were 
minor.  Findings that FV3-like virus was in non-significantly higher proportion in females and 
juvenile animals warrant further work, especially if there is a potential for vertical transmission. 
Clinical signs of fracture and diarrhea were significantly associated with infection. Since fracture 
is a common finding in turtles presented to rehabilitation facilities (Brown and Sleeman, 2002; 
Schrader et al., 2010), this finding may have been biased by the types of presentations.  It is also 
possible that animals infected with a virus that causes acute disease with a high mortality could 
affect the behavior of the turtle and cause it to be more likely to become injured (e.g., hit by car).  
Infection was detected both in blood and oral swabs, and future studies should continue to use 
these samples for detection. These findings elucidate that FV3-like infection has several signs of 
an acute systemic disease: low prevalence, few clinical signs, and no biologically significant sex-
specific prevalence. The higher prevalence in juveniles is supported by other studies that show 
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higher mortality in juvenile salamanders (Miller et al., 2011), but more work is needed to 
determine if this is true in experimental settings as well.   
Eastern box turtles presented to rehabilitation centers are more likely to be detected with 
FV3-like infections than free-living eastern box turtles. The presence of FV3-like in free-ranging 
animals may indicate a threat to population sustainability and future research is needed to 
determine the impacts to endangered populations. 
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Table 4.1.  Prevalence of frog virus 3-like DNA determined by quantitative PCR in eastern box turtles sampled from the southeastern 
US. 
 
Location  FV3-like 
positive 
FV3-like 
negative 
Prevalence 95% CI 
Free-living*  1 308 0.3% 0 – 1.8 % 
Rehabilitation*  7 217 3.13% 1.5 – 6.3% 
 UT 3  35  7.9% 2.7 – 20.1 % 
 WCV 2 120 1.6% 0.4 – 5.9 % 
 NCSU 0 46 0.00% 0 – 7.7 % 
 AWC 2 14 14.3% 4.0 – 39.9 % 
 UGA 0 9 0.00% 0 – 29.9 % 
 
                               Total      8  532  1.5%        0.8 – 2.9 % 
 
* Significantly higher prevalence in rehabilitation turtles (p=0.01) than free-living turtles. 
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Table 4.2.  Prevalence of frog virus 3-like virus in blood and oral swab samples determined by quantitative PCR in eastern box turtles 
from 2007-2011. 
 
Year  FV3-like 
positive 
FV3-like 
negative 
Prevalence 95% CI 
2007  1 107 0.9 % 0.2 – 5.1 % 
2008  3 80 3.6 % 1.2 – 10.1 % 
2009  0 7 0.0% 0 – 35.4 % 
2010  3 207 1.4% 0.5 – 4.1 % 
2011  1 131 0.8% 0.1 – 4.2 % 
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Table 4.3.  Prevalence of frog virus 3-like virus in blood and oral swab samples determined by quantitative PCR in eastern box turtles 
based on age class and sex from 2007-2011. 
 
Variable  FV3-like 
positive 
FV3-like 
negative 
Prevalence 95% CI 
Female  3 168 1.8 % 0.6 – 5.0 % 
Male  0 218 0.00% 0 – 1.7 % 
      
Adult  2 398 0.5 % 0.1 – 1.8 % 
Juvenile  2 55 3.5 % 0.9 – 11.9 % 
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Table 4.4.  Descriptive statistics for DNA concentration and DNA purity (A260/A280 ratio) for extracts of blood and oral swab 
samples from eastern box turtles from 2007 through 2011. 
 
  Blood  Swab 
  Median 10-90% 
percentiles 
Min/Max  Median 10-90% 
percentiles 
Min/Max 
FV3-like virus 
copy 
 13297 3854 - 24287 3854 - 28060 6871 5011 - 24337 5011 - 29893 
         
DNA 
concentration 
78.1
#
 19.5 - 401.2 2.7 - 1472.6  14.9
#
 3.7 - 43.8 0.32 - 132.9 
         
DNA 
purity 
 1.84 1.65 - 1.89 0.78 - 2.77  1.83 1.4 - 2.15 0 - 25.7 
 
#
 Statistically significant higher in blood samples, p<0.0001 
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Table 4.5.  Descriptive statistics for DNA concentration and DNA purity (A260/A280 ratio) for extracts of blood and oral swab 
samples from eastern box turtles from 2007 through 2011 with or without molecular evidence for frog virus 3. 
  FV3-like Positive   FV3-like Negative  
  Median 10-90% 
percentiles 
Min/Max  Median 10-90% percentiles Min/Max 
Blood 
DNA 
concentration 
22.5 14.1 - 100 14.1 - 124.7  97.2 19.4 - 495.4 2.7 - 1472.6 
        
DNA purity 1.75 1.57 - 1.86 1.57 - 1.88  1.84 1.67 - 1.89 0.78 - 2.77 
         
Swab 
DNA 
concentration 
41.3 11.0 - 56.8 11 - 57.2  14.5 3.5 - 43.85 0 -132.6 
        
DNA purity 1.94 1.85 - 2.14 1.85 - 2.2  1.83 1.39 - 2.14 0 -25.7 
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Figure 4.1. Distribution of eastern box turtles by sex and year evaluated for frog virus 3-like virus. 
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Figure 4.2.  Proportion of eastern box turtles that presented each month by year. 
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Figure 4.3. Proportion of eastern box turtles that presented each month by institution. 
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Figure 4.4. GPS locations of individual eastern box turtles observed using canine searches 
(yellow dot), incidental human captures using 50m x 50m transect searching (red dot), and 
incidental human encounters (turquoise dot) from 2006 through 2008 at the Oak Ridge, TN site. 
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CHAPTER 5 
 
EVALUATING THE EFFECTS OF EXPERIMENTAL FROG VIRUS 3-like virus ON RED-
EARED SLIDERS (TRACHEMYS SCRIPTA ELEGANS) HELD AT DIFFERENT 
ENVIRONMENTAL TEMPERATURES
 3
  
 
Abstract:  Ranaviral disease has been reported in several species of reptiles, but the disease 
progression and mortality in relation to environmental temperature has yet to be determined. In 
this study, adult female red-eared slider turtles (Trachemys scripta elegans) were evaluated after 
experimental inoculation with a ranavirus isolate at 22°C and 28°C. Mortality at 22°C was 100% 
(4/4), while mortality at 28°C was 50% (2/4). Median survival time for turtles exposed to 22°C 
was 24 days, while it was 30 days in the 28°C trial. Consistent histologic lesions were observed 
only in the 22°C inoculated turtles and included fibrinoid necrosis of vessels in the spleen, 
vascular and sinusoidal thrombi in the liver, necrotizing myositis, and a mild heterophilic 
interstitial pneumonia. Quantitative PCR was able to detect viral copies in whole blood, oral and 
cloacal swabs, tongue, skeletal muscle, lung, heart, liver, spleen, ovary, and kidney in all affected 
individuals of both trials. Viral copy number in antemortem clinical samples was non-
significantly highest in whole blood compared to oral swabs and cloacal swabs, while kidney had 
the non-significantly highest viral copy number in postmortem samples.  Means of each sample 
type had non-significantly higher viral copy number in turtles exposed to 22°C compared to 
28°C. This study determined that environmental temperature affects the survival and disease 
                                                        
3
 Content of this chapter has been partially or fully submitted for publication as cited in 
bibliography as Allender et al., 2012c. 
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progression in ranavirus-infected red-eared sliders, which will aid in managing animals in a 
clinical or free-ranging setting.  
 
Key Words: chelonian, reptile, iridovirus, transmission, pathogenesis 
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Introduction 
Wildlife diseases have been on the rise across the world (Daszak et al., 1999). It is 
important to develop an understanding of these disease events as they can have a dramatic 
impact on local populations (Daszak, 1999). Over 80 epizootics, on five continents,  specifically 
involving ranaviruses in reptiles and amphibians have been reported in the literature since 1991, 
(Miller et al., 2011). A majority of the epizootics have involved amphibians; however, there has 
been an increase in the number of  reports in chelonians, and specifically box turtles, in the US 
(Johnson et al., 2008; Allender et al., 2006, DeVoe et al., 2004).  
Ranaviruses, members of the family Iridoviridae, are large, icosohedral, DNA viruses 
that can be found in an enveloped or non-enveloped form (Chinchar, 2009). Frog virus 3 (FV3) 
is the type species in the genera, and FV3-like virus has accounted for all of the known cases of 
disease in chelonians. Disease events have been scattered between captive and free-ranging 
animals with no apparent pattern, and much of the epidemiology of this virus in chelonians is 
unknown. 
A previous report describing an experimental challenge in red-eared slider turtles 
(Trachemys scripta elegans) fulfilled Koch’s postulates, establishing FV3-like as the causative 
agent of disease in a chelonian (Johnson et al., 2007). The study, however, did not evaluate the 
effect of temperature on the development of disease.  Temperature has been shown to have a 
profound impact on survival and pathology in iridoviral infections in fish and amphibians (Rojas 
et al., 2005; Jun et al., 2009), and merits study in reptiles.  
The purpose of this study was to evaluate the role of temperature in the pathogenesis of 
FV3-like infection in red-eared slider turtles.  The specific biological hypotheses tested in this 
study included: 1) Turtle survival will be higher in FV3-like infected animals maintained at a 
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higher environmental temperature; 2) Less severe pathological changes will be noted in  FV3-
like infected turtles maintained at higher environmental temperatures; 3) Viral copies from  oral 
and cloacal swabs, whole blood, and necropsy tissues collected from FV3-like virus infected 
turtles will be  lower in turtles maintained  at a higher environmental temperature ; and 4) There 
will be no significant difference in viral copies between any ante-mortem sampling method (oral 
swab, cloacal swab, whole blood).  
 
Materials and Methods 
Animals and husbandry. All activities were approved by the University of Illinois Institutional 
Animal Care and Use Committee (Protocol: 11050). Animals in this study were concurrently 
sampled as part of a separate study (Allender et al., 2012c). Sixteen adult female RES were 
acquired from a commercial turtle farm. Using computer-generated randomization, four animals 
were assigned to receive treatment and four animals were assigned to remain as uninfected 
controls in each of the two environmental temperature trials. The first trial was carried out in a 
15’9” x 12” environmental chamber held at 22°C.  This trial was carried out with both the 
inoculated and control animals in the same room separated by a double plastic barrier and 2-foot 
hallway created between the plastic barriers. The second trial was carried out with the inoculated 
and control animals housed in separate, but identical, environmental chambers at 28°C.  Each 
temperature trial included a seven day acclimatization period and was terminated at 31 days post-
inoculation.  The first trial began in July 2011 and the second began in November 2011. Animals 
were housed singly in 45 or 50 gallon plastic enclosures with 20 gallons of water and access to a 
dry dock (cinder block). Animals were fed a commercial aquatic turtle diet (Fluker Farms, Port 
Allen, LA) every other day.   
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 A ranavirus isolated from an infected eastern box turtle was grown in Terrapene heart 
cells (TH-1). Flasks were scraped when cells exhibited 100% cytopathic effects. Cells and media 
were then transferred to 15ml tubes, centrifuged at 4,500xg for 30 minutes, and the supernatant 
discarded. The cell pellets were resuspended in residual media, then frozen and thawed three 
times, thoroughly vortexed before and after each freeze cycle, and centrifuged again at 4,500xg 
for 30 minutes. DNA was extracted, conventional PCR utilized to amplify a 531 bp segment of 
the major capsid protein, and sequenced to be 100% homologous to FV3. Quantitative PCR was 
then performed as previously described to quantify viral DNA. Viral titers were determined 
using serial dilutions of virus in cell culture.   
 At the start of the study each animal was examined and weighed; blood (1.5 mls), oral 
and cloacal swabs (plastic handled cotton-tipped applicator, Fisher Scientific) were collected 7 
days (-7 d) and 4 days (-4 d) before the virus challenge. Blood samples were collected from the 
subcarapacial sinus. Quantitative PCR was performed on the whole blood and both swabs from 
both days to confirm negative status.  On day 0, each treatment animal was given 5 x 10
5
 TCID50 
FV3-like virus intramuscularly in the right forelimb. Each control animal was administered an 
equal volume of uninfected TH-1 cell lysate on the same day.  Each animal was weighed and 
clinical samples (blood, oral and cloacal swabs) were collected from each animal on days 3, 7, 
10, 14, 17, 21, 24, 28, and 31 post-inoculation.  Whole blood was immediately placed in two 
lithium heparin microtainers, while the swabs were each placed in separate 2.0 ml polypropylene 
eppendorf tubes. All samples were stored at -20°C until analysis. 
Clinical signs. Clinical signs were evaluated daily and recorded. The presence or absence of 
clinical signs compatible with those previously described for Ranavirus infection or other non-
specific systemic disease were documented. Specific clinical signs evaluated daily included: 
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cutaneous abscessation, nasal discharge, ocular discharge, oral plaque, and lethargy. Other less 
common clinical signs were recorded as they occurred for each animal. Each sign was scored as 
absent (=0) or present (1).  
Quantitative PCR. Quantitative PCR was performed as previously described (Allender et al., 
2012a).  Briefly, DNA was extracted from whole blood, oral, and cloacal swabs using 
manufacturer’s instructions (QIAmp Blood Mini Kit, Qiagen, Valencia, CA). Tissues collected 
at necropsy were weighed and DNA extracted following manufacturer’s instructions (DNeasy 
kit, Qiagen). TaqMan assay was performed using forward (AACGCCGACCGAAAACTG), 
reverse (GCTGCCAAGATGTCGGGTAA), and probe (CCGGCTTTCGGGC) targeting a 54 bp 
segment of the major capsid protein (MCP) of FV3. All samples were assayed in three technical 
repeats using a real-time PCR thermocycler (7500 ABI real-time PCR System, Applied 
Biosystems, Carlsbad, CA), analyzed using commercial software (Sequence Detection Software 
v2.05, Applied Biosystems, Carlsbad, CA), and results averaged.  
Pathology.  Turtles were euthanized when clinical signs of infection became severe (dyspnea, 
open-mouth breathing, weight loss greater than 20%/week or at 30d post-inoculation). Ketamine 
(100mg/kg) was administered intramuscularly in the left forelimb, followed by an overdose of 
pentobarbital (Fatal-Plus, 2ml total dose) in the subcarapacial sinus after the animal had lost 
consciousness.  Each animal was necropsied separately under a biological safety hood within 3 
hours, except for one turtle that was necropsied within 48 hours for reasons beyond control.  
There was no histopathologic evidence of autolysis in that turtle. Sterile procedures were used to 
collect samples of tongue, right forelimb skeletal muscle, liver, heart, lung, spleen, kidney, and 
ovary for qPCR.  Duplicate samples of tissues were collected and placed in formalin. Samples 
were processed routinely, sectioned at 3 µm, and stained with hematoxylin and eosin. Presence 
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and severity of histopathological abnormalities associated with ranaviral disease, such as 
intracytoplasmic inclusions and necrosis, were evaluated. Initially, all slides were subjectively 
evaluated to determine if a lesion scoring method was feasible. The pathologist was blinded to 
the treatment and control status of the turtles in each temperature group. 
Statistical analysis. Animals were classified as either inoculated (administered FV3-like virus) 
or control (administered uninfected cell lysate), then further analyzed as either infected 
(developed disease and qPCR presence) or uninfected (did not develop disease or qPCR 
presence) for each temperature trial. Sample size was determined using the a priori information 
of alpha=0.05 and Power=0.8 to detect a significant difference in disease prevalence if 75% of 
the inoculated animals are infected and less than 25% of the control animals are infected. 
Descriptive statistics were produced for each continuous variable (weight, viral copy number) at 
each time point, including the mean/median, 95% confidence interval/10-90% percentiles, and 
minimum/maximum.  Normality of data was determined using the Shapiro-Wilk test.  
Associations between disease status and categorical variables (clinical signs, sample type) were 
assessed using Fisher’s Exact/Chi-squared test.  In the experimental study, due to missing values 
from individuals that died due to the study design, four time points were included in the final 
analysis: the “pre-” sample (two pre-inoculation samples were averaged), the immediate “post-
”inoculation sample, and the “terminal” sample (the last sample taken prior to death). The timing 
of the pre- and the post-samples were the same days for every RES; however, the final sample 
was collected at the last time point prior to animal death  (day 7- 31 post-inoculation). Repeated 
measures (Friedman’s for non-normally distributed data or repeated measures ANOVA for 
normally distributed continuous variables described above) analysis was performed over time, 
independent of treatment and temperature exposure in RES. Then, separately, the same analysis 
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was performed for turtles in each temperature and RES treatment trial, respectively. The 
sensitivity and specificity to detect ranaviral infection in clinical samples was determined based 
on the gold standard of the necropsy results. Repeated measures analysis of categorical variables 
(clinical signs) were evaluated using a Cochran’s Q test, and, if significance was found, specific 
time point differences were further evaluated using the McNemar’s test. Differences between 
temperatures (22°C and 28°C) for continuous variables (listed above) at the same time point 
were evaluated using an independent samples t-test. Life tables were constructed for days to 
survival in inoculated turtles and those individuals that survived to the completion of the study 
were censored. Kaplan-Meier estimates were used to determine any difference in survival based 
on environmental temperature. Statistical significance was considered for all p values <0.05.  All 
analysis was performed using commercial software (SPSS 20, IBM statistics, Chicago, IL). 
 
Results 
Animals and viral isolate. All turtles were grossly examined and deemed apparently free of 
disease at the start of the study. Duplicate oral and cloacal swabs and whole blood samples 
collected 7 days and 4 days prior to inoculation were negative for FV3-like DNA.  
Survival. Median survival time for red-eared slider turtles experimentally inoculated with FV3-
like disease was 24 days (Min/max: 14 to 30 days) for animal maintained at 22°C and 30 days 
(Min/max:  17 to 30 days) for animals maintained at 28°C. All inoculated turtles in the 22°C 
were euthanized due to the severity of clinical signs observed, while only two (50%) animals 
were euthanized in the 28°C trial.  The remaining two inoculated animals in the 28°C trial 
survived with no apparent clinical signs and were euthanized at the termination of the study (30 
days).  One control animal (animal 6) died in the 28°C study due to bacterial septicemia and was 
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negative for ranavirus. Survival estimates are shown in Figure 5.1.  There was no significant 
difference in survival between environmental temperatures (p=0.346). When combining both 
temperature trials, there was a significant association between inoculation and infection 
(p=0.003).  For turtles in the 22°C study, there was a significant difference in infection between 
inoculated and control animals (p=0.014). There was no significant difference between 
inoculation and infection in turtles from the 28°C study (p=0.214)  
Natural history characteristics. Weights of red-eared sliders were compared between 
temperatures and over time.  There were no significant differences in weights between 
temperatures at the same time points (pre-inoculation p=0.124; initial post-inoculation p=0.133; 
terminal p=0.147) between temperature trials.  There also was no significant difference in weight 
at any one point between inoculated and control turtles during the 22°C study (pre: p= 0.497; 
post: p=0.432; terminal: p=0.313) or 28°C study (pre: p= 0.660; post: p=0.941; terminal: 
p=0.900), although there was a significant trend in the infected animals at 22°C to increase over 
time and no significant trend in the control turtles (Table 5.1). 
Molecular characteristics. There were no significant differences in DNA concentration between 
temperature for whole blood (pre: p=0.816; post: p=0.498; terminal: p=0.341), oral swabs (post: 
p=0.708; terminal: p=0.708), or cloacal swabs (pre: 0.540; post: p=0.669; terminal p=0.333) at 
either temperature over the entire series of sampling. There was significantly higher DNA 
concentration in oral swabs of inoculated turtles than control turtles for the pre-inoculation 
sample (p=0.009). There were no significant differences in DNA concentration over time within 
whole blood (p=0.057, Power=0.562), oral swabs (p=0.285, Power=0.180), or cloacal swabs 
(p=0.332, Power=0.155). Results of DNA concentration and purity (A260/A280 ratio) are 
summarized in Table 5.2. 
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Quantitative PCR.  All turtles inoculated in the 22°C trial were detected with FV3-like DNA in 
whole blood, oral swab samples, cloacal swab samples, and each of the eight tissues collected. 
Only the two ranavirus-inoculated turtles that died due to severity of clinical signs in the 28°C 
trial had detectable FV3-like DNA.  These 28°C-infected turtles were positive in whole blood, 
cloacal swabs, and all eight necropsy tissues, but not in oral swabs. All control turtles of both 
temperature trials and the two 28°C-inoculated turtles that failed to develop clinical signs failed 
to have detectable FV3-like DNA in any clinical or necropsy tissue at any time point. 
For the 22°C infected trial there was no significant change over time in the FV3-like copy 
number in whole blood (P=0.109), oral swabs (p=0.417), or cloacal swabs (p=0.296).  There also 
was no significant difference over time in DNA concentration  (whole blood: p=0.259; cloacal 
swabs: p=0.238; or oral swab samples: p=0.301) or DNA purity (whole blood: p=0.051; oral 
swabs: p=0.244; cloacal swabs: p=0.330). For the 28°C group there was no significant change 
over time in the FV3 copy number for any of the samples (whole blood, p=0.153; oral swabs: 
p=1.00; cloacal swabs: p=0.422), DNA concentration (whole blood: p=0.15; oral swabs: 
p=0.102; cloacal swabs: p=0.279), or DNA purity (whole blood: p=0.954; oral swabs: p=0.106; 
cloacal swabs: p=0.197). 
The sensitivity and specificity of whole blood was 100% when comparing the terminal 
sample collected and the presence of ranavirus in necropsy tissues. However, the sensitivity and 
specificity for oral swabs was 83% and 100%, respectively for the same comparison. However, 
All infected turtles in the 22°C trial were positive for FV3-like DNA in the terminal sample of 
whole blood, oral swab, and cloacal swab (Figure 5.7). In the 28°C trial, both infected animals 
were positive in whole blood in the terminal sample and one each was positive in the terminal 
samples or oral swab or cloacal swab. The infected animal in the 28°C trial that was negative in 
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the terminal oral swab sample, was positive in the oral swab sample two days prior.  Over the 
course of the last six sampling points, the infected animal in the 22°C trial that survived the 
longest (30 days) was positive for detectable FV3-like DNA in oral and cloacal swabs twice, 
then negative twice in a row, and then positive for the last two samples.  The two negative 
samples corresponded to the lowest whole blood viral copies for that animal. 
Clinical signs. Descriptive statistics for clinical signs observed in exposed turtles are presented 
in Table 5.4. There were no clinical signs recorded that were significantly different between 
infected and uninfected turtles over the entire study period. However, when evaluating clinical 
signs between infected and uninfected turtles at the pre, initial post, and terminal time points, 
there were significant changes over time for nasal discharge (p=0.018), ocular discharge 
(p=0.018), lethargy (p=0.002), and inoculation site swelling (p=0.007).  There were no 
significant differences observed over time in inoculated animals for the presence of oral plaques 
(p=0.223) or skin abscesses (p=0.135). There were no observed clinical signs in any control 
animal or the two 28°C inoculated animals that failed to develop disease at the pre-inoculation, 
post-inoculation, or terminal time points, except for the observance of lethargy once in one 
animal and leg swelling twice in two animals.  There was no significant change over time in the 
negative animals for lethargy (p=0.368) or leg swelling (0.135). 
Pathology. Gross necropsy revealed few changes, but included ulcers of the hard palate in two 
(25%) animals (Figure 5.2), widening of the nares in four (50%) animals (Figure 5.3), 
intracoelomic fluid in three (37.5%) animals, and severe disseminated subcutaneous swelling in 
three (37.5%) animals (Figure 5.4).  
 The most consistent and significant histologic lesions were observed in the spleens of the 
22°C inoculated group and were present in all four (100%) turtles. No changes were detected in 
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any tissue of any control animal in the 22°C group.  Changes included total effacement of the 
splenic architecture with hemorrhage, fibrin, and heterophils in two of the four turtles. 
Remaining vessels contained abundant fibrin and heterophils in the vessel wall, and there was 
lymphoid depletion. The two infected turtles in the 28°C group had similar lesions in the spleen, 
but architecture was more preserved. The splenic arterioles and ellipsoids were affected, as no 
vessels observed were spared. One of the control animals in the 28°C group died from severe 
bacterial septicemia, without the fibrinoid vasculitis observed in ranavirus-infected turtles. 
Lesions in the liver included thrombi in small vessels and in sinusoids which was observed in all 
four turtles of the 22°C group. All turtles had hepatocellular intracytoplasmic vacuolar change 
(glycogen and lipid) and collections of hepatic melanomacrophages; however, there were no 
differences in magnitude of vacuolar change or melanomacrophage collections between any of 
the groups of turtles. Vascular lesions of capillary thrombosis were also present in the lung in the 
22°C inoculated group, but it was observed in only one (25%) of the turtles. Additionally, the 
lung of two (50%) out of four turtles in this group had a mild to moderate heterophilic interstitial 
pneumonia, consisting of heterophils in the faveolar interstitium and increased heterophils in the 
faveolar capillaries. Two (50%) out of four turtles in this group also had necrotizing myositis, 
characterized by lytic to degenerating skeletal myocytes that were effaced with fibrin and 
heterophils. Rare scattered heterophils were present in the liver and ovary of a few of these 
turtles (Figure 5.2). 
 Histologic lesions in the 28°C inoculated group were less striking. The two inoculated 
turtles in this group that were PCR negative for FV3-like virus did not have any significant 
microscopic lesions. One of the two turtles that were PCR positive for FV3-like virus had 
intravascular bacilli in multiple vessels that were associated with thrombi, indicating bacteremia 
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and sepsis. This turtle also had fibrinoid necrosis of the splenic vessels. The other FV3-like PCR 
positive turtle in this group had a heterophilic interstitial pneumonia and necrotizing myositis, 
but no lesions were observed in the spleen. Viral inclusions were not observed in any of the 
turtles from either temperature group. Turtles from all groups had a few granulomas in different 
organs that were centered on spirorchid-type trematode eggs. Additionally, a few turtles had rare 
protozoal cysts within skeletal myocytes that were not associated with any necrosis or 
inflammation. The trematode eggs and protozoal cysts were interpreted as incidental findings. 
Eight tissues were collected from each animal at necropsy for FV3-like virus qPCR 
analysis (Table 5.6). There was a significantly higher viral copy in heart tissue at 22°C compared 
to 28°C (p=0.012), and while there was no significant difference in viral copy found for the other 
tissues (all p> 0.05 for all 63 comparisons), there was a reduction in the number of viral copies 
found when comparing tissues from animals maintained at 28°C compared to the 22°C  (Table 
5.5).  DNA concentration and purity (A260/A280 ratio) were not significantly different by 
environmental temperature, and therefore the data was combined (p>0.05 for all eight tissue 
types). Descriptive statistics for DNA concentration and purity are summarized in Table 5.6.  
  
Discussion 
 Temperature has been determined to have a profound effect on reptile response and 
progression to many diseases, but has not been described with regard to ranaviral infection. 
Furthermore, in addition to an anticipated more robust immune response at higher temperatures 
in reptiles, ranavirus isolates cannot grow above 32°C (Chinchar et al., 2009). These host and 
pathogen factors would theoretically lead to an increase in survival at higher temperatures.  
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An increased mortality of red-eared slider turtles exposed to a ranavirus isolate was seen 
at the lower temperature in this study compared to controls, and a non-significant increase in 
mortality was seen at the higher temperature. When comparing the mortality between the turtles 
at the two temperatures, there was no significant difference in mortality but power was lacking in 
the comparison (Power=0.34). Attempts to strengthen the power of the analysis were made using 
a larger control population, with the concern that latent disease in the control animals could be 
problematic. Increased mortality at low temperatures was similarly reported in salamanders 
(Rojas et al., 2005). Red-eared slider turtles had previously been reported to be susceptible to 
experimental infection with a ranavirus, but temperature was not controlled in that experiment 
(Johnson et al., 2007). The temperatures chosen is this study were based in part on the previous 
experimental challenge simultaneously exposed (access to higher temperature basking spot) to 
turtles to range of temperatures that included 22°C and 28°C and in part because these 
temperatures are natural environmental temperatures encountered across the species range in 
North America (Johnson et al., 2007).  While there was a non-significant difference in mortality 
for red-eared sliders in this study, it may not be similar for other species. However, red-eared 
sliders are a ubiquitous species in North America and may represent a potential reservoir species. 
Investigations into the capacity of this species to survive infections at different environmental 
temperatures with subsequent shedding when environmental temperatures decrease are needed.  
 There were several clinical signs that were observed in this study. The weight of turtles 
exposed to ranavirus increased throughout the course of the study in both temperature trials, 
while there was no significant difference in the weight of the control turtles. Disease processes in 
most species of mammals, birds, or reptiles can lead to anorexia and subsequent weight loss. 
However, in this study, the cause of the weight gain may have been due to increased food 
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consumption or fluid retention. It is unlikely that increased appetite lead to the weight gain 
because lethargy was a significant finding and turtles were all fed the same amount of diet. In 
ranavirus-infected turtles, nasal discharge, ocular discharge, lethargy, and inoculation site 
swelling were also observed. These signs are consistent with other reports in turtles, but are also 
consistent with general signs of respiratory disease seen with other common pathogens, 
including Mycoplasma and herpesvirus infections (Brown et al. 1994; Christopher at al., 2003; 
Origgi et al., 2004; Johnson et al., 2005). Another clinical sign of FV3-like infection reported in 
box turtles and red-eared slider turtles has been oral plaques (DeVoe et al., 2004; Johnson et al., 
2007), and while oral plaques on the hard palate were observed in all of the 22°C temperature 
inoculated turtles, they were not reliably seen over time. The turtles would commonly present 
with an oral plaque that may be present for several days, but then resolve or result in pinpoint 
oral ulcers on the hard palate. Regardless, the severity and location (none seen on the tongue) of 
the oral plaques was not consistent with other cases in box turtles and red-eared slider turtles 
(Allender et al., 2006; Johnson et al., 2007) or with tortoises with herpesvirus infection (Origgi et 
al., 2004). One of these previous studies identified a single red-eared slider with an oral plaque 
on the dorsal palate, which may represent a difference in species pathogenesis. It is possible that 
while herpesvirus infections may be more chronic and enable plaque development, ranavirus is 
more acute and development of plaques on the tongue does not occur in this species at these 
temperatures. 
 The microscopic lesions of fibrinoid necrosis and vasculitis with thrombosis in multiple 
organs of infected turtles is consistent with previous studies of ranavirus in turtles (Johnson et 
al., 2007). This study, like others, also demonstrated that the spleen was the organ that was most 
frequently and most severely affected histologically. Consistent with the clinical signs and FV3-
  100 
like virus PCR findings, turtles in the 22°C infected group all had severe histologic changes 
within the spleen, and in contrast, the only turtle in the 28°C inoculated group that had splenic 
lesions was also bacteremic, further supporting the theory that turtles at the lower environmental 
temperature compared to the higher environmental appear to develop more severe disease. 
Microscopic lesions in other organs for both groups were inconsistent between turtles. Although 
a previous paper described splenic lesions centered on splenic ellipsoids and not affecting splenic 
arterioles, the turtles in this study had lesions in all the splenic vessels. This may reflect the 
severity of the lesions that were present, potentially obscuring initial lesion in the ellipsoids. It 
has been proposed that the filtering mechanism of the spleen facilitates the deposition of immune 
complexes, and therefore the lesions in this organ are a result of virus within circulating 
inflammatory cells (Johnson et al., 2007). 
 Viral inclusions were not observed in any of the turtles from either temperature group. 
Although ranaviral inclusions are a prominent feature of infections in some fish, amphibians, and 
turtles, other studies have also found that they are not prominent in ranaviral infections in 
experimentally inoculated red- eared sliders (Johnson et al., 2006). The reasons for the lack of 
inclusions in these red-eared sliders is unknown, but may be dose dependent, species-specific, 
temperature-based, or occur during more chronic infections. Future studies should compare 
several species of chelonians in response to ranavirus infection and varying experimental 
conditions. 
Turtles infected with FV3-like virus and maintained at 22°C survived a median of 24 
days and all developed signs of disease, while only two animals in the 28°C trial were euthanized 
because of the severity of their disease.  If the study had been maintained past 30 days, the 
median survival time for the 28°C group would likely be much longer than was determined in 
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this study and may have resulted in a significant difference between temperatures. The 30 day 
study period was chosen for this study based on the hypothesized duration of disease in 
chelonians with this virus seen in the previous challenge study in red-eared sliders that were 
conducted over a temperature range that included our temperature trials, but future studies should 
follow animals past 30 days. Furthermore, there was no DNA evidence of ranavirus in any 
sample (antemortem or postmortem) in the two inoculated turtles that survived to 30 days in the 
28°C group which indicates that FV3-like DNA is either detectable and leads to disease or is 
undetectable. In cell culture, ranaviruses do not survive above 32°C, and it is likely that as this 
temperature was approached, the in vivo mortality would also decrease, especially in light that 
reptile immune systems are more active at higher temperatures which are additionally protective 
(Duguy, 1970).  
 Quantitative PCR was able to detect ranaviral DNA in every clinical sample type tested 
in this study in infected animals. While detection in necropsy tissues is invaluable, the usefulness 
to management of ongoing outbreaks to determine infection in animals prior to death is equally 
important. The evaluation of the sensitivity and specificity of antemortem sampling of turtles 
with ranavirus had not been previously evaluated. Common clinical samples previously reported 
for turtles have been whole blood, oral and cloacal swabs (Allender et al., 2006; Johnson et al., 
2007). In the current study, it was determined that whole blood has 100% sensitivity and 
specificity and would be appropriate clinical samples.  However, oral and cloacal swabs had only 
83% sensitivity and might therefore lead to false negative results. However, in evaluating the 
results longitudinally, oral swabs had detectable FV3-like DNA in every infected turtle at some 
point, while one turtle was negative in cloacal swabs despite being positive in every necropsy 
tissue. A recent cross-sectional study evaluating ranavirus status in box turtles also demonstrated 
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that oral swabs and whole blood do not fully agree. In that study, 50% of the positive animals 
(n=4) were oral swab positive and whole blood negative (Allender et al., 2012b). Different 
techniques in sampling the oral and cloacal cavity, changes in viral shedding in the oral and 
cloacal cavities, or changes in systemic viral load make multiple parallel testing strategies 
needed when performing surveillance studies. Additionally, there may be species differences that 
lead to differences in viral shedding, or differences in assay specificity in other species due to 
non-specific inhibitors present in box turtles and not in red-eared sliders.  
 The viral copies in the clinical samples from the infected turtles quickly went from 
undetectable to millions or billions of copies. All six diseased turtles had between 2 and 4 
positive samples prior to death, corresponding to 1 to 3 weeks duration of viral shedding. This 
virus appears to associated with an acute disease process in susceptible animals, suggesting there 
may be limited opportunities to intervene in a clinical setting or when managing an outbreak in a 
wild population. Furthermore, the disease appears to acutely affect susceptible animals, which 
may lead to disease events occurring in free-ranging reptiles without being detected. In one turtle 
during the low temperature trial, the animal developed clinical signs and detectable FV3-like 
DNA in all clinical samples for 1 week, then whole blood FV3-like DNA decreased for 1 week 
at the same point that it became undetectable in oral and cloacal swabs, followed by a dramatic 
increase in viral load in whole blood and reemergence if viral DNA in oral and cloacal swabs.  
There may be several factors that were responsible for the occurrence in this animal including 
sampling error, PCR inhibitors, inefficient amplification, but may also reflect a transient host 
immune response to clear infection.  Future studies should investigate lower viral inoculation 
doses to determine if viral loads fluctuate when the host is not overwhelmed. Furthermore, the 
acute nature under experimental conditions in this study may not reflect natural conditions and 
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should be investigated. But if similar, the acute course of disease may limit spread in free-
ranging populations of solitary animals, such as the box turtle.  
 All eight tissue types tested in infected animals had detectable ranavirus, indicating 
systemic distribution and were non-significantly different from whole blood samples. The 
highest ranaviral copy numbers were found in skeletal muscle, which is not surprising as this was 
the site of inoculation. The kidney had the next highest viral copy numbers. The kidney has been 
proposed as the site of viral persistence in Xenopus (Robert et al., 2007). This has not been 
established for any other species and further work is required to determine if it is true in reptiles. 
However, there were no observed trends between subjective histopathological severity and viral 
copy number. Viral loads were higher in all tissues of the 22°C study than the 28°C, but were 
only significant for the heart and liver.  
 Turtles in this study were inoculated via intramuscular injection, similar to previous 
reports in red-eared sliders (Johnson et al., 2007). This is an unlikely mechanism of natural 
transmission, however vector borne routes (similar to IM injection) have been suggested 
(Johnson et al., 2007). Natural infections may also occur through direct contact with infected 
turtles, through water, or via fomites. Transmission through water and direct contact has been 
documented for amphibians (Brunner et al., 2007). However, oral inoculation of red-eared sliders 
did not result in infection in a previous report (Johnson et al., 2007). Research is needed to 
determine the other possible routes of transmission in turtles and the effects temperature has on 
disease development. 
 Ranavirus has been suggested as a threat to the biodiversity of amphibian populations 
(Pearman et al., 2005; Gray et al., 2009a; Teacher et al., 2010; Miller et al., 2011). The threat 
level on reptile populations is less well-understood, largely due to a lack of epidemiologic and 
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disease ecologic studies for ranavirus in this group. The red-eared slider turtle has been shown to 
be a competent model for ranaviral disease, however its ability to adequately translate to other 
species is unknown. The red-eared slider turtle has an expanding range and likely shares habitat 
with other animals experiencing ranavirus outbreaks, yet there have been no documented cases in 
free-ranging red-eared slider turtles to the authors’ knowledge. It has been shown that the 
parasites in the invasive red-eared slider turtles can host-switch to native species outside its 
traditional range, such as Emys orbicularis and Mauremys leprosa (Verneau et al., 2011). If the 
red-eared slider turtle can be a potential host and reservoir, its expanding range may pose a threat 
to the spread of this virus. Differences in temperature may allow for a reservoir status. When a 
group of apparently healthy outdoor-raised red-eared sliders were acquired in September and 
experimentally exposed to 16°C, 42% (n=5) of the animals developed clinical and qPCR 
evidence of ranaviral disease (unpub. data). The role of the red-eared slider as a reservoir needs 
further investigation as the expanding range of this species, may likely contribute to outbreaks in 
novel locations. 
In summary, red-eared slider turtles infected with a ranavirus isolate exhibit more 
mortality and decreased survival time at lower environmental temperatures. Pathological 
findings of vasculitis are consistent with other reports in turtles. Clinical samples with the 
highest sensitivity and specificity are whole blood and cloacal swabs and these samples should 
be collected in suspected cases in the future. Kidney contains the highest viral copy number in 
systemic samples and is a potential site of primary viral persistence or replication. This study 
helps to elucidate the epidemiology of ranavirus in chelonians.  
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Table 5.1.  Distribution of weights of red-eared slider turtles over time experimentally exposed to frog virus 3-like virus.  The weights, 
confidence intervals (CI), and minimums/maximums are reported in grams. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Significant increase over time (F=11.1, p=0.045) and significant difference between the change in weights (terminal weight minus 
the pre-inoculation weight) of infected and uninfected animals (p=0.035). 
 
 
  
   22°C  28°C 
Pre-inoculation Mean (g) 1693.5625*  1977 
95% CI 1244.1322 2142.9928  1582.6936 2543.5564 
Min/max 1397.45 2077.50  1654.50 2300.00 
        
Initial post-
inoculation 
Mean (g) 1692.50*  2005 
95% CI 1252.99 2132.01  1519.77 2645.23 
Min/max 1390 2060  1606 2404 
        
Terminal Mean (g) 1802.50*  2097.50 
95% CI 1310.57 2294.43  1686.49 2632.51 
Min/max 1535 2245  1772 2423 
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Table 5.2.  Descriptive statistics of DNA concentration and DNA purity (A260/A280 ratio) from whole blood (WB), oral swab, and 
cloacal swab samples collected from red-eared slider turtles after experimental inoculation with frog virus 3-like virus. 
 
 
   22°C  28°C 
Concentration (μg/ml)       
 WB Mean 97.35*
%
  25.31*
%
 
  95%CI 27.84 166.86  15.48 35.14 
  Min/Max 40.1 139.26  17.07 31.98 
        
 Oral swabs Mean 26.66
#%@
  12.56
#%@
 
  95%CI 17.9 35.41  7.3 17.83 
  Min/Max 21.06 33.41  9.71 16.24 
        
 Cloacal swabs Mean 11.39^
%@
  5.81^
%@
 
  95%CI 9.11 13.67  3.23 8.38 
  Min/Max 9.87 12.92  4.44 7.97 
        
DNA purity (A260/A280 ratio)      
 WB Mean 1.82  1.81 
  95%CI 1.79 1.85  1.75 1.86 
  Min/Max 1.81 1.85  1.77 1.84 
        
 Oral swabs Mean 1.91  1.83 
  95%CI 1.75 2.08  1.77 1.89 
  Min/Max 1.77 2.02  1.79 1.86 
        
 Cloacal swabs Mean 1.86  1.96 
  95%CI 1.65 2.06  1.71 2.22 
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  Min/Max 1.68 1.99  1.79 2.17 
 
Table 5.2, continued. 
 
 
* Statistically significant p=0.044 
# 
Statistically significant p=0.005 
^ Statistically significant p=0.002 
% 
Statistically higher DNA concentration in whole blood than oral swabs (p=0.026) and cloacal swabs (p=0.014) 
@
 Statistically higher DNA concentration in oral swabs than cloacal swabs (p=0.001) 
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Table 5.3.  Median viral copy numbers of frog virus 3-like virus that were recovered from red-eared slider turtles experimentally 
inoculated during transmission studies at 22°C and 28°C. Control turtles all had 0 viral copies at each time point in each temperature 
group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  # Only 1 animal had detectable levels
   22°C  28°C 
Pre-
inoculation 
Whole Blood 0  0 
Oral swab 0  0 
Cloacal swab 0  0 
        
Initial post-
inoculation 
Whole Blood 0  0 
Oral swab 0  0 
Cloacal swab 0  0 
        
Terminal Whole Blood 1.23 x 10
7
  6.74 x 10
3
 
Oral swab 7.23 x 10
6
  4.23 x 10
2#
 
Cloacal swab 1.37 x 10
6
  3.36 x 10
3#
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Table 5.4.  Proportion of clinical signs observed in red-eared slider turtles experimentally inoculated with frog virus 3-like virus at two 
environmental temperatures.  The proportions represent the presence or absence of clinical signs at any time during the course of the 
study.  
 
 
 
 
 
  
  22°C  28°C 
Nasal discharge  4/4  0/2 
Ocular discharge  4/4  0/2 
Oral plaque  4/4  0/2 
Skin abscess  3/4  1/2 
Lethargy  4/4  2/2 
Leg Swelling  4/4  2/2 
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Table 5.5.  Copies of frog virus 3-like virus detected (per g of tissue) in several necropsy tissues from red-eared slider turtles 
experimentally inoculated at two environmental temperatures. Median is presented with an *. 
  22°C  28°C 
       
Tongue Mean/median* 1.25 x 10
9
*  5.94 x 10
6
* 
 95%CI/10-90% 
percentiles* 
3.58 x 10
5
 2.56 x 10
10
*  3.58 x 10
5
 5.94 x 10
6
* 
 Min/Max 6.19 x 10
5
 3.37 x 10
10
  3.58 x 10
5
 1.15 x 10
7
 
       
Skeletal 
Muscle 
Mean/median* 3.7 x 10
10
*  3.64 x 10
8
* 
 95%CI/10-90% 
percentiles* 
1.76 x 10
10
 1.9 x 10
11
*  7.40 x 10
7
 3.64 x 10
8
* 
 Min/Max 1.76 x 10
10
 2.39 x 10
11
  7.40 x 10
7
 6.53 x 10
8
 
       
Lung Mean/median* 6.29 x 10
9
*  5.01 x 10
9
* 
 95%CI/10-90% 
percentiles* 
3.27 x 10
9
 1.94 x 10
10
*  2.61 x 10
8
 5.01 x 10
9
* 
 Min/Max 3.27 x 10
9
 2.32 x 10
10
  2.61 x 10
8
 9.76 x 10
9
 
       
Heart
#
 Mean/median* 2.92 x 10
10
  1.27 x 10
9
* 
 95%CI/10-90% 
percentiles* 
1.58 x 10
10
 4.36 x 10
10
  7.05 x 10
6
 1.27 x 10
9
* 
 Min/Max 1.89 x 10
10
 3.72 x 10
10
  7.05 x 10
6
 2.54 x 10
9
 
       
Liver^ Mean/median* 2.15 x 10
9
  1.70 x 10
7
* 
 95%CI/10-90% 
percentiles* 
1.13 x 10
9
 3.16 x 10
9
  1.87 x 10
6
 1.70 x 10
7
* 
 Min/Max 1.32 x 10
9
 2.85 x 10
9
  1.87 x 10
6
 3.21 x 10
7
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Table 5.5, continued 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
#
 Significant difference between environmental temperatures, p=0.012 
^ Significant difference between environmental temperatures, p=0.011 
 
 
  
       
Spleen Mean/median* 2.23 x 10
10
*  5.44 x 10
7
* 
 95%CI/10-90% 
percentiles* 
6.43 x 10
9
 1.4 x 10
11
  1.52 x 10
8
 5.44 x 10
8
* 
 Min/Max 6.43 x 10
9
 1.77 x 10
11
  1.52 x 10
8
 9.36 x 10
8
 
       
Ovary Mean/median* 8.93 x 10
9
*  9.06 x 10
6
* 
 95%CI/10-90% 
percentiles* 
4.53 x 10
8
 1.28 x 10
10
*  0 9.06 x 10
6
* 
 Min/Max 4.52 x 10
8
 1.31 x 10
10
  0 1.81 x 10
7
 
       
Kidney Mean/median* 3.46 x 10
10
*  2.54 x 10
8
* 
 95%CI/10-90% 
percentiles* 
1.77 x 10
9
 5.16 x 10
10
*  2.43 x 10
7
 2.54 x 10
8
* 
 Min/Max 1.77 x 10
9
 5.69 x 10
10
  2.43 x 10
7
 4.84 x 10
8
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Table 5.6.  Descriptive statistics for DNA concentration and purity (A260/A280 ratio) from extracts of tissues taken at necropsy from 
red-eared slider turtles experimentally infected with frog virus 3-like virus performed at two environmental temperatures.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Mean 95% Confidence Interval Min/Max 
DNA concentration (ug/ml)      
 Tongue 139.90 11.20 268.60 2.95 278.40 
 Lung* 107.57 20.56 194.58 24.88 241.17 
 Heart^ 38.24 15.92 60.55 3.04 65.96 
 Liver 151.78 41.47 262.08 63.62 351.62 
 Spleen 97.18 33.26 161.10 12.01 170.79 
 Skeletal 
Muscle
#
 
23.85 7.80 39.90 6.65 40.03 
 Ovary 71.06 24.84 117.29 3.38 134.89 
 Kidney 109.99 26.20 193.78 .96 229.96 
       
DNA purity (A260/A280 ratio)     
 Tongue 2.61 .71 4.50 1.89 5.34 
 Lung 1.84 1.75 1.92 1.69 1.89 
 Heart 1.72 1.46 1.98 1.25 1.91 
 Liver 1.70 1.53 1.86 1.39 1.83 
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Table 5.6, continued. 
 
 
 
 
 
 
 
 
 
 
 
 
* Significantly higher than skeletal muscle, p=0.046 
^ Significantly lower than liver (p=0.025), spleen (p=0.028), ovary (p=0.046), and kidney (p=0.046)  
#
 Significantly lower than liver (p=0.033), spleen (p=0.035), ovary (p=0.031), and kidney (p=0.031). 
 
  
 Spleen 1.86 1.78 1.93 1.72 1.93 
 
 Skeletal 
Muscle 
1.72 1.54 1.90 1.43 1.93 
 Ovary 1.79 1.55 2.02 1.33 1.93 
 Kidney 3.80 0 8.73 1.86 13.40 
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Figure 5.1.  Survival analysis of red-eared slider turtles experimentally exposed to frog virus 3-
like virus at 22°C (1; blue) and 28°C (2; green).  State what the temperatures are for each legend.  
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Figure 5.2.  Oral plaque on the dorsal palate of the oral cavity of a red-eared slider 
experimentally inoculated with ranavirus. 
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Figure 5.3. Oral ulceration in a red-eared slider after experimentally inoculated with ranavirus. 
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Figure 5.4. Widening of the nares observed in a red-eared slider experimentally inoculated with 
ranavirus. 
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Figure 5.5. Ranavirus-infected red-eared slider demonstrating severe edema that occurred in less 
than a 24 hour period at 28C.  The animal was also confirmed to be septic. 
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Figure 5.6. (A) Red eared slider in 22°C ranavirus-challenge group with no lesions in the spleen. 
H&E. (B) Red eared slider in 22°C inoculation group with splenic necrosis that effaces the 
splenic architecture. H&E. (C) Red eared slider in 22°C inoculation group with fibrinoid necrosis 
of a splenic vessel. H&E. (D) Red eared slider in 22°C inoculation group with heterophilic 
interstitial pneumonia. Heterophils fill faveolar capillaries and are present in the interstitium 
(asterisk). H&E. (E) Red eared slider in 22°C inoculation group with a thrombus filling a hepatic 
vessel.  H&E. (F) Red eared slider in 22°C inoculation group with thrombi in hepatic sinusoids 
(arrows). H&E. (G) Red eared slider in 22°C transmission group with no lesions in the skeletal 
muscle. H&E. (H) Red eared slider in 22°C inoculation group with necrotizing myositis. Fibrin 
and heterophils efface the skeletal myocytes and myocytes exhibit necrosis and degeneration. 
H&E. 
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Figure 5.7.  Proportion of frog virus 3-like DNA detected whole blood (B), oral swabs (OS), and cloacal swabs (CS) 5/6in red-eared 
slider turtles at ten time points before and after experimental inoculation in eight red-eared sliders at 22°C and 28°C. 
 
 
 
 
  
22°B
22°OS
22°CS
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Pre Day 4 Day 8 Day 11 Day 15 Day 18 Day 22 Day 25
Day 29
Day 31
22°B
28°B
22°OS
28°OS
22°CS
28°CS
  121 
 
CHAPTER 6 
 
HEMATOLOGIC RESPONSE TO EXPERIMENTAL AND NATURAL INFECTIONS OF 
FROG VIRUS 3-like virus IN TWO SPECIES OF CHELONIANS
4
 
 
Abstract: Clinical pathology is routinely used to diagnose and monitor response to disease. 
Hematologic changes during ranavirus infection have yet to be characterized. In this study, 
hematology was analyzed in sixteen red-eared slider turtles (Trachemys scripta elegans; RES) 
and 384 eastern box turtles (Terrapene carolina carolina; EBT).  Six red-eared slider turtles and 
three box turtles were infected experimentally or naturally with a ranavirus, frog virus 3-like 
virus (FV3-like), respectively. Total solids were significantly decreased (p=0.034) over time in 
the red-eared slider turtles infected with FV3-like virus. Lymphocytes were significantly 
decreased in box turtles infected with FV3-like virus, and a non-significant decreasing trend in 
lymphocyte numbers was noted in red-eared sliders with FV3-like infection. Intracytoplasmic 
inclusions were seen in variable prevalence in box turtles in different institutions (0 – 44%). 
Presence of inclusions in WBC were observed in non-FV3-like infected EBT, but were not seen 
in uninfected RES.. Inclusions were seen in two red-eared slider turtles and one box turtle with 
FV3-infection. White blood cell count was higher in box turtles with inclusions, regardless of 
FV3 status. Hematology may be a valuable tool for monitoring disease in turtles with FV3-like 
virus, but further work is needed with higher sample sizes to characterize the actual response. 
Key Words: Reptile, Terrapene, Trachemys, hematology, iridovirus 
                                                        
4 Content of this chapter has been partially or fully submitted for publication as cited in 
bibliography as Allender et al., 2012d. 
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Introduction 
 Several terrestrial and aquatic chelonians are experiencing population declines across the 
world.  The International Union for Conservation of Nature 2011 redlist currently considers 32 
chelonians as critically endangered, 44 as endangered, and 58 as vulnerable. It lists an additional 
species as conservation dependent and 36 as near threatened (van Dijk, 2011). Therefore, of the 
328 total species of chelonians in the world, 178 (53%) are listed with population stability as 
near-threatened or worse, including 8 species that are already extinct (Rhodin et al., 2010). The 
North American box turtle (Terrapene carolina carolina) has recently experienced significant 
population declines in numerous areas throughout its range, leading to its population status being 
downgraded in 2011 from near threatened to vulnerable (van Dijk, 2011). Free-ranging box 
turtles have experienced numerous disease events that may impact population stability, including 
ranavirus infections (Sleeman, 2008, Donaldson and Echternact, 2005; Ultsch, 2006; Allender et 
al., 2012b). 
Ranaviruses are a significant threat to populations of amphibians and reptiles (Miller et 
al., 2011). Diagnostic assays that can quickly and correctly identify the presence of ranavirus are 
crucial to early diagnosis and potential intervention. Currently, quantitative PCR (qPCR) or 
conventional PCR, viral isolation, and histopathology are the primary diagnostic methods used to 
confirm the presence of this pathogen (Allender et al., 2012a; Johnson et al., 2007).  However, a 
previous report has described the presence of intracytoplasmic inclusions within circulating 
white blood cells with ranavirus, specifically frog virus 3-like virus (FV3-like) infection 
(Allender et al., 2006). Differential white blood cell counts are often used as a non-invasive field 
health assessment tool. The advantages of this type of diagnostic test are that it can be done in 
the field, having a more rapid turnaround time than qPCR, and is not as invasive as biopsy and 
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histopathology.  These characteristics might make evaluating the relationship and progression of 
complete blood cell count parameters ideal for characterizing or managing outbreaks in 
vulnerable species. 
 Intracytoplasmic inclusions have rarely been associated with white blood cells in reptiles, 
except for a case report of ranavirus in a box turtle (Allender et al., 2006) and a report of 
Chlamydia and poxvirus in monocytes of chameleons (Jacobson and Telford, 1990). More often, 
inclusions within erythrocytes have been reported in reptiles due to viruses, parasites, and 
degenerate cellular components (Alleman et al., 1992; Telford and Jacobson, 1993; Clark et al., 
2001; Basile et al., 2011; Wellehan et al., 2008; Alves de Matos et al., 2002; Johnsrude et al., 
1997).  While two of these erythrocyte reports involve iridoviruses, ranavirus-specific inclusions 
have not been reported. Other tissues are more commonly observed to develop inclusions, most 
notably associated with viruses such as herpesviruses, adenoviruses, and inclusion body disease 
of boids (Rivera et al., 2009; Jacobson et al., 1986; Wozniak et al., 2000). 
 The specific aim of the study was to evaluate the hematological response of two species 
of chelonians to ranavirus infections under experimental and natural infections. Additionally, a 
secondary aim was to determine if inclusions within white blood cells occur routinely as part of 
this response. The biological hypotheses tested in this study were: 1) There will be no difference 
in complete blood count (CBC) parameters [packed cell volume (PCV), total solids (TS), total 
white blood cell count (WBC), heterophils, lymphocytes, monocytes, eosinophils, or basophils] 
after experimental FV3-like infection in red-eared slider turtles (RES) (Trachemys scripta 
elegans); 2) Intracytoplasmic inclusions will be found within white blood cells of red-eared 
sliders experimentally infected with FV3-like virus; 3) There will be no difference in CBC 
parameters between naturally occurring FV3-like positive and FV3-like negative eastern box 
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turtles (EBT) (Terrapene carolina carolina); and 4) Intracytoplasmic inclusions will be will be 
found within white blood cells of box turtles naturally infected with FV3. 
 
Materials and Methods 
Experimental study. All activities were approved by the University of Illinois Institutional 
Animal Care and Use Committee (Protocol: 11050). Animals in this study were concurrently 
sampled as part of a separate study (Allender et al., 2012c). Sixteen adult female RES were 
acquired from a commercial turtle farm. Using computer-generated randomization, four animals 
were assigned to receive inoculation and four animals were assigned to remain as uninfected 
controls in each of the two environmental temperature trials. The first trial was carried out in an 
15’9” x 12” environmental chamber held at 22°C.  This trial was carried out with both the 
inoculated and control animals in the same room separated by a double plastic barrier and 2-foot 
hallway created between the plastic barriers. The second trial was carried out with the inoculated 
and control animals housed in separate, but identical, environmental chambers at 28°C.  Each 
trial was terminated at 31 days post-inoculation.  The first trial began in July 2011 and the 
second began in November 2011. Animals were housed singly in 45 or 50 gallon plastic 
enclosures with 20 gallons of water and access to a dry dock (cinder block). Animals were fed a 
commercial aquatic turtle diet (Fluker Farms, Port Allen, LA) every other day.   
 A Ranavirus isolate was grown in Terrapene heart cells (TH-1). Flasks were scraped 
when cells exhibited 100% cytopathic effects. Cells and media were then transferred to 15ml 
tubes, centrifuged at 4,500xg for 30 minutes, and the supernatant discarded. The cell pellets were 
resuspended in residual media, then frozen and thawed three times, thoroughly vortexed before 
and after each freeze cycle, and centrifuged again at 4,500xg for 30 minutes. Quantitative PCR 
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was then performed to confirm the presence and quantify viral DNA. Viral titers were 
determined using serial dilutions of virus in cell culture.   
 At the start of the trial each animal was examined and weighed; blood (1.5 mls), oral and 
cloacal swabs (plastic handled cotton-tipped applicator, Fisher Scientific) were collected 7 days 
(-7 d) and 4 days (-4 d) before the virus challenge. Blood samples were collected from the 
subcarapacial vein. Quantitative PCR was performed on the whole blood and both swabs from 
both days to confirm negative status.  On day 0, each treatment animal was given 5 x 10
5
 TCID50 
FV3-like virus intramuscularly in the right forelimb. Each control animal was administered an 
equal volume of uninfected TH-1 cell lysate on the same day.  Each animal was weighed and 
clinical samples (blood, oral and cloacal swabs) were collected from each animal on days 3, 7, 
10, 14, 17, 21, 24, 28, and 31 post-inoculation.  Whole blood was immediately placed in two 
lithium heparin microtainers, while the swabs were each placed in separate 2.0 ml polypropylene 
eppendorf tubes. All samples were stored at -20°C until analysis. 
Natural Infection. All procedures were approved by the Institutional Animal Care and Use 
Committees at the University of Tennessee (UT: 1630-0507) and University of Illinois (UI: 
10057). The box turtles evaluated in this study were subjects from a concurrent study (Allender 
et al., 2012b) that had multiple objectives. The study population included eastern box turtles 
presented to wildlife centers at the University of Tennessee (UT)(Knoxville, TN), Wildlife 
Center of Virginia (WCV)(Waynesboro, VA), and North Carolina State University (NCSU) 
(Raleigh, NC) in 2007(Allender et al., 2011; Allender et al., 2012a; Allender et al., 2012b); and 
from free-ranging, wild box turtles in Oak Ridge, TN (OR) in 2010 and 2011 (Way and 
Allender, 2012).  
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 Blood samples were collected from the subcarapacial sinus and immediately placed into a 
lithium heparin coated microtainer (Becton Dickinson, Franklin Lakes, NJ). The blood tubes 
were labeled with a unique identification number and remained on-site at -20ºC, batch shipped, 
and stored at -20ºC until analysis. Samples were also processed to create two blood smears, 
stained with diff-quik (Dipquick, VetLab Supply), and shipped with whole blood tubes. Slides of 
blood smears collected in 2007 were cover-slipped for optimal preservation, while slides from 
2010 and 2011 were evaluated at the time they were made. 
Quantitative PCR. Quantitative PCR was performed as previously described (Allender et al., 
2012a).  Briefly, DNA was extracted from whole blood using the manufacturer’s instructions 
(QIAmp Blood Mini Kit, Qiagen, Valencia, CA).  TaqMan assay was performed using forward 
(AACGCCGACCGAAAACTG), reverse (GCTGCCAAGATGTCGGGTAA), and probe 
(CCGGCTTTCGGGC) targeting a 54 bp segment of the major capsid protein (MCP) of FV3. All 
samples were assayed in three technical repeats using a real-time PCR thermocycler (7500 ABI 
real-time PCR System, Applied Biosystems, Carlsbad, CA), analyzed using commercial software 
(Sequence Detection Software v2.05, Applied Biosystems, Carlsbad, CA), and results averaged. 
Quantitative PCR results for 2007 UT samples (Allender et al., 2012b) and 2007 WCV, 2007 
NSCU, and 2010-2011 OR samples that had separate objectives have been presented previously 
(Allender et al., 2012b), but are referenced in this study only as it pertains to the effect of FV3 
infection on clinical pathology results and leukocytic inclusions. 
Complete Blood Count (CBC). For the experimental study and the OR animal samples collected 
in 2010 and 2011, whole blood was placed in two microhematocrit tubes, centrifuged, and 
percent red cells manually determined (PCV). Microhematocrit tubes were broken at the 
interface of red cells and plasma, plasma placed on a refractometer, and total solids recorded 
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(TS). An avian leukopet system (VetLab Supply, Palmetto Bay, FL) was used to stain 
heterophils and eosinophils according to the manufacturer’s instructions and counted routinely 
on a hemacytometer. Differential white blood cell counts were manually evaluated using light 
microscopy with 40X objective.  Percent heterophils and eosinophils were used with the results 
of the hemacytometer to determine total white blood cell (WBC) counts as previously described 
(Campbell, 2006). For all of the box turtles presented to rehabilitation centers, estimated white 
blood cell counts were performed from a stained blood smear. Differential cell counts were 
performed by several individuals, but all individuals were trained similarly and a subset of slides 
from each year were confirmed by the primary author (MCA). Presence of intracytoplasmic 
inclusions within white blood cells was recorded as present or absent for each sample. A 
minimum 100 white blood cells or 100 fields (under 40X objective) were evaluated. Inclusions 
were identified based on size, shape, color, and displacement of the nucleus. CBC results from 
2010 OR have previously been reported with independent objectives (Way and Allender, 2012), 
but were referenced and combined with 2011 data (metanalysis) in this study only as it pertains 
to the effect of FV3 infection on clinical pathology and leukocytic inclusions. 
Statistical analysis.  Descriptive statistics were produced for each continuous variable (weight, 
WBC, PCV, differential white blood cells, TS) for each time point, including the mean/median, 
95% confidence interval/10-90% percentiles, and minimum/maximum. Normality of data was 
determined using the Shapiro-Wilk test. In the experimental study, due to missing values from 
individuals that died due to the study design, four time points were included in the final analysis: 
the “pre-” sample (two pre-inoculation samples were averaged), the immediate “post-
”inoculation sample, and the “terminal” sample (the last sample taken prior to death). The timing 
of the pre- and the post-samples were the same days for every RES; however, the final sample 
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was collected at the last time point prior to animal death  (day 7- 31 post-inoculation). Repeated 
measures (Friedman’s for non-normally distributed data or repeated measures ANOVA for 
normally distributed continuous variables described above) analysis was performed over time, 
independent of treatment and temperature exposure in RES. Then, separately, the same analysis 
was performed for turtles in each temperature and RES treatment group, respectively.  Specific 
between group (temperature and exposure) differences for RES PCV, TS, and WBC were further 
evaluated using a paired sample t-test/related samples Wilcoxon signed rank test. Specific group 
(institution, sex, age, year) differences for WBC in EBT were evaluated using Kruskal-Wallis 
one-way ANOVA and a Mann-Whitney U for between group differences. Differences between 
temperatures for continuous variables at the same time point in RES were evaluated using an 
independent samples t-test. Presence or absence of inclusions within white blood cells was 
tabulated (categorical variable) and compared based on temperature (RES), sex (EBT), age 
(EBT), location (EBT), and FV3-like-status (all). Statistical significance was considered for all p 
values <0.05.  All analysis was performed using SPSS 20 statistical software (IBM Statistics, 
Chicago, IL). 
 
Results 
RES. Packed cell volume, total solids, and total WBC over each sample period are shown for 
each temperature in Table 6.1. When evaluating the pre-inoculation, post-inoculation, and 
terminal samples for RES, there was no significant difference in any CBC parameter in the 
challenged turtles between the two environmental temperatures and therefore the data was 
combined (Table 6.2). There was no difference between pre-inoculation, post-inoculation, and 
terminal samples for PCV (p=0.444) or WBC (p=0.421) for infected turtles.  There was a 
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significant decrease over those three time points for total solids (p=0.034) in infected turtles.  For 
white blood cell differentials, heterophils (p=0.236), lymphocytes (p=0.862), monocytes 
(p=0.325), eosinophils (p=0.497), and basophils (0.165) were not different over time in infected 
turtles. Intracytoplasmic inclusions were seen in two infected animals in the last sample that was 
collected prior to death. There were no differences in prevalence of intracytoplasmic inclusion 
between infected and uninfected turtles. 
Eastern box turtles.  White blood cell counts were performed in 84 turtles in 2007, 170 in 2010, 
and 134 in 2011. Differential cell counts were performed on 48 turtles in 2007, 170 in 2010, and 
134 in 2011. There was a significant difference in WBC (p<0.0001), heterophils (p<0.0001), 
lymphocytes (p<0.0001), monocytes (p<0.0001), eosinophils (p<0.0001), and basophils 
(p<0.0001) based on method of quantification. There was a significant difference in WBC 
(p<0.0001), heterophils (p<0.0001), lymphocytes (p<0.0001), monocytes (p<0.0001), 
eosinophils (p<0.0001), basophils (p<0.0001), PCV (p<0.0001), and TS (p=0.041) by year 
(Table 6.3 and Table 6.4).  There was no significant difference in weight by year (p=0.141). 
White blood cell inclusions were seen only from rehabilitation turtles in 2007 (Figure 6.1). White 
blood cell inclusions were seen with significantly different proportions based on institution 
(p<0.0001). White blood cell count in turtles with (median 11,200 cells/μl; 10-90% percentile: 
1640 – 21880 cells/μl) inclusions was non-significantly higher than without (5200 cells/μl; 10-
90% percentile: 3800 – 46000 cells/μl). White blood cell count was significantly higher for 
turtles in 2007 that had inclusions (Table 6). There was no association between FV3-like virus 
positive animals and white blood cell inclusions (p=0.307). The third positive animal in 2007 did 
not have a blood smear evaluated. The two FV3-like virus positive animals that had estimated 
WBC had counts of 14400 and 11600 cells/μl, which was not significantly different from FV3-
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like virus negative turtles (p=0.147). The predominant white blood cell in both FV3-like infected 
box turtles was the heterophil 5904 and 10018 heterophils/μl, respectively, which was not 
significantly different from FV3-like virus negative turtles (p=0.858). Neither of the FV3-like 
virus positive turtles had any lymphocytes which was significantly lower than FV3-like virus 
negative turtles (p=0.044) 
 
Discussion 
 Hematology is a commonly used diagnostic assay to evaluate the general health and 
disease status of humans and animals.  While this diagnostic is also commonly used with reptiles 
(Campbell, 2006), reference intervals for many species of reptiles have not been established, and 
when established can vary by season, potentially limiting the value of this diagnostic method. 
Furthermore, the hematologic response following exposure to specific pathogens is unknown in 
reptile diseases, including ranavirus.  The characterization of this response could be invaluable in 
the diagnosis and therapeutic monitoring of diseases in reptiles and is worth pursuing. 
 This study monitored the hematological response in two species of chelonians to an 
emerging viral disease, FV3, under experimental and natural conditions.  In the case of 
experimental inoculation of FV3-like virus in red-eared sliders, the only variable that was 
significantly different over time was a decrease in total solids (44.7%). Total solids as 
determined by refractometer are a measure of the total protein in the body.  Low protein may be 
seen with malnutrition, severe blood loss, or chronic liver or kidney disease (Campbell, 2006). 
These animals had significant vasculitis has a hallmark of the pathologic response, which may 
have accounted for leakage of proteins from the vasculature (Allender et al., 2012c). 
Additionally, multi-systemic organ failure is commonly seen as the cause of death in ranavirus 
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infections in chelonians and may account for the hypoproteinemia. It is notable that a viral 
infection would be expected to cause a response in humoral immunity that would cause an 
increase in total solids, but the acute nature of ranaviral disease likely doesn’t allow an individual 
to mount a response. Future studies need to look at protein electrophoresis and acute phase 
proteins, which are currently being pursued. 
 The WBC is commonly used to diagnose or monitor the progression of an inflammatory 
response in a vertebrate. In this study, the WBC was not significantly different in RES or box 
turtles with FV3-like infection compared with conspecifics without disease.  The absence of a 
change in the WBC could have been due to the natural response of the host to this particular 
virus or the virus’ ability to elude the host defense mechanisms or study related factors such as a 
small sample size and a limited study duration. Season has been shown to cause significant 
variation in WBC in reptiles (Duguy, 1970), and may have a profound impact on the response 
seen to infectious pathogens. There were too few FV3-like virus positive samples in this study to 
investigate season, but ongoing monitoring is being performed in a free-ranging population. 
White blood cell counts were significantly different by year in eastern box turtles. This 
difference may be due to time of year sampled, potential exposure to infectious disease, or 
subjective evaluation of blood smears. There was no significant difference between 2007 (blood 
smear estimate) and 2011 (leukopet) despite different methods of determining the WBC. 
However, the leukopet method used in 2010 and 2011 was the same, possibly indicating that the 
person evaluating the differential white blood cell count might be a confounding factor.  Each 
year had a separate individual evaluating the blood smears and might introduce variation into the 
evaluation.  
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 Differential WBC types were not significantly different between FV3-like virus positive 
and FV3-like virus negative turtles for any cell type in either study, except for a decrease in 
lymphocytes seen in box turtles with FV3-like infection.  There was also a trend towards a 
reduction in the lymphocytes in the RES, but it was not significant (observed power ranged from 
0.05 through 0.448). Lymphocytes are commonly increased in response to viral disease to 
modulate cell-mediate immunity in mammals. In acute diseases or in early stages of a disease 
process, lymphocytes may be mobilized to the sites of viral infection prior to the compensatory 
increased production. This might explain why there was a decrease in lymphocytes in our study. 
Increased sample size would be needed to determine if lymphopenia is a feature of ranavirus 
infection in turtles. Low observed power was determined post-hoc indicating a potential Type II 
error. The response to specific pathogens in tortoises is largely anecdotal, however tortoises with 
herpesvirus infection demonstrated lymphocytosis and heteropenia compared to uninfected 
animals (Muro et al., 1998). This difference in lymphocyte proportion between herpesvirus and 
ranavirus might be due to the course of disease. Herpesvirus can be more chronic in tortoises 
(Origgi et al., 2004), thereby allowing ample time for subsequent response to viral infection. 
Future studies should critically evaluate lymphopenia in turtles demonstrating clinical evidence 
of ranavirus, and may be helpful in documenting clinical improvement. 
 Packed cell volume, a measure for red blood cell concentration, is commonly used to 
evaluate animals for the presence or absence of anemia. The PCV reference interval calculated 
for these animals was consistent with other studies. Interestingly, the PCV values obtained from 
these turtles were not significantly different based on FV3-like status in either the experimentally 
infected RES or naturally infected box turtles. Anemia is commonly seen is chronic disease 
states in vertebrates, and reptiles are no exception (Campbell, 2006), but is not routinely reported 
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in reptiles. It is possible that no change was noted because of the acute nature of the ranavirus 
infection. The longevity of erythrocytes in reptiles is much longer than in mammals, with some 
snakes having erythrocytes live for as long as 600 days (Campbell, 2006). Therefore, the cell loss 
may not be detected in a disease of short duration under natural infection or in the experimental 
study presented here because it was limited to 30 days. Additionally, pure blood samples in 
reptiles are commonly diluted with lymph fluid due to the confluence of blood and lymph vessels 
in close approximation, including the subcarapacial sinus. While the jugular vein may be the 
preferred site for venipuncture to minimize the likelihood of sample dilution, it is often not 
possible to collect samples from this site in chelonians without anesthesia. In the turtle sample 
populations presented here, there were some PCV values that were considered low, and likely 
diluted with lymph. However, it appears that the potential for dilution was similar across the 
different turtle groups.  
 Inclusions in tissues are commonly seen with many viruses (Johnson et al., 2007), and 
inclusions in circulating white blood cells have been reported in a box turtle with ranavirus 
(Allender et al., 2006). In this study, we determined that inclusions in the white blood cells occur 
with greater frequency in box turtles than red-eared sliders, and may be high in turtles without 
qPCR detectable ranavirus.  This study found a high prevalence in rehabilitation turtles that 
presented to one institution. Potential causes of these cytoplasmic inclusions need to be 
investigated, but may include other viruses, parasites, and active or degenerate cellular 
components (Alleman et al., 1992; Telford and Jacobson, 1993; Clark et al., 2001; Basile et al., 
2011; Wellehan et al., 2008; Alves de Matos et al., 2002; Johnsrude et al., 1997).  Turtles in this 
study had evidence of active inflammation with cellular granules (basophilic stippling) that may 
be mistaken for inclusions. Basophilic stippling has been reported previously in reptiles in 
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response to inflammation (Campbell, 2006). However, inclusions were characterized in this 
study based on cellular type, size, shape, and relationship to nucleus. Electron microscopy, such 
as that performed to confirm a previous report of ranavirus will be required in future cases and 
should be pursued. 
There were several limitations identified in this study. First, the two methods of 
determining the total white blood cell count introduced bias because one method relied on the 
subjective evaluation of a blood smear. Attempts to minimize this bias were to have the same 
individual (MCA) train all individuals and evaluate a subset of slides from all years and 
locations. However, it is still possible that this lead to the significant differences observed. 
Additionally, the method of determining inclusions was not specific and needs to be expanded to 
include electron microscopy. And lastly, total solids were determined using a refractometer, and 
more accurate determination using protein electrophoresis needs to be performed. 
 In summary, the acute nature of ranavirus infection in chelonians does not appear to 
result in significant changes in a hematologic profile in these animals. Furthermore, while 
intracytoplasmic inclusions are a characteristic of ranavirus infection in turtles, this is neither a 
feature consistently observed nor a finding specific to ranavirus.  Hematology may be a valuable 
tool for monitoring disease in reptiles, but further work is needed with higher sample sizes of 
FV3-like virus positive turtles to characterize the actual response. Equipment that is capable of 
minimizing the potential bias used with the techniques currently used to process these samples is 
currently not available, but may soon be. If it is available, utilizing it may prove useful. In 
addition, research should focus on other areas that evaluate the immune response including acute 
phase proteins and cell cytochemistry. 
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Table 6.1.  Median values for packed cell volume (PCV), total solids (TS), and white blood cell count (WBC) from inoculated and 
control RES exposed to FV3-like virus at two different environmental temperatures. 
 
 
  PCV (%)  
Day 22C  28C 
 Treatment Median Control p  Treatment Median Control p 
Pre-exposure 21.13 22.63   18.50 17.25  
Day 4 25.75 19.25   23.75 16.00  
Day 8 13.25 25.00 .02  23.50 19.50  
Day 11 27.50 28.00   17.00 11.00  
Day 15 26.00 26.75   12.75 15.00  
Day 18 30.50 24.00   14.50 24.00  
Day 22 30.50 27.00   16.75 11.50  
Day 25 31.25 16.75   16.00 15.00  
Day 29 ND ND   26.50 9.50  
        
TS (mg/dl)  
Pre-exposure 3.78 3.71   2.05 2.40  
Day 4 4.55 3.75   3.35 1.50  
Day 8 3.30 3.80   3.48 1.38  
Day 11 4.55 3.90   3.80 2.60  
Day 15 2.30 4.13   2.35 2.90  
Day 18 2.80 3.70   3.80 3.70  
Day 22 4.40 3.80   1.73 1.30  
Day 25 2.80 3.80   2.58 1.03  
Day 29     3.15 .88  
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Table 6.1, continued 
  
WBC (/μl)  
Pre-exposure 4839.80 5288.19   4109.30 2879.31  
Day 4 8989.43 4554.48   4394.94 1920.24  
Day 8 2808.55 6265.64   5601.19 1716.80 .02 
Day 11 8691.05 7000.00   15018.67 1002.22 .02 
Day 15 8268.99 4696.18   7453.63 1189.19  
Day 18 10625.19 2660.95 .03  12743.86 4964.93  
Day 22 8000.00 5299.56 .04  5574.73 1771.27  
Day 25 5332.63 3126.04   3614.29 1489.01  
Day 29     13118.89 1581.78  
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Table 6.2.  Complete blood count parameters from pre-inoculation, initial post-inoculation, and terminal blood samples collected from 
RES experimentally inoculated with FV3-like virus at two different environmental temperatures. 
 
  
  Mean/median* 95% CI/ 10-90% 
percentiles* 
Min Max 
PCV Pre-inoculation 21* 9 22.13* 9 22.5 
(%) Post-inoculation 24.7 14.7 34.6 7 35 
 Terminal 19.1 10.3 27.8 3 26 
TS^ Pre-inoculation 3.8 2.8 4.7 2.3 5 
(mg/dl) Post-inoculation 3.8 2.6 5 2 5 
 Terminal 2.1 1.4 2.9 1 3 
WBC Pre-inoculation 4544.5 3364.7 5724.3 2400 5628 
(cells/ul) Post-inoculation 7389.3 1668.6 13110.1 1203 16264 
 Terminal 4073* 1232 6283.4* 1232 12623 
Heterophils Pre-inoculation 1388.5 1016.6 1760.5 933.9 1916 
(cells/ul) Post-inoculation 2429.3 813.9 4044.7 346 4091 
 Terminal 1537 620.8 2453.3 344.9 2777.2 
Lymphocytes Pre-inoculation 870.3 184.5 1556.1* 223 1799.4 
(cells/ul) Post-inoculation 944.1* 223 1594.6* 0 3764 
 Terminal 372* 24.6 1569.6* 24.6 4544.4 
Monocytes Pre-inoculation 654.9 314.2 995.5 272 1118 
(cells/ul) Post-inoculation 910* 204.8 3167.3* 204.8 3600 
 Terminal 805.1 457.1 1153.2 344.9 1205 
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Table 6.2, continued 
 
 
 
 
 
 
 
 
 
 
 
^ Significant difference in mean over time, p=0.034 
 
  
Eosinophils Pre-inoculation 1331.6 457.5 2205.7 432.8 2207 
(cells/ul) Post-inoculation 1377.4 138.3 2616.6 481 3600 
 Terminal 418.4 40 1225.9 40 2650.9 
Basophils Pre-inoculation 244.1* 0 500.1* 0 797.2 
(cells/ul) Post-inoculation 837.1 338.3 1335.9 135 1309 
 Terminal 487.5* 258.7 942* 258.7 1641 
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Table 6.3.  Descriptive statistics for complete blood count parameters in eastern box turtles from 2007, 2010, and 2011. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Significant difference 
  2007  2010
#
  2011
#
 
WBC Median 5800*  13058*  6488 
(cells/ul) 10-90 Percentile 1800 – 23000  3913 – 31639  3411 - 11636 
 Min/Max 400 - 64400  1552 - 72160 1342 - 25589 
       
PCV Median   23  27 
(%) 10-90 Percentile   13.1 – 32.0  18.0 – 37.4 
 Min/Max   4 - 40  8 - 50 
       
TS Median   4  3 
(mg/dl) 10-90 Percentile   2 – 5  2 – 5 
 Min/Max   1 - 7  1 - 6 
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between 2007 and 2010, p<0.0001 
#
Significant difference between 2010 and 2011 for WBC (p<0.0001), PCV (p<0.0001), and TS (p=0.041)  
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Table 6.4.  Descriptive statistics for differential white blood cells in eastern box turtles from 2007, 2010, and 2011. 
 
 
    2007  2010  2011 
Heterophils Median 6632  1075  1690 
(cells/ul) 10-90 Percentile 2587 – 24127  364 – 2481  669 - 3551 
 Min/Max 1071 - 55080 145 - 7884  172 - 8064 
       
Lymphocytes Median 242  7271  654 
(cells/ul) 10-90 Percentile 0 – 1128  1816 – 20527  211 - 1909 
 Min/Max 0 - 3240  791 - 46904  0 - 6271 
       
Monocytes Median 578  285  135 
(cells/ul) 10-90 Percentile 97 – 3274  0 – 1248  0 - 609 
 Min/Max 0 - 12920  0 - 10490  0 - 2015 
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Table 6.4, continued. 
 
 
 
 
 
 
 
 
 
#
Significant difference between 2010 and 2011 for heterophils (p<0.0001), lymphocytes (p<0.0001), monocytes (p<0.0001), and 
basophils (p=0.026) 
  
Eosinophils Median 1222  1801  1938 
(cells/ul) 10-90 Percentile 0 – 1312  497 – 4071  736 - 3953 
 Min/Max 0 - 3240  140 - 11205  95 - 14586 
       
Basophils Median 490  1751  1383 
(cells/ul) 10-90 Percentile 0 – 3274  357 – 5367  421 - 3843 
 Min/Max 0 - 5328  0 - 21648  24 - 13099 
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Table 6.5.  Prevalence of eastern box turtles with intracytoplasmic inclusions in white blood cells sampled in 2007.  
 
Institution n Prevalence 
(%) 
95% CI  
(%) 
    
UT 25 44.0 26.7 - 62.9 
WCV 23 4.6 0.8 - 21.8 
NCSU 36 5.6 1.5 - 18.2 
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Figure 6.1. White blood cells from healthy red-eared sliders. Heterophils (A; D, arrowhead), 
lymphocyte (B, thin arrow), thrombocyte (B, arrowhead), eosinophil (C; D, inverse arrowhead), 
monocyte (D, three thin arrows), and basophil (E). 
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Figure 6.2. White blood cells in apparently healthy free-ranging eastern box turtles. Heterophils 
(A, thin arrow; C), lymphocyte (A, arrowhead), thrombocyte (B), eosinophil (D), and basophil 
(E). 
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Figure 6.3. Intracytoplasmic inclusions within circulating heterophils (A,B) and monocytes 
(C,D) observed in red-eared sliders after experimental infection with ranavirus. 
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Figure 6.4. Intracytoplasmic inclusions in circulating heterophils (A) and monocytes (B,C,D) 
observed in eastern box turtles with natural ranaviral infection. 
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CHAPTER 7 
 
PHARMACOKINETICS OF A SINGLE ORAL DOSE OF ACYCLOVIR AND 
VALACYCLOVIR IN NORTH AMERICAN BOX TURTLES (TERRAPENE SP.)
 5
 
 
SHORT COMMUNICATION 
 Eastern box turtle (Terrapene carolina carolina) populations have significantly declined 
throughout their range (Currylow et al., 2011).
 
While a combination of factors are likely playing 
a role in the declines of the box turtle, disease outbreaks have been emerging across the eastern 
US in chelonians and may be important (Allender et al., 2011; DeVoe et al., 2004; Johnson et 
al., 2008).  
Herpesviruses and iridoviruses are two common virus families that lead to clinical signs 
of upper respiratory tract disease in affected chelonians (Allender et al., 2011; Brown et al., 
1999; Harper et al., 1982; Johnson et al., 2008). Acyclovir has been used anecdotally in the 
treatment of both viral agents in chelonians (DeVoe et al., 2004; Funk & Diethelm, 2006; 
Marschang et al., 1997); however, to date, only a single pharmacokinetic study has been 
performed in a single species (Gaio et al., 2007).  
Acyclovir and its pro-drug valcyclovir are guanine analogue antiviral drugs (Elion, 
1993). They are activated by phosphorylation of a virus-specific thymidine kinase (TK). 
Acyclovir uptake has been shown to be enhanced in herpesvirus-infected cells, with a 10- to 30- 
fold greater affinity for infected cells than uninfected cells (Beutner, 1995).  Once incorporated 
                                                        
5
 Content of this chapter is in press for publication as cited in bibliography as Allender et al., 
2012e. 
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into the viral genome, relatively low levels of the drug are needed to achieve viral inhibition, and 
adequate intracellular concentrations can be maintained for several hours (Beutner, 1995). 
Thymidine kinase genes or functional TK enzymes have similarly been identified in iridoviruses 
(Coupar et al., 2005; Jakob et al., 2001; Scholz et al., 1988; Tsai et al., 2005).  
The current study evaluated the pharmacokinetics of acyclovir and valcyclovir after a 
single oral dose in twelve North American box turtles.  Animals were housed individually in 
Vision cages (Model #332, Vision Products Plus, Inc., Canoga Park, CA, USA) that maintained a 
thermal gradient of 72°F to 87°F.  A varied diet of fruits and vegetables was provided every 
other day. All activities were approved by the University of Illinois IACUC (protocol 11003). 
A pilot study using oral acyclovir was initially performed at doses of 40 and 80 mg/kg in 
one animal each.  After the results demonstrated low maximum observed plasma concentration 
(Cmax) at the doses used, a decision was made to evaluate the pharmacokinetics of oral 
valcyclovir at 20 and 40 mg/kg in one animal each.  Based on these results, eight animals were 
administered a single oral dose of 40 mg/kg valcyclovir.  Venipuncture was performed via the 
subcarapacial sinus for all phases of the study. For the final study, blood (up to 0.3 ml) was 
collected in a 3 ml syringe with a 22 ga needle at 0, 0.25, 0.5, 1, 2, 4, 8, 12, 24, 48, 72, 96, and 
120 h following oral valcyclovir. Samples were placed in a lithium heparin microtainer (Becton 
Dickinson, Franklin Lakes, NJ, USA), centrifuged immediately, the plasma placed in a separate 
cryovial, and stored at -20°C.  Samples were transported on dry ice to the Pharmacology 
Laboratory at the University of Tennessee for analysis. 
Plasma samples were analyzed using a reverse phase high-performance liquid 
chromatography method (HPLC). The system consisted of a 2695 separations module, a 2475 
fluorescence detector and a computer equipped with Empower software (Waters, Milford MA, 
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USA). Valcyclovir and acyclovir were extracted from plasma samples using 1 cc HLB solid 
phase extraction (SPE) cartridges. The compounds were separated on an Atlantis T3 (4.6 x 100 
mm, 5µm) column with a guard column. The mobile phase was a mixture of (A) 10 mM 
ammonium phosphate pH 2.9 and (B) acetonitrile (97:3). The flow rate was 1.2 ml/min and the 
column temperature ambient.  Fluorescence was measured at an excitation of 260 nm and an 
emission of 375 nm with a gain of x100.  
Standard curves for plasma analysis were prepared by fortifying untreated, pooled turtle 
plasma with valcyclovir and acyclovir to produce a linear concentration range of 10-1500ng/ml. 
Average recovery for both drugs was 87% while intra and inter-assay variability were less than 
10%. The lower limit of quantification was 10 ng/mL. 
Pharmacokinetic parameters for valcyclovir and acyclovir were calculated using 
WinNonlin 5.2 (Pharsight Corp., Mountain View, CA) (Table 7.1, Figure 7.1). No valcyclovir 
was detected in any sample and all analysis consisted solely based on plasma acyclovir. Values 
for plasma half-life (t½), Cmax, time to maximum plasma concentration (Tmax), and area under the 
plasma concentration time curve (AUC0- ) from time 0 to infinity were calculated from non-
compartmental analysis. The AUC and AUMC were calculated using the log-linear trapezoidal 
rule. Mean residence time (MRT) was calculated as AUMC0- /AUC0- .  The compartmental 
pharmacokinetic model was a one-compartment model with first order elimination and weighted 
1/Yhat*Yhat  and the model was used to simulate the concentration–time profile for several 
dosage regimens. In this model, it is assumed that K01>>>K10, or that there is no ‘flip-flop’ 
effect caused by slow absorption. The best model included an absorption term and biexponential 
decay. Parameters of this average model were V_F (mL/kg),_K01 (1/h), and K10 (1/h) which were 
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29.3971 ± 13.6595, 0.2241± 0.1718, and 0.0456 ± 0.0083, respectively and were used to 
generate Figure 7.2. 
The half-life of acyclovir after a single oral dose of valcyclovir in box turtles was 14.6 h. 
This is longer than the half-life of acyclovir in humans (3.1 h), cats (3.1 h) and horses (5.05 h) 
given oral valcyclovir and marginated tortoises (Testudo marginata) (8.8 h) given oral acyclovir 
(Gaio et al., 2007; Owens et al., 1996; Garre et al., 2007; Beutner, 1995).  The results 
demonstrate a slower elimination in box turtles, which could reduce dosing intervals.   
Valcyclovir, an esterified version of acyclovir, is rapidly converted to acyclovir after 
absorption and has greater oral bioavailability than acyclovir (Garre et al., 2008).  The oral 
bioavailability of valcyclovir is 3-5 times greater in humans, 8 times greater in horses and 2-3 
times greater in cats than oral acyclovir  (Garre et al., 2007; Nasisse et al., 1997). In our pilot 
study evaluating 80 mg/kg oral acyclovir, our Cmax was 2200 ng/ml.  This was within one 
standard deviation of our 40 mg/kg valcyclovir dose Cmax.  While bioavailability was not 
measured in the current study or the previous study in marginated tortoises, this pilot data 
indicates that, despite a lower dose of valcyclovir, it reached the same concentration as the 
higher acyclovir dose in box turtles. 
Acyclovir has been proposed for treatment of herpesvirus in several species, and for 
iridovirus in chelonians (Beutner, 1995; Gaio et al., 2007). For herpesvirus in humans and 
horses, inhibitory concentrations need to be maintained above 0.45 μg/ml and 3 μg/ml, 
respectively (Gaio et al., 2007).  However, in vitro concentrations that completely inhibit tortoise 
herpesvirus were above 50 μg/ml (Marschang et al., 1997).  Additionally, in vitro studies against 
an iridovirus indicated only a dose-dependent partial inhibition at 25 μg/ml acyclovir 
concentration (Johnson, 2006). There have been no in vivo studies evaluating efficacy or 
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inhibitory concentrations in chelonians against either virus.  The Cmax of valcyclovir obtained in 
this study was 1.94 μg/ml, which is far below the partial in vitro inhibitory concentration of the 
chelonian studies.  However, the Cmax observed in this study is higher than the concentration 
considered effective for herpes virus infection in humans (0.45 μg/ml), but lower than those 
shown to be effective in feline herpes virus infection (18 ug/ml) (Beutner, 1995; Owens et al., 
1996).  Future studies should further evaluate in vivo efficacy against iridoviruses to determine if 
higher concentrations of drug are reached in infected cells, as has been demonstrated with 
herpesviruses in other species. 
Toxicity was not specifically evaluated in this study; however, anorexia was seen in two 
animals, and prolonged lethargy was seen in a turtle administered valcyclovir.  This study was 
performed in October and it is possible that these problems were physiologic responses to the 
time of year. In cats, nephrotoxicity and bone marrow suppression were seen with repeated 
dosing of acyclovir and valcyclovir (Owens et al., 1996).   
In summary, valcyclovir appears to reach therapeutic plasma concentrations in box turtles 
based on in vivo doses effective for herpesvirus infections in humans (0.45 μg/ml), but not in 
vitro studies for herpesvirus or iridovirus in chelonians.  However, its increased affinity for 
infected cells may allow intracellular concentrations to reach therapeutic levels for these 
pathogens when plasma concentrations do not. A simulated oral dose of 40 mg/kg every 24 h is 
predicted to maintain concentrations above 0.45 μg/ml in the average animal. Some limitations 
of our predictions include the assumption of linear pharmacokinetics within the range of 
simulated concentrations, the unknown effect of inter-individual pharmacokinetic variability in 
the population of turtles (temperature, season), the lack of bioavailability data, and the 
application of a human therapeutic window to turtles. Therefore, although our selected dosage 
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regimen is a reasonable starting point, pharmacodynamic and repeat dosing pharmacokinetic 
studies are needed to further characterize optimal dosing of acyclovir in turtles. 
In conclusion, this study provides valuable insight into the treatment of clinically 
important diseases in this species.  Furthermore, it provides a scientific rationale for development 
of other dose regimes for related species. 
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Table 7.1. Pharmacokinetic parameters (mean ± SD) of acyclovir in the plasma of eight box 
turtles after a single oral dose (40 mg/kg) of valcyclovir. 
Pharmacokinetic parameter Acyclovir  
t ½* (h) 15.2 ± 2.3 
Tmax (h) 13.0 ± 7.0 
Cmax (µg/mL)  1.94 ± 0.81 
AUC0–∞ (h∙µg/mL) 42.0 ± 15.3 
AUMC0–∞ (h∙h∙µg/mL) 958.9 ± 307.5 
MRT0–∞(h) 23.1 ± 3.4 
V_F (mL/kg) 29.3971 ± 13.6595 
K01 (1/h) 0.2241± 0.1718 
K10 (1/h) 0.0456 ± 0.0083 
Cl_F (mL/h/kg) 1116 ± 370 
K01 T½ (h) 3.1 ± 1.0 
K10 T½ (h) 17.2 ± 3.6 
* Harmonic mean 
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Figure 7.1. Mean ± SD acyclovir plasma concentrations (µg/ml) following oral administration of valcyclovir (40mg/kg) to eight box 
turtles.  
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Figure 7.2. Simulated average pharmacokinetic profile of plasma acyclovir concentrations (µg/ml) after oral administration of 
valcyclovir at 40 mg/ml every 24 hours. 
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CHAPTER 8 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 Chelonians are experiencing significant population declines, and the impacts of disease 
on limiting biodiversity in this Order have been under-investigated . To better determine the 
effect of disease on biodiversity, the epidemiology of important diseases need to be adequately 
characterized. The research in this dissertation contributed to the further characterization of the 
epidemiology of  ranaviral disease in chelonians and  can be used to develop a better 
understanding of the diagnosis, transmission, and management of this virus in captive and free-
ranging populations. 
 Three quantitative PCR assays were developed that can detect ranaviral DNA. From this, 
the TaqMan PCR assay was found to be highly sensitive and specific for use in chelonians and 
can detect viral DNA in small quantities. However, based on the transmission study, it appears 
that detection of small quantities of virus may not be required to detect infection. Animals 
experimentally challenged with ranavirus either had below the detectable limit of copies (<529 in 
most assays) or had multiple million to billions of copies. The detection limit of conventional 
PCR is 529,000, which is more than adequate to determine clinical infection. Quantitative PCR, 
however, would be useful in determining lower viral quantities in tissues that may be involved in 
viral persistence or replication. It was determined that viral copy number was highest in the 
kidney in this study, which is similar to the findings in previous studies with Xenopus. In this 
anuran, the kidney was identified as a tissue for viral persistence. Evaluating whether this is true 
in chelonians is needed, and the application of this qPCR assay for serial detection of viral 
quantities in the kidneys and other tissue samples may allow for that determination in chelonians. 
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Additionally, this qPCR might help to identify subclinical carriers or reservoirs that haven’t been 
identified yet. To date, no chelonian species has had detectable levels of ranavirus on PCR 
without evidence of disease, but future surveillance studies should investigate multiple species 
and then follow up in those species that have presence without disease with appropriate 
transmission studies.   
 While this dissertation provides new insight into the epidemiology of ranaviral disease in 
chelonians, there is much more that needs to be investigated. To date, there have been numerous 
reports of ranavirus outbreaks in amphibians; however, no such outbreaks have been documented 
in free-ranging chelonians. The reasons for this are potentially varied, but may be attributed to 
the fact that chelonians are: 1) a spill-over host and are not affected either in great numbers or it 
is difficult to identify affected animals, 2) chelonians are a reservoir host that fail to develop 
clinical signs unless immunocompromised, or 3) the mechanisms of transmission are different in 
chelonians and this provides some protection to disease. It is my opinion that outbreaks may very 
well occur, but go unnoticed because of the natural history characteristics (e.g., solitary lifestyle, 
deep aquatic habitat, wide home ranges) of these animals as well as the absence of many long-
term studies evaluating the health of chelonians. This study described a component of a long-
term health project monitoring box turtles in Tennessee that began in 2008 and has recently been 
funded through 2015. The study has also sampled aquatic terrapins in surrounding water bodies, 
in which a positive red-eared slider turtle was detected. Expanding this study to include 
additional species as well as continuing to monitor box turtle health will be helpful in further 
characterizing the epidemiology of ranavirus in chelonians. 
 One aspect of the epidemiology of ranavirus that deserves further investigation is the 
possibility that invasive chelonian species are responsible for the introduction and  persistence of 
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the virus in the environment. It has been shown that translocation of tiger salamanders from the 
Midwest to Arizona has caused nearly annual ranaviral outbreaks in native amphibians. A reptile 
species that is similarly invasive and expanding in range is the red-eared slider turtle. This turtle 
species has been implicated for introducing parasites in previously naïve native turtles, so it is 
feasible it could similarly introduce a virus (Verneau et al., 2007). The results of the 
experimental infection study in this dissertation confirm that red-eared sliders are susceptible to 
ranavirus infection, but provided additional insight into the effect of environmental temperature 
on the pathogenesis of the virus. Reptiles are ectotherms and are physiologically and 
immunologically dependent on their environment. Viruses, likewise, are heavily influenced by 
the environment(s) in which they are found. Ranaviruses are known to thrive in cooler 
temperatures, and the results of this study further support this as it relates to a chelonian host, 
with more severe disease and mortalities in animals held at cooler temperatures.  The effect of 
temperature may also play a role in the persistence of the virus and transmission of the virus 
among chelonians in the environment. In this dissertation, a constant temperature was maintained 
throughout the entire experimental  period.  However, in a free-ranging setting, temperature 
fluctuates, sometimes dramatically, throughout the day.  This may lead to differences in both 
viral replication and immune response in the reptilian host that may protract the disease and 
allow for persistent shedding into the environment. Additional transmission studies should be 
performed to further elucidate the role of temperature on the interactions between  Ranavirus and 
chelonians. 
 The development and refinement of additional diagnostic assays would be useful in 
further characterizing the response of chelonians to ranavirus infection/exposure.  This should 
combine both pathogen- and pathogen-exposure assays. Pathogen-based assays such as qPCR, 
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virus isolation, IHC, EM, and histopathology are useful in not only determining whether 
ranavirus is present, but if it is active. Many of these assays have an ideal sample type or assay 
conditions that need to be validated in chelonians. Future studies that develop an IHC for 
ranavirus in turtles would be useful in examining retrospective samples that might frame the 
historical relationship of ranavirus and chelonians. A pathogen-exposure assay was attempted in 
this dissertation, but was unsuccessful due to the lack of a positive control. A serologic assay 
would be valuable in screening populations where reservoirs animals exist, if indeed they do. 
However, based on our current understanding of this virus in chelonians, the virus appears to 
cause acute disease and high mortalities. Therefore, a serologic test would likely have limited 
value.  
Additionally, it appears that ranaviral disease in reptiles is an acute disease in chelonians 
and many animals may fail to develop a humoral response before they die. It is possible that red-
eared sliders require more than 30 days to mount an antibody response, as it has similarly been 
determined that tortoises take 6 to 8 weeks to mount an immune response to Mycoplasma 
infection. Alternatively, it is possible that a cell-mediated response is responsible for the 
protection to ranavirus in chelonians, which has been described as a component of the immune 
response in Xenopus. However, Xenopus also produces an antibody response, but it is not 
detected until after a second infection.  Therefore, future experiments should challenge turtles 
with a non-lethal ranavirus infection and then re-infect after a period of time and investigate for 
presence of antibodies. 
 Other non-specific mechanisms that characterize the immune response to ranavirus in 
turtles are also needed. Hematology was shown to not be helpful in diagnosing infections, which 
has been my experience with other reptilian diseases as well. However, it is possible that a spike 
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in WBC or other changes might have been missed by the twice-weekly sampling intervals. 
Future studies should sample more frequently after infection to determine if a measurable 
response is observed. One aspect of the clinical pathology that did show changes was the 
measured total solids. Total solids are composed of many different types of compounds, mainly 
proteins, and including immunoglobulins. Future studies should investigate not only protein 
electrophoresis to characterize the immunologic response, but also acute phase proteins. Acute 
phase proteins are well-conserved among all vertebrates, and have been used to characterize 
acute disease responses in these animals.   Currently, there are plans to add this diagnostic test to 
the ongoing long-term box turtle study in Tennessee.    
 The treatment of ranavirus in chelonians has not been successful for most cases. The 
development of therapies will be useful in managing captive cases, but also may be useful in 
managing endangered populations of free-ranging animals. Valcyclovir was shown to be 
detectable in box turtles, but its therapeutic use needs to be evaluated in a pharmacodynamics 
study. Additional treatment modalities need to be investigated as well, including the modulation 
of temperature. In a study that accidentally induced natural ranaviral disease when red-eared 
sliders were exposed to 16°C, the course of clinical signs reversed and resulted in only one 
mortality after the environmental temperature was changed to 28°C. This preliminary study 
indicates that temperature manipulation shows promise as a reasonable approach to managing 
captive animals, and that natural fluctuations in environmental temperature may serve as a 
control method for this virus in wild chelonians.  Future studies should perform similar treatment 
studies at a range of environmental temperatures to assess their effectiveness. Additionally, 
spatial and temporal studies characterizing the effects of ranavirus in wild populations of 
chelonians should evaluate the influence of temperature on outcome. 
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 In conclusion, the research in this dissertation answered several questions about the 
epidemiology of ranavirus in chelonians. But like any good project, it created more questions 
that need to be answered. Future research should investigate this disease and others that might be 
present and yet undetected. Surveillance for emerging pathogens is critical for the conservation 
of any species. The research presented here can be used as part of population management and 
planning, but also as a template to investigate the health and diseases of other reptile populations.  
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APPENDIX A 
METHODS TO DEVELOP AN ENZYME LINKED IMMUNOSORBENT ASSAY FOR 
DETECTION OF ANTIBODIES TO RANAVIRUS IN EASTERN BOX TURTLES AND 
RED-EARED SLIDERS 
 
Introduction 
The benefit of measuring exposure to infectious diseases cannot be understated.  Enzyme 
linked immunoassays (ELISA) have been previously used to successfully detect antibodies to 
different pathogens in chelonians (Ariel et al., 1995; Johnson et al., 2006). While ELISA has 
been used in one study to detect Ranavirus exposure in gopher tortoises and one population of 
repatriated box turtles in Pennsylvania
 
(Johnson et al., 2010), no wide scale effort has been 
performed in free-ranging box turtles in the southeast US. Utilization of this assay is extremely 
important for diseases, such as Ranavirus, that have high mortality in naive individuals, but 
potentially low morbidity during subclinical infections or reservoir individuals.  It is crucial to 
identify exposure in these individuals to determine a more accurate prevalence of the disease and 
potential risk to the population. 
Our specific hypotheses:  A newly developed enzyme-linked immunosorbent assay 
(ELISA) will be at least 80% sensitive and specific for detection of anti-Ranavirus antibodies, 
respectively.   
 
Materials and Methods 
Viral Isolate 
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A Ranavirus isolated and partially characterized from a naturally infected box turtle in 
Tennessee was used as the antigen in the development of the ELISA.  Briefly, polymerase chain 
reaction (PCR) targeting a portion of ranaviral major capsid protein genes followed by 
nucleotide sequencing demonstrated that the isolate shared 100% sequence identity of 
approximately 500 bp with the major capsid protein gene of Frog Virus 3.  
Antigen Preparation  
The Ranavirus isolate was grown in Terrapene heart cells (TH-1). Flasks were scraped 
when cells exhibited 100% cytopathic effects.  Uninfected flasks were concurrently processed in 
the same manner to serve as control antigen to detect any background cross reactivity of plasma 
to cellular proteins.  Cells and media were then transferred to 15ml tubes, centrifuged at 4,500xg 
for 30 minutes, and the supernatant discarded. The cell pellets were resuspended in residual 
media, frozen and thawed three times, thoroughly vortexed before and after each freeze cycle, 
and centrifuged again at 4,500xg for 30 minutes. PCR was performed to confirm the presence of 
viral DNA. 
ELISA Methods and Results Timeline 
An indirect ELISA was attempted to determine the presence of anti-Ranavirus antibodies similar 
to previous reports in red-eared sliders and ornate box turtles
 
(Johnson et al., 2010) and similarly 
used in identifying the presence of anti-tortoise herpesvirus and Mycoplasma antibodies in 
tortoises (Origgi et al., 2004). The FV3 isolate was used as the antigen in the assay.  
Mar 2011. Checkerboard. Initially, each well of a 96 well high-protein binding microplate 
(Immulon HB4X) was coated overnight at 4 C with 50 μl of two-fold serial dilutions 1:50 
through 1:800 dilution of either an uninfected lysate from Terrapene heart cells (TH-1, ATCC-
CCL 50, American Type Culture Collection, Rockville, MD) or TH-1 cell lysate from cells 
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infected with FV3.  Lysates were diluted in 0.01 M sodium phosphate buffer (pH 7.2) containing 
0.15 NaCl and 0.02% NaN3 (PBS/Azide).  Wells were washed four times in ELISA wash buffer 
(PBS/Azide with 0.05% Tween-20).  This washing process was repeated in between all of the 
following steps. Wells were blocked with 300 μl of Superblock blocking buffer (Pierce) for one 
hour at room temperature. All remaining steps will be incubated for one hour at room 
temperature. Positive plasma sample (“Old Lady” box turtle – from University of Florida) were 
added in 50μl volumes at a two-fold serial dilutions from 1:50 to 1:1600 in blocking buffer. The 
secondary antibody used was a biotin-conjugated mouse anti-tortoise immunoglobulin (Ig) 
monoclonal antibody diluted to a final intended concentration of 1μg/ml in blocking buffer, 
however initial dilution was inadvertently calculated to 0.1 μg/ml.  Alkaline phosphatase-
conjugated-streptavidin (Zymed Laboratories, Inc., San Francisco, CA) was applied to each well 
at 50 µL of a 1:2500 dilution in PBS/Azide. Next, 200 µl of a 1.0 mg/ml P-nitrophenyl 
phosphate (Ready to use formula, MP Biomedicals).  The optical density (OD) of each well will 
be read at A405 using a BioTek Synergy 2 ELISA reader microplate reader (Awareness 
Technology, Palm City, Florida, USA) after 30 minutes.   – No absorbance above baseline was 
detected in any sample. 
March 2011. Enzyme reaction test. Tested enzyme reaction step of alkaline-phosphatase 
streptavidin with pNPP in eppendorf tube.  Added 5 ul AP-streptavidin with 150 ul and 200 ul of 
pNPP in separate tubes, respectively.  Both turned a bright yellow color. Then diluted the AP-
streptavidin 1:1000 and 1:2500 and added to 200 ul of pNPP. Both turned yellow after 20-30 
minutes. 
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March 2011. Checkerboard. Created another checkerboard of positive and negative cell lysates  
(dilutions of 1:50 through 1:800) with positive (“Old Lady”) and negative turtle plasma 
(dilutions 1:50 through 1:800). – No absorbance above baseline was detected in any sample. 
April 2011. Troubleshooting plate. Loaded plate with serial dilutions of FV3 and turtle plasma 
directly (two-fold serial dilutions 1:10 through 1:320). Turtle plasma was a mixture of plasma 
from 15 turtles diluted in superblock buffer. Used 3 dilutions of monoclonal: 0.5 ug/ml, 1 ug/ml, 
2 ug/ml.  Diluted AP-streptavidin 1:1000 in PBS/Azide. – No absorbance above baseline was 
detected in any sample. 
April 2011. Checkerboard. Determined that original dilution of monoclonal was off by a factor 
of 10. Diluted monoclonal to 1 ug/ml and repeated checkerboard with plasma mixture and FV3. 
– No absorbance above baseline was detected in any sample. 
June 2011. Troubleshooting plate. Made fresh dilutions of turtle plasma in PBS/Azide in serial 
two-fold dilutions 1:8 through 1:4096. Made fresh dilutions of monoclonal antibody 1 ug/ml to 2 
ug/ml.  Made fresh dilution of AP-streptavidin 1:1000 in PBS/Azide.  Loaded rows A and B 
directly with turtle plasma mixture, row C directly with 1 ug/ml monoclonal, row D directly with 
2 ug/ml monoclonal, rows E and F directly with AP-streptavidin 1:1000. All wells showed a 
color change. This indicates that 1) the interaction between the unknown turtle plasma and 
monoclonal worked; 2) the monoclonal reacted with the streptavidin and; 3) the enzyme 
reaction between the streptavidin and pNPP worked. 
June 2011. Checkerboard with FV3 antigen dilutions and positive turtle plasma (“Old Lady”; 
“Smudge sample” – University of Florida; RES (+) – University of Florida). – No absorbance 
above baseline was detected in any sample. 
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July 2011. Checkerboard and troubleshooting. Made fresh dilutions of all buffers. Made fresh 
dilutions of antigen, positive and negative controls, monoclonal antibody, and AP-streptavidin. 
Obtained new ELISA plate (Nunc Maxisorp) that was used in previous published report 
(Johnson et al., 2010). Loaded row A through D with FV3, row E with turtle plasma, row F with 
monoclonal, and row G with streptavidin.  – No absorbance above baseline was detected in any 
sample loaded with FV3. All troubleshooting wells loaded directly with turtle plasma, 
monoclonal, and AP-streptavidin was observed WITH a color change.  This confirmed that 
the antigen or antigen-positive antibody complex were at fault. Need to investigate other 
potential positive controls as the ones used may not be good again. 
December 2011. New potential positive controls and new FV antigen. Received plasma from 14 
captive eastern box turtles form the Maryland Zoo that were collected in October 2011 
(Appendix B). The collection of turtles had experienced a ranavirus outbreak during June 
through August 2011. Prepared dilutions of two formulations of FV3 (scraped cells frozen and 
thawed, in addition to previous method of freeze/thaw cell culture flask). Loaded rows A through 
C with FV3 antigen dilutions and Maryland zoo plasma dilutions. Loaded rows D and E with 
Maryland zoo turtle plasma, row F with monoclonal, and row G with AP-streptavidin. – No 
absorbance above baseline was detected in any sample from rows A through C. Rows D 
through G all showed a color change. This demonstrated that the ELISA worked for the same 
turtle plasma that failed to react with FV3.  
January 2012. New positive controls. Tested plasma from experimentally infected red-eared 
sliders.  Plasma was harvested from all six turtles that became infected from the last time they 
were sampled. – No absorbance above baseline was detected in any sample, except for 
troubleshooting rows (see above). 
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Conclusions and Future Directions 
 The ELISA that attempted to detect anti-FV3-like virus antibodies in turtles in this study 
failed to work. The troubleshooting identified either the viral antigen or the positive control as 
the steps that failed. FV3-like virus has been shown to be in the enveloped or non-enveloped 
form. It is possible that virus isolation produced either form exclusively and that antibodies are 
only made to the opposite form.  However, virus isolation techniques were similar to other 
reports. Alternatively, it is possible that the FV3 antigen failed to bind to the plate. However, this 
appears unlikely because other proteins (unknown plasma, monoclonal) on the same plate bound 
well and were detected.  
 Even though the FV3-like viral antigen may be the cause of failure, the more probable 
cause is the lack of a true positive control. As has been described in this dissertation, the acute 
nature of the disease may fail to allow enough time to produce antibodies. And the original 
positive controls that were used in this study were generated from other studies at the University 
of Florida and were several years old and stored in blocking buffer. This may have rendered 
these positive controls ineffective. Additionally, it has been shown that primary infection of 
FV3-like virus does not produce antibodies in Xenopus, but upon reinfection an active IgY 
response occurs. This could account for why our experimentally infected turtles failed to react. 
 Future studies should evaluate several possibilities: 1) Determine using electron 
microscopy if the FV3-like virus is bound to the ELISA plate; 2) Determine the form (enveloped 
or non-enveloped) of virus that is present in the sample; and 3) Develop a true positive control 
by following experimentally infected turtles out to 3-4 months and during re-infection. 
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APPENDIX B 
BRIEF DESCRIPTION OF THE APPLICATION OF A NEWLY DEVELOPED QPCR FOR 
MONITORING AN ONGOING OUTBREAK OF FV3-LIKE DISEASE IN A CAPTIVE 
EASTERN BOX TURTLE COLLECTION 
 
Introduction 
 Twenty-two eastern box turtles from the Maryland zoo began to show signs of ranaviral 
infection during the summer of 2012. Initial diagnosis was made on necropsy tissues using 
conventional PCR at the University of Florida.  After confirmation, qPCR that was developed 
during this dissertation (Allender et al., 2012a) was applied to monitor the progression of 
disease. This is a brief report that describes the methods and results that were performed. 
 
Materials and Methods 
Quantitative PCR.  DNA was extracted from swabs and whole blood using the DNA mini kit 
following the manufacturer protocols (Qiagen, Valencia, CA, USA).  Real-time qPCR assays 
were performed using a real-time PCR thermocycler (7500 ABI, MFR) and data was analyzed 
using associated software (SDS, MFR).  Sense (GCTGCCAAGATGTCGGGTAA) and anti-
sense (AACGCCGACCGAAAACTG) primers were used to identify a 65 bp segment of the frog 
virus 3 major capsid protein. Each TaqMan reaction contained 12.5 μl TaqMan Platinum PCR 
Supermix-UDG with ROX, 1.25 μl TaqMan primer-probe, 2.5 μl FV3 dilution, and water to a 
final concentration of 25 μl.  Cycling parameters for all assays (SYBR green and TaqMan) were 
as follows: 1 cycle at 50°C for 2 minutes followed by 95°C for 10 minutes, then 40 cycles at 
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95°C for 15 seconds and 60°C for 60 seconds, and a final cycle of 72°C for 10 minutes.  A 
standard curve was performed on each 96 well plate using a control plasmid containing FV3. 
Statistical Analysis.  Categorical variables were evaluated over time using the Cochran’s Q test.  
Specific between group differences were evaluated using the McNemar test. Non-normally 
distributed continuous variables were evaluated over time using the Freidman’s ANOVA. 
Specific between group differences were evaluated using the Wilcoxon Signed Ranks test. 
 
Results 
There were significant differences over time in prevalence (p<0.0001).  The prevalence 
of ranavirus was higher in July than late August (p=0.39) and September (p=0.001), and between 
early August and September (p=.031).  There was no difference between the prevalence of 
ranavirus in July and early August (p=0.219), early August and late August (p=0.25), and late 
August and September (p=0.25).  (Table 1). 
The number of viral copies were significantly different over time (p<0.0001) (Table 2).  
There were significantly more ranaviral copies detected in July than September (p=0.003) and 
early August than September (p=0.028).  There were no other significant differences between 
dates in viral copies (Table 2). Of positive animals, median viral copies were highest in late 
August (Table 3).   
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Table B.1.  Prevalence of ranavirus DNA detected from oral swabs using quantitative PCR in 
captive eastern box turtles.  
Date n Positive (%) Negative (%) 
July 22 72.7 27.3 
August (early) 18 50 50 
August (late) 16 31.3 68.8 
September 15 0 100 
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Table B.2.  Number of ranaviral copies detected from oral swabs determined by quantitative 
PCR in all positive and negative captive eastern box turtles. 
Date n Median 10-90% iles Min-Max 
July 22 78558.22 0 – 2.16 * 
10
9
 
0 – 5.12 * 
10
9
 
August 
(early) 
16 66937660.5 0 – 1.44 * 
10
9
 
0 – 4.78 
*10
9
 
August (late) 15 925348.3 0 – 7.78 * 
10
8
 
0 – 2.096 
*10
9
 
September 15 0 0 - 0 0 - 0 
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Table B.3.  Number of ranaviral copies detected from oral swabs determined by quantitative PCR in only positive captive eastern box 
turtles. 
Date n Median 10-90% iles Min-Max 
July 16 7062831.6 14271.77 – 3.36 * 109 8097.25 – 5.12 * 109 
August (early) 9 91085900 1850696.6 – 4.78 * 108 1850696.6 – 2.096 * 109 
August (late) 5 2463556.8  78753.23 – 2.39 * 109 78753.23 – 4.79 * 109 
 
  
  202 
APPENDIX C 
 
DEVELOPMENT AND VALIDATION OF TWO SYBR GREEN QUANTITATIVE PCR 
ASSAYS FOR DETECTION OF FROG VIRUS 3-LIKE VIRUS IN EASTERN BOX 
TURTLES (TERRAPENE CAROLINA CAROLINA) 
 
Abstract: Ranavirus has caused disease epidemics and mass mortality events globally in free-
ranging fish, amphibian, and reptile populations. Viral isolation and conventional PCR are the 
most common methods for diagnosis. In this study, quantitative real-time PCR (qPCR) assays 
were developed using two distinct SYBR Green primer set assays all derived from a highly 
conserved region of the major capsid protein of frog virus 3 (Family Iridoviridae, genera 
Ranavirus). Standard curves were generated using each primer set from a viral DNA segment 
cloned within a plasmid. One SYBR Green assay detected viral DNA 1000 times lower than 
conventional PCR. Thirty-one clinical samples (whole blood and oral swabs) from box turtles 
were tested using these assays and the prevalence of the virus determined. Quantitative PCR 
allows for a superior, rapid, sensitive, and quantitative method for detecting Ranavirus in box 
turtles, and this assay will be useful for early detection and disease monitoring. 
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Introduction 
Diagnostic assays that are validated and optimized to detect the presence of pathogens in 
certain species are key to characterizing the disease and understanding disease ecology. 
Quantitative real-time PCR (qPCR) has been previously developed for detection of ranavirus in 
turtles using TaqMan (Allender et al., 2012a). 
 The purpose of this study was to develop and evaluate different diagnostic methods for 
characterizing an emerging pathogen, frog virus 3-like virus (FV3; genera Ranavirus, Family 
Iridoviridae) in box turtles. The hypotheses tested in this study were that qPCR SYBR green 
based assays would be both sensitive and specific for characterizing FV3-like virus in box 
turtles. This is essential when considering the application of these assays to additional free-
ranging populations and/or experimental models. Furthermore, it allows for evaluating potential 
climatic and environmental impacts of the disease, treatment, and management options.   
 
Materials and Methods 
 DNA extraction, conventional PCR, sequencing, and cloning was performed as 
previously described for these same samples (Allender et al., 2012a). 
SYBR qPCR Assay 
 Primer sets for SYBR green (SYBR-BTR 1 and 2) based qPCR were designed using a 
commercial software program based qPCR assay were designed using a commercial software 
program (Primer Express
®
, Applied Biosystems, Carlsbad, CA) based on published sequences of 
the major capsid protein of FV3 (Mao et al., 1997).   Real-time qPCR assays were performed 
using a real-time PCR thermocycler (7500 ABI real-time PCR System, Applied Biosystems, 
Carlsbad, CA) and data was analyzed using associated software (Sequence Detection Software 
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v2.05, Applied Biosystems, Carlsbad, CA).
.
 Each SYBR-Green reaction were performed with a 
25 μl total reaction containing 12.5 μl of 2X SYBR green Mastermix,i 0.25 pmoles sense and 
anti-sense primers, 2.5 μl turtle-derived FV3 dilution, and 9.5 μl dH20. Cycling parameters for all 
assays were as follows: 1 cycle at 50°C for 2 minutes followed by 95°C for 10 minutes, then 40 
cycles at 95°C for 15 seconds and 60°C for 60 seconds, and a final cycle of 72°C for 10 minutes. 
Standard curve, Specificity, and Sensitivity 
 Specificity of positive results from SYBR green reactions were confirmed on purified and 
cloned PCR products using sequencing. To determine the sensitivity, assays were performed in 
three technical repeats on dilutions of turtle-derived positive control plasmid of FV3 MCP DNA 
(5.29x10
9
 - 5.29x10
1
 copies/rxn) within a single run. Standard curves were generated using the 
cycle threshold (Ct) values of the positive control plasmid dilutions. Intra-assay variation was 
determined for both assays by calculating the mean Ct values, standard deviations (SD), and 
coefficient of variations (CV) separately for each control plasmid DNA dilution.  
Box turtle samples 
 Thirty-one eastern box turtles that were presented to the University of Tennessee College 
of Veterinary Medicine Wildlife clinic were examined during March through October 2007. 
Whole blood and swabs of the oral cavity were collected as previously described (Allender et al., 
2011). The University of Tennessee Institutional Animal Use and Care Committee approved all 
animal use (protocol 1864).  Whole blood and oral swab extracts of samples from animals with 
unknown disease status were evaluated using both SYBR-BTR 1. Results for detection were 
compared to published conventional PCR results for the same samples (Allender et al., 2011).   
Statistical Analysis 
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 The quantity of ranavirus target DNA in infected whole blood and oral swabs was 
determined using a standard curve method. The copy number of the target DNA was determined 
from the standard curve generated with ten-fold dilutions of the positive control plasmid that 
contained the target sequence of the respective qPCR assay. 
 Copy numbers were tabulated and evaluated for normality using the Shapiro-Wilk test.  
Mean, median, standard deviation, 95% confidence interval, and 10-90% percentiles were 
determined for positive cases (copy number) for each assay. The Mann-Whitney U test was used 
to evaluate between assay differences. The prevalence of ranavirus was determined for each 
assay (categorical variable assigned; 1=positive, 0=negative). Exact 95% binomial confidence 
intervals were determined for all proportions. Level of agreement (kappa) was determined 
between both the real-time PCR assays and the conventional PCR previously reported based on 
prevalence.  All statistical analysis was performed using statistical software (IBM SPSS 
Statistics 20, Chicago, IL). 
 
Results 
Conventional PCR was performed to evaluate turtle-derived FV3-like virus dilutions 
using both MCP 4 and SYBR- BTR 1. The SYBR primer sets were designed to detect various 
length gene segments of a conserved portion of the MCP gene of FV3 (Table 1).   The SYBR-
BTR 1 primer pairs successfully amplified the 113 bp segment with a single melting point of 
84.90 ± 0.26°C (Figure 1a).  The SYBR-BTR 2 primer pairs amplified a 110 bp segment with a 
single melting point of 86.28 ± 0.37°C (Figure 1b). These results were validated as specific 
amplifications with sequencing and gel electrophoresis  (Figure 4).   
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 Serial ten-fold dilutions of positive control plasmids were assayed with SYBR- BTR 1 
and SYBR- BTR 2 primer pairs and standard curves were generated based on Ct values (Figure 
2).  The linear range for SYBR-BTR 1 and SYBR-BTR 2 qPCR was seen between 5.29 x 10
9
 to 
5.29 x 10
4
 viral copies with coefficients of variation (R
2
) of 0.997 (slope = -3.164) and 0.997 
(slope = -3.182), respectively.  
 The intra- and inter-assay reproducibility was evaluated for the serial dilutions of the 
control plasmids (Table 2). The intra-assay CVs for SYBR-BTR and SYBR-BTR 2 were 
between 0.06 – 0.57% and 0.07 – 0.59%, respectively. The inter-assay CVs were 0.1 – 0.68% 
and 0.19 – 3.66%, respectively. These results indicate high reproducibility between assays for 
SYBR-BTR 1 at all dilutions and for dilutions with greater than 10
4
 concentration of FV3 in 
SYBR-BTR 2. 
When using conventional PCR to amplify the gene segments and gel electrophoresis, the 
level of detection using MCP 4 and SYBR-BTR 1 primers was 5.29 x 10
5
 and 5.29 x 10
3
 viral 
copies per reaction, respectively. The dynamic range for qPCR assays at which point the Ct 
value of the triplicates were variable or amplification plot was reliable was from 5.29 x 10
9
 to 
5.29 x 10
1
 for SYBR-BTR 1 and 5.29 x 10
9
 to 5.29 x 10
4
 for SYBR-BTR 2. 
Box turtle samples 
 Twenty-nine blood samples and thirty oral swabs were collected routinely from turtles 
presented to the University of Tennessee from March through October 2007. Characteristics 
from these samples are presented elsewhere (Allender et al., 2012a) Quantitative PCR 
determined the presence of ranavirus in blood was 3% (95% CI:0-9) using the SYBR-BTR 
primer set. Prevalence of ranavirus in the oral swab samples was also 3% (95% CI:0-9).  Mean 
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viral quantity in blood for the single animal that was positive using both SYBR-BTR was 2.67 x 
10
8
. The mean viral copies in the swab sample from the same individual were 2.8 x 10
9
.  
 
Discussion 
 Within each assay there was a difference in level of detection (dynamic range) as well as 
specificity. The level of detection determined by Ct value, low CV, and melting curve analysis 
were 5.29 x 10
5
 and 52 for the SYBR-BTR 2 and SYBR-BTR, respectively. The level of 
detection included a lower viral copy than the linear range for each of the three assays.  The 
linear range was more reliable for quantification of higher viral copies than lower viral copies. It 
is likely that primer concentrations need to be optimized for low viral copy numbers, resulting in 
a separate protocol based on viral copy.  Future studies should lower primer concentrations in 
assays with viral copies less than 5.29 x 10
4
 to establish a linear range that is more reliable for 
quantification.  In the absence of that optimization, the developed assays are reliable for absolute 
quantification of ranaviral DNA, with greater than 5.29 x 10
4
 viral copies and relative 
quantification for the entire dynamic range. 
Critical threshold values were lower in both SYBR probes than the TaqMan assay 
previously reported (Allender et al., 2012a). Non-specific products, such as primer-dimers, are 
quantified in SYBR assays and are likely responsible. Additionally, TaqMan assays utilize a 
third selection step (probe), which provides for greater specificity not seen with SYBR assays. 
The higher Ct values seen at the same dilutions may be due to either amplification being slowed 
in this TaqMan step or due to the lack of strong specificity in detecting true templates of the 
SYBR assays. 
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All assays had highly reproducible results with intra- and inter-assay variability 
coefficient of variation of less than 5%.  The primers were designed to be specific for a segment 
of the major capsid protein gene that previous studies have targeted with conventional PCR (Mao 
et al., 1997).  
DNA from twenty-nine blood samples and thirty oral swabs were then screened for 
ranavirus.  These samples were selected because they had previously been screened using 
conventional PCR and qPCR (Allender et al., 2011; Allender et al., 2012a). The results indicate 
that the SYBR-BTR quantitative PCR assay developed in this study was able to identify the 
same number of FV3-like virus positive samples. This may signify that this population of turtles 
indeed had a low prevalence of FV3-like virus (not infected), were not shedding ranavirus in the 
sample, or did not have enough viral copies to return a positive result. The epidemiology of 
ranavirus in turtles is not known, and therefore it is possible that when a susceptible individual is 
exposed to the virus, it either replicates to a level above 529,000 viral copies (conventional PCR 
level of detection) or does not replicate well.  This would explain the results of conventional 
PCR and qPCR being similar.  Regardless of the viral copies present in a clinical animal (as 
represented by these samples), early and subclinical detection will provide a valuable tool for 
control, monitoring, and management of this disease. To further elucidate the sensitivity of these 
assays compared with conventional PCR, it will be important to apply it to a set of experimental 
samples where the prevalence of disease is high. As such, the quantitative assays reported here 
may be more useful in detecting and tracking the persistence and development of disease as 
clinical animals are overwhelmed with similar viral loads. 
Purity of DNA, determined by A260/A280 ratio, was within the ideal range (1.7 – 1.9) 
based on extraction guidelines for both whole blood and swab samples. However, the ratio was 
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non-normally distributed for swab samples and the range was greater than whole blood samples. 
When the purity of the sample is outside the ideal range, it can lead to a decrease in assay 
efficiency or an increase in non-specific parameters and inaccurate results. Therefore, purity 
should be evaluated prior to qPCR assay for all swab samples and samples outside the ideal 
range should be further purified before assaying. 
 The current study demonstrated that two SYBR green assays are reliable, specific, and 
sensitive for the detection of a gene segment of the MCP of frog virus 3.  
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Table C.1.  Primer and primer-probe sets used to amplify the major capsid portion of frog virus 3-like virus using conventional and 
quantitative PCR. 
Assay Primer name Direction Sequence 5’ . . . 3’ Expected 
amplicon size 
qPCR SYBR-BTR 1 Sense GACGCTCTCCACAATGTTG 113 
  Anti-sense CCTGGTTGGTGCTCAAGAC 113 
 SYBR-BTR 2 Sense AACCAGGCGTTGAGGATG 110 
  Anti-sense TTCACCAAGCTGCCGTCT 110 
Conventional PCR SYBR-BTR Sense GACGCTCTCCACAATGTTG 113 
  Anti-sense CCTGGTTGGTGCTCAAGAC 113 
 MCP 4 (Mao)  GACTTGGCCACTTATGAC 531 
   GTCTCTGGAGAAGAAGAA 531 
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Table C.2.  Intra- and inter-assay variability of two SYBR green and one TaqMan qPCR assays detecting frog virus 3 major capsid 
protein. 
 Intra-assay Inter-assay 
Viral Copy 
CT 
mean 
CT 
SD CV Melting point CT mean CT SD CV 
Melting 
point 
SYBR-BTR 
1         
5290000000 11.85 0.08 0.57% 84.83 11.86 0.07 0.52% 84.86 
529000000 15.14 0.04 0.21% 84.99 15.14 0.03 0.19% 85.02 
52900000 18.59 0.03 0.14% 85.11 18.62 0.05 0.24% 85.1 
5290000 21.95 0.02 0.06% 85.23 21.96 0.02 0.10% 85.2 
529000 24.94 0.03 0.09% 85.15 24.96 0.03 0.10% 85.13 
52900 27.45 0.09 0.29% 84.99 27.47 0.08 0.26% 84.95 
5290 28.81 0.12 0.36% 84.74 28.8 0.09 0.29% 84.79 
529 29.48 0.03 0.08% 84.61 29.6 0.15 0.48% 84.56 
52 29.72 0.10 0.29% 84.46 29.81 0.13 0.40% 84.49 
NTC 31.35 0.13  83.00 31.48 0.23 0.68% 82.75 
 
SYBR-BTR 
2         
5290000000 11.76 0.02 0.14% 86.64 11.8 0.04 0.31% 86.62 
529000000 15.03 0.02 0.09% 86.68 15.07 0.04 0.27% 86.68 
52900000 18.54 0.02 0.10% 86.64 18.58 0.05 0.23% 86.62 
5290000 21.85 0.02 0.08% 86.56 21.88 0.05 0.19% 86.56 
529000 24.85 0.02 0.07% 86.40 24.9 0.05 0.20% 86.38 
52900 27.34 0.05 0.17% 86.07 27.37 0.06 0.19% 86.1 
5290 28.63 0.21 0.59% 85.74 28.2 1.15 3.66% 85.67 
529 29.33 0.05 0.15% 85.85 29.48 0.16 0.51% 85.87 
52 30.07 0.13 0.37% 85.95 30.11 0.15 0.46% 85.96 
NTC 31.85 0.35  86.01 32.13 0.34 0.98% 85.94 
 
